<!DOCTYPE html>

<html lang="en">


<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
      
      
        <link rel="prev" href="../Immunology/">
      
      
      
      <link rel="icon" href="../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.5.3, mkdocs-material-9.5.12">
    
    
<title>Literature Survey (VPE)</title>

    
      <link rel="stylesheet" href="../assets/stylesheets/main.7e359304.min.css">
      
        
        <link rel="stylesheet" href="../assets/stylesheets/palette.06af60db.min.css">
      
      


    
    
  <!-- Add scripts that need to run before here -->
  <!-- Add jquery script -->
  <script src="https://code.jquery.com/jquery-3.7.1.js"></script>
  <!-- Add data table libraries -->
  <script src="https://cdn.datatables.net/2.0.1/js/dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/2.0.1/css/dataTables.dataTables.css">
  <!-- Load plotly.js into the DOM -->
	<script src='https://cdn.plot.ly/plotly-2.29.1.min.js'></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/buttons/3.0.1/css/buttons.dataTables.css">
  <!-- fixedColumns -->
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/dataTables.fixedColumns.js"></script>
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/fixedColumns.dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/fixedcolumns/5.0.0/css/fixedColumns.dataTables.css">
  <!-- Already specified in mkdocs.yml -->
  <!-- <link rel="stylesheet" href="../docs/custom.css"> -->
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/dataTables.buttons.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.dataTables.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/jszip/3.10.1/jszip.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/pdfmake.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/vfs_fonts.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.html5.min.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.print.min.js"></script>
  <!-- Google fonts -->
  <link rel="stylesheet" href="https://fonts.googleapis.com/icon?family=Material+Icons">
  <!-- Intro.js -->
  <script src="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/intro.min.js"></script>
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/minified/introjs.min.css">


  <!-- 
      
     -->
  <!-- Add scripts that need to run afterwards here -->

    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../assets/_mkdocstrings.css">
    
      <link rel="stylesheet" href="../custom.css">
    
    <script>__md_scope=new URL("..",location),__md_hash=e=>[...e].reduce((e,_)=>(e<<5)-e+_.charCodeAt(0),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

<header class="md-header" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href=".." title="Literature Survey for Swathi" class="md-header__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2Z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Literature Survey for Swathi
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Oncology
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6zm0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4zM7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3Z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var media,input,key,value,palette=__md_get("__palette");if(palette&&palette.color){"(prefers-color-scheme)"===palette.color.media&&(media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']"),palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent"));for([key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
      </label>
      <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
      <div class="md-header__source">
        <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
            
<nav class="md-tabs" aria-label="Tabs" data-md-component="tabs">
  <div class="md-grid">
    <ul class="md-tabs__list">
      
        
  
  
  
    <li class="md-tabs__item">
      <a href=".." class="md-tabs__link">
        
  
    
  
  Home

      </a>
    </li>
  

      
        
  
  
  
    <li class="md-tabs__item">
      <a href="../Immunology/" class="md-tabs__link">
        
  
    
  
  Immunology

      </a>
    </li>
  

      
        
  
  
    
  
  
    <li class="md-tabs__item md-tabs__item--active">
      <a href="./" class="md-tabs__link">
        
  
    
  
  Oncology

      </a>
    </li>
  

      
    </ul>
  </div>
</nav>
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
                
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" hidden>
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    


  


<nav class="md-nav md-nav--primary md-nav--lifted" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href=".." title="Literature Survey for Swathi" class="md-nav__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    Literature Survey for Swathi
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href=".." class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Home
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../Immunology/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Immunology
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
    
  
  
  
    <li class="md-nav__item md-nav__item--active">
      
      <input class="md-nav__toggle md-toggle" type="checkbox" id="__toc">
      
      
      
      <a href="./" class="md-nav__link md-nav__link--active">
        
  
  <span class="md-ellipsis">
    Oncology
  </span>
  

      </a>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
                
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              <article class="md-content__inner md-typeset">
                
                  

  
  


  <h1>Oncology</h1>

<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
</head>

<body>
  <p>
  <i class="footer">This page was last updated on 2026-02-02 09:38:35 UTC</i>
  </p>

  <div class="note info" onclick="startIntro()">
    <p>
      <button type="button" class="buttons">
        <div style="display: flex; align-items: center;">
        Click here for a quick intro of the page! <i class="material-icons">help</i>
        </div>
      </button>
    </p>
  </div>

  <!--
  <div data-intro='Table of contents'>
    <p>
    <h3>Table of Contents</h3>
      <a href="#plot1">1. Citations over time on Oncology</a><br>
      <a href="#manually_curated_articles">2. Manually curated articles on Oncology</a><br>
      <a href="#recommended_articles">3. Recommended articles on Oncology</a><br>
    <p>
  </div>

  <div data-intro='Plot displaying number of citations over time 
                  on the given topic based on recommended articles'>
    <p>
    <h3 id="plot1">1. Citations over time on Oncology</h3>
      <div id='myDiv1'>
      </div>
    </p>
  </div>
  -->

  <div data-intro='Manually curated articles on the given topic'>
    <p>
    <h3 id="manually_curated_articles">Manually curated articles on <i>Oncology</i></h3>
    <table id="table1" class="display" style="width:100%">
    <thead>
      <tr>
          <th data-intro='Click to view the abstract (if available)'>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th data-intro='Highest h-index among the authors'>Highest h-index</th>
          <th data-intro='Recommended articles extracted by considering
                          only the given article'>
              View recommendations
              </th>
      </tr>
    </thead>
    <tbody>

        <tr id="Sustained smouldering, or low-grade activation, of myeloid cells is a common hallmark of several chronic neurological diseases, including multiple sclerosis1. Distinct metabolic and mitochondrial features guide the activation and the diverse functional states of myeloid cells2. However, how these metabolic features act to perpetuate inflammation of the central nervous system is unclear. Here, using a multiomics approach, we identify a molecular signature that sustains the activation of microglia through mitochondrial complex I activity driving reverse electron transport and the production of reactive oxygen species. Mechanistically, blocking complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in an animal disease model in vivo. Complex I activity in microglia is a potential therapeutic target to foster neuroprotection in chronic inflammatory disorders of the central nervous system3. Blocking mitochondrial complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in vivo in an animal disease model.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf" target='_blank'>
                Mitochondrial complex I activity in microglia sustains neuroinflammation
                </a>
              </td>
          <td>
            L. Peruzzotti-Jametti, C. Willis, G. Krzak, R. Hamel, L. Pirvan, Rosana-Bristena Ionescu, J. Reisz, H. Prag, M. E. Garcia-Segura, V. Wu, Y. Xiang, B. Barlas, A. Casey, A. van den Bosch, A. Nicaise, L. Roth, G. R. Bates, H. Huang, P. Prasad, A. E. Vincent, C. Frezza, C. Viscomi, G. Balmus, Z. Takáts, J. Marioni, A. D'alessandro, M. P. Murphy, I. Mohorianu, S. Pluchino
          </td>
          <td>2024-03-13</td>
          <td>Nature</td>
          <td>142</td>
          <td>31</td>

            <td><a href='../recommendations/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

        <tr id="The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the dynamics of early cellular responses to this disease remains limited1. Here in our SARS-CoV-2 human challenge study, we used single-cell multi-omics profiling of nasopharyngeal swabs and blood to temporally resolve abortive, transient and sustained infections in seronegative individuals challenged with pre-Alpha SARS-CoV-2. Our analyses revealed rapid changes in cell-type proportions and dozens of highly dynamic cellular response states in epithelial and immune cells associated with specific time points and infection status. We observed that the interferon response in blood preceded the nasopharyngeal response. Moreover, nasopharyngeal immune infiltration occurred early in samples from individuals with only transient infection and later in samples from individuals with sustained infection. High expression of HLA-DQA2 before inoculation was associated with preventing sustained infection. Ciliated cells showed multiple immune responses and were most permissive for viral replication, whereas nasopharyngeal T cells and macrophages were infected non-productively. We resolved 54 T cell states, including acutely activated T cells that clonally expanded while carrying convergent SARS-CoV-2 motifs. Our new computational pipeline Cell2TCR identifies activated antigen-responding T cells based on a gene expression signature and clusters these into clonotype groups and motifs. Overall, our detailed time series data can serve as a Rosetta stone for epithelial and immune cell responses and reveals early dynamic responses associated with protection against infection. A human SARS-CoV-2 challenge study in individuals without previous exposure to the virus or vaccines provides detailed profiles of local and systemic epithelial and immune cell response dynamics over time and infection status.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/380489b0c6f9106219184f0c5fe6612e0b4e165a" target='_blank'>
                Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
                </a>
              </td>
          <td>
            Rik G. H. Lindeboom, Kaylee B. Worlock, L. Dratva, M. Yoshida, David Scobie, Helen R. Wagstaffe, Laura Richardson, A. Wilbrey-Clark, Josephine L. Barnes, Lorenz Kretschmer, K. Polański, J. Allen-Hyttinen, Puja Mehta, D. Sumanaweera, J. M. Boccacino, W. Sungnak, R. Elmentaite, Ni Huang, L. Mamanova, R. Kapuge, L. Bolt, E. Prigmore, B. Killingley, M. Kalinova, Maria Mayer, A. Boyers, Alex J. Mann, Leo Swadling, M. Woodall, Samuel Ellis, Claire M. Smith, V. Teixeira, Sam M. Janes, R. Chambers, M. Haniffa, A. Catchpole, R. Heyderman, M. Noursadeghi, Benjamin M. Chain, Andreas Mayer, Kerstin B. Meyer, Christopher Chiu, Marko Z. Nikolić, Sarah A. Teichmann
          </td>
          <td>2024-06-19</td>
          <td>Nature</td>
          <td>80</td>
          <td>76</td>

            <td><a href='../recommendations/380489b0c6f9106219184f0c5fe6612e0b4e165a' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
          <th>View recommendations</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

  <div data-intro='Recommended articles extracted by contrasting
                  articles that are relevant against not relevant for Oncology'>
    <p>
    <h3 id="recommended_articles">Recommended articles on <i>Oncology</i></h3>
    <table id="table2" class="display" style="width:100%">
    <thead>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </thead>
    <tbody>

        <tr id="Identifying host factors that mediate protection against newly-emergent viruses is needed for improved pandemic preparedness. Here, we analysed pre- and early post-exposure immune factors associated with resisting SARS-CoV-2 infection after human challenge in seronegative individuals, using multiplex protein, cytometric and RNA sequencing approaches in the nasopharynx and circulation. Pre-existing cross-reactive antibodies correlate poorly with clinical outcome. Instead, protection is associated with heightened nasopharyngeal CCL13 levels locally produced by conventional dendritic cells and monocytes, along with cross-reactive T cells and less differentiated NK cells. Conditional independence network analysis implicates nasal CCL13 as the central node connected to pre-existing non-structural protein-specific T cells by CD1c+ DCs. In those who became infected, baseline cross-reactive T cell and less differentiated NK cell frequencies also correlate with shorter infection duration. Thus, pre-existing mucosal chemokine levels may promote rapid innate and innate-like responses that effectively block infection. ClinicalTrials.gov identifier NCT04865237. Human challenge studies with SARS-CoV-2 have shown changes in the innate and adaptive immune response. Here the authors are examining potential correlates of infection in virus challenged recipients by assessing baseline immune parameters and how this predicts virus control.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/491d4d516b113109ac72078677aee9124493f965" target='_blank'>
              Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Helen R. Wagstaffe, R. Thwaites, Jasmin K. Sidhu, Rik G. H. Lindeboom, Lorenz Kretschmer, Kaylee B. Worlock, L. Dratva, Ao Huang, S. Ascough, L. Papargyris, Richard McKendry, Ashley M. Collins, Jiayun Xu, Nana-Marie Lemm, Ben Killingley, M. Kalinova, Alex J. Mann, A. Catchpole, Leo Swadling, J. Tsang, MK Maini, M. Noursadeghi, Marko Z. Nikolić, Sarah A. Teichmann, P. Openshaw, Christopher Chiu
          </td>
          <td>2025-12-07</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5f1f74512f2c8fb2837ffe4b5130c19b0f4eb9b9" target='_blank'>
              Primary Human Reactive Microglia Display Mitochondrial Dysfunction and Metabolic Imbalance Upon Lipopolysaccharide Exposure
              </a>
            </td>
          <td>
            Gabriel Fontes, Lívia de Sá Hayashide, Daniel Fernandes Messor, Mariana Marques, Vitor Emanuel Leocadio, Pedro Amorim, A. Minho, Elaine Paiva-Pereira, L. Savio, Patricia Dias Fernandes, Rafael Serafim Pinto, L. P. Diniz
          </td>
          <td>2026-01-07</td>
          <td>Neurochemical Research</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Severe pneumonia is associated with an increased risk of cognitive decline and dementia, particularly in the elderly. Changes in microglia, the most abundant immune cell population in the brain, are also associated with cognitive decline and dementia, including the emergence of a transcriptional cell state referred to as disease-associated microglia (DAM). We sought to test the hypothesis that non-neuroinvasive influenza A virus (IAV) pneumonia results in transcriptional responses in brain microglia that drive premature expansion of DAM. Using bulk and single-cell RNA-sequencing, metabolomics, and spatial transcriptomics, we profiled neuroimmune populations in young, middle-aged, and old male mice during IAV infection and recovery. We observed an increased abundance of DAM, interferon-responsive microglia (IRM), CD4+ T cells, and CD8+ T cells in white matter regions beginning in middle age and persisting in old animals, irrespective of IAV infection. DAM exhibited a metabolic shift toward aerobic glycolysis with disrupted TCA cycling, citrulline depletion, and an elevated itaconate/α-ketoglutarate ratio. Spatial transcriptomic profiling of the human middle frontal gyrus (MFG) in normal agers, SuperAgers, and patients with dementia revealed an analogous accumulation of DAM and CD8+ T cells in white matter. IAV pneumonia induced a transient immunosenescent-like response in microglia, marked by glucocorticoid-responsive gene expression and Ccnd3 upregulation. In response to IAV pneumonia, DAM expanded in middle-aged mice, whereas old mice were elevated at baseline and were largely unaffected by IAV infection. The age-related expansion of DAM was unaffected by pharmacological depletion and repopulation of microglia with a CSF1R antagonist or genetic gain or loss of function of the phagocytic receptor MERTK, suggesting the DAM phenotype is driven by the CNS microenvironment, rather than cell-intrinsic mechanisms. Our findings suggest that IAV pneumonia induces an acute immunosenescence response in microglia and accelerates the age-dependent expansion of DAM in white matter.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0fda447848e1da3e24e80cd9f6f09a302a4923b4" target='_blank'>
              Influenza A infection accelerates disease-associated microglia formation during physiological aging
              </a>
            </td>
          <td>
            R. Grant, C. Runyan, Grace Minogue, J. Stoolman, Satoshi Watanabe, Fei Chen, Karolina J. Senkow, L. Cusick, M. Schleck, R. Nafikova, Ziyan Lu, E. Bunyan, H. Abdala-Valencia, Jacob I. Sznajder, Robert J. Vassar, Rudy J Castellani, Changiz Geula, T. Gefen, Navdeep S. Chandel, A. Misharin, G. S. Budinger
          </td>
          <td>2025-12-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="Aging and cerebrovascular pathology drive neuroinflammation in vascular dementia (VaD) but immune mechanisms underlying this interplay remain unresolved. Leveraging multi-modal high-dimensional imaging, flow cytometry, and split pool ligation transcriptomic sequencing in a mouse model of VaD, we constructed a brain immune cell atlas spanning young and aged mice in health and disease. We profiled microglia, T cells, macrophages, neutrophils, and B cells and integrated transcriptomics, cell-cell communication, multiplex imaging, and comparative analysis with human microglia. We found striking depletion of Ccr7+ naïve T cells and expansion of Gzmk+ cytotoxic Cd8+ effector memory T cells in the aging brain. At the same time, microglia shifted toward a pro-inflammatory state with enhanced activity of major histocompatibility class complex I (MHC-I) to T cell receptor and co-stimulation from CD86 to CD28. These shifts suggest enhanced neuroinflammatory polarization within the aged brain and in VaD. These signals were strongest from activated microglia to Gzmk+ Cd8+ TEM cells, indicating that age-related microglial polarization may sustain cytotoxic T cell activation in the aged brain. Our findings suggest pro-inflammatory microglia and Gzmk+ CD8+ TEM cells are central drivers of immune brain aging and highlights a therapeutic potential to disrupt age-related neuroinflammatory cascades in VaD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/42ac3a3908e79bc0f916a88d264039358a6730c2" target='_blank'>
              High-Dimensional Single-Cell Analysis Reveals Coordinated Age-Dependent Neuroinflammatory Microglia-T cell Circuits in the Brain
              </a>
            </td>
          <td>
            Md Akkas Ali, Md. Hasanul Banna Siam, Donald Vardaman, Chase Bolding, J. N. Brazell, Ashleigh D. Whatley, Christopher A. Risley, Harrison Tidwell, Syed Nakib Hossain, Juhi Samal, Ashley S. Harms, Mallikarjun Patil, Daniel J. Tyrrell
          </td>
          <td>2025-12-13</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Abstract Objectives Here, we characterised the diversity and persistence of immunological memory cells—particularly tissue‐resident memory T (TRM) and B (BRM) cells—in the nasopharyngeal lymphoid tissues of healthy vaccinated (HV) individuals and those who experienced SARS‐CoV‐2 breakthrough infection (BR). Methods Nasopharynx (NP) samples were obtained using brushing from HV and BR subjects. Immune cell populations were analysed using transcriptomic profiling and flow cytometry. Results Transcriptomic profiling revealed that the NP of SARS‐CoV‐2‐infected individuals exhibited distinctive signatures of lymphocyte‐mediated immunity, underscoring its role as a key site for viral invasion and immune activation. Effector memory CD4+ and CD8+ T (TEM) cells, along with non‐germinal center (GC) B cells, predominated in the NP. Although overall frequencies of memory T cells were comparable between HV and BR groups, CD4+ TEM and GC B cells were significantly enriched in the NP of BR individuals at least 1 year post infection. Notably, over 80% of CD4+ TEM and 40% of CD8+ TEM cells were TRM, and more than 30% of memory B cells exhibited a BRM phenotype. These populations of CD4+, CD8+ TRM and BRM persisted in the NP for over 2 years following SARS‐CoV‐2 infection or vaccination. In particular, CD4+ TRM cells were significantly more abundant and durably maintained in the NP mucosa of BR individuals. Conclusion Our findings identify the nasopharynx as a key site of long‐lived immunological memory, marked by persistent TRM and BRM cells after SARS‐CoV‐2 exposure.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c20bfe5c17c656c119446777c61d66a022e4c6a3" target='_blank'>
              Prolonged persistence of tissue‐resident memory cells in the upper airway following SARS‐CoV‐2 infection and vaccination
              </a>
            </td>
          <td>
            Hyunkyung Cha, J. Won, S. Kim, Suhyun Lim, Sujin Kim, Siyeon Jin, Sung-Dong Cho, Hyun Jik Kim
          </td>
          <td>2026-01-01</td>
          <td>Clinical & Translational Immunology</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1ebc988a2e535f97628e98387b125e8c2474e58f" target='_blank'>
              A CAR-T Cell-Based Strategy for Eliminating Pathogenic Microglia in ALS
              </a>
            </td>
          <td>
            M. Cicardi, Daniela Tejada-Martinez, S. Markandaiah, Karthik Krishnamurthy, Chiara Scopa, Brij Oza, Ivette Martorell Serra, Andrea Feci, Edoardo Manca, Adam E. Snook, A.R. Haeusler, P. Pasinelli, Davide Trotti
          </td>
          <td>2025-12-29</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="Long COVID (LC) involves a spectrum of chronic symptoms after acute severe acute respiratory syndrome coronavirus 2 infection. Current hypotheses for the pathogenesis of LC include persistent virus, tissue damage, autoimmunity, endocrine insufficiency, immune dysfunction and complement activation. We performed immunological, virological, transcriptomic and proteomic analyses from a cohort of 142 individuals between 2020 and 2021, including uninfected controls (n = 35), acutely infected individuals (n = 54), convalescent controls (n = 24) and patients with LC (n = 28). The LC group was characterized by persistent immune activation and proinflammatory responses for more than 180 days after initial infection compared with convalescent controls, including upregulation of JAK-STAT, interleukin-6, complement, metabolism and T cell exhaustion pathways. Similar findings were observed in a second cohort enrolled between 2023 and 2024, including convalescent controls (n = 20) and patients with LC (n = 18). These data suggest that LC is characterized by persistent activation of chronic inflammatory pathways, suggesting new therapeutic targets and potential biomarkers of disease. Long COVID (LC) involves a spectrum of chronic symptoms after resolution of acute severe acute respiratory syndrome coronavirus 2 infection. Barouch and colleagues show that LC is characterized by persistent activation of chronic inflammatory pathways and T cell exhaustion.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/aab56a374cbf5ee6260c69533626e491afa089f3" target='_blank'>
              Long COVID involves activation of proinflammatory and immune exhaustion pathways
              </a>
            </td>
          <td>
            Malika Aid, Valentin Boero-Teyssier, K. McMahan, R. Dang, Michael Doyle, Nazim Belabbaci, E. Borducchi, A. Y. Collier, J. Mullington, D. Barouch
          </td>
          <td>2025-12-12</td>
          <td>Nature Immunology</td>
          <td>1</td>
          <td>117</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/79b1d945bce38bd9f93dc15198bc867b0ca62223" target='_blank'>
              Disruption of the hypothalamic orexin system links SARS-CoV-2 infection to persistent cortical neuronal pathology
              </a>
            </td>
          <td>
            G. Yoon, , J. Choi, Yoon Ha, Se Yeon Seo, K. Ku, Do Yeon Kim, Woo Yeon Hwang, G. Jeong, Dae-Gyun Ahn, Kyun-Do Kim, Je-Keun Rhee, Won-Ho Shin, Young-Chan Kwon
          </td>
          <td>2026-01-23</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/674509938f9c563edb49d12a46467f6b4538fa2f" target='_blank'>
              Single-Cell Dissection of Immunometabolic Rewiring in the Porcine Ileum during Salmonella Typhimurium Infection
              </a>
            </td>
          <td>
            José M. Suárez-Cárdenas, Tomàs Montserrat-Ayuso, Mónica Alfonso-Núñez, A. Esteve-Codina, Raúl Fernández-Rodríguez, Antonio Romero-Guillén, Tránsito García-García, Cristina Arce, Amparo Martínez Martínez, Juan J. Garrido, S. Zaldívar-López
          </td>
          <td>2025-12-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Despite systemic viral suppression, people living with HIV (PLHIV) on antiretroviral therapy (ART) remain highly susceptible to pneumococcal colonisation and disease. Here, we show that long-term ART does not restore nasal mucosal immunity. Using flow cytometry, single-cell transcriptomics, and neutrophil functional assays, we identify a persistent mucosal immune signature in PLHIV-ART > 1 yr marked by epithelial-driven neutrophilic inflammation, T cell exhaustion, and cellular senescence. Neutrophils exhibit mitochondrial stress, senescence-associated secretory phenotype (SASP) gene expression, and impaired oxidative burst, particularly in individuals with pneumococcal carriage. Epithelial cells express elevated neutrophil-recruiting ligand genes, while nasal T cells display pro-apoptotic and exhaustion gene profiles. Neutrophilic inflammation is strongly associated with pneumococcal carriage density, implicating a feedforward loop between inflammation and microbial persistence. Our findings reveal tissue-specific immune dysregulation despite ART and suggest that targeting epithelial-immune signalling or neutrophil senescence may offer novel therapeutic avenues to reduce respiratory pathogen burden in PLHIV. People living with HIV (PLHIV) on antiretroviral therapy (ART) remain highly susceptible to pneumococcal colonisation and disease. In an analysis of 132 adults in Malawi, the authors report that long-term ART does not restore nasal mucosal immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8a4a931320861dfa1656d868c4d925aa230a71ef" target='_blank'>
              Persistent pneumococcal colonisation in antiretroviral-treated HIV infection is associated with nasal inflammation
              </a>
            </td>
          <td>
            J. Phiri, L. Sibale, Gloria Kapira, Lukerensia Mlogoti, James Nyirenda, N. Mitole, A. Kusakala, Charles Ndovi, Precious Chigamba, Aaron P. Chirambo, Klara Doherty, Robert K Nyirenda, T. Kayembe, J. Zambezi, E. Lisimba, Memory Mvula, David V Mhango, Leonard Mvaya, S. Gordon, Benjamin Kumwenda, Christopher Moxon, Daniela M Ferreira, Henry Mwandumba, K. Jambo
          </td>
          <td>2025-12-15</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Alzheimer´s disease (AD) is dominated by a complex cellular pathology which involves most brain cell types with glial cells increasingly recognized as playing fundamental roles in neurodegeneration. Astrocytes, which perform essential functions in preserving brain homeostasis, present a reactive phenotype in the AD brains with still unknown consequences. In this study, we generated and characterized human induced pluripotent stem cell (hiPSC)-derived astrocytes from AD patients harboring the APOE4/4 genotype, the greatest genetic risk factor for late-onset AD. Disease astrocytes showed a reactive phenotype. In addition, they showed altered mitochondrial network including perinuclear clustering of mitochondria, enhanced mitochondrial fusion and higher production of reactive oxygen species which, unexpectedly, were coincident with increased oxidative phosphorylation and glycolysis. As these mitochondrial features are related to the acquisition of cell senescence, we evaluated this at the transcriptome level and found that these AD-derived astrocytes significantly upregulated gene signatures of cellular senescence and displayed a senescence-associated secretory phenotype (SASP). To verify this finding, we observed senescence-related DNA damage response in a significant proportion of cells in the cerebral cortex of AD patients, with most of these cells being astrocytes. Finally, we confirmed that this astrocytic senescent and proinflammatory phenotype is associated with a reduced neuronal support, evidencing that APOE4/4 AD astrocytes present intrinsic features that may compromise brain homeostasis and promote neurodegeneration. Addressing the causes and consequences of this astrocytic dysfunctionality should help to elucidate novel therapeutic targets able to modify the neurodegeneration present in AD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fb7d32fdd86ae0120bf83566cd83dd24e2f344b9" target='_blank'>
              Human iPSC-derived APOE4/4 Alzheimer´s disease astrocytes exhibit a senescent and pro-inflammatory state that compromises neuronal support
              </a>
            </td>
          <td>
            Laura Cáceres-Palomo, E. Sánchez‐Mejías, Laura Trujillo-Estrada, Juan J. Pérez-Moreno, Tau Elba Lopez-Oliva, En Lim, Leah DeFlitch, Serena H. Chang, Lucas Kampman, Ryan Corces, Mathew Blurton-Jones, Inés Moreno-González, Alberto Pascual, J. Vitorica, Juan Antonio, Antonia Gutierrez
          </td>
          <td>2025-12-12</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c637aed82bc13a754c516d97000ace5f1af7bfc8" target='_blank'>
              Tonic interferons defend against respiratory viruses in primary human lung organoid-derived air-liquid interface cultures
              </a>
            </td>
          <td>
            Rinu Sivarajan, Paul C Kirchgatterer, Jan Lawrenz, Eszter Tanner-Matiz, Jessica Lindenmayer, Verena Renz, Tapan Joshi, Heike Oberwinkler, Thorsten Walles, G. Fois, Alexander Kleger, Manfred Frick, Jan Münch, Moritz M Gaidt, Maria Steinke, Konstantin M. J. Sparrer
          </td>
          <td>2025-12-10</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="N6-methyladenosine (m6A), the most prevalent RNA modification, plays a pivotal role in regulating mRNA metabolism and cellular processes such as immune responses. Although the m6A methyltransferase METTL3 is known to regulate T-cell homeostasis and influence experimental autoimmune encephalomyelitis (EAE, a model for multiple sclerosis (MS)), its function within B cells remains poorly defined. Crucially, we observed that METTL3 expression is significantly downregulated in peripheral blood mononuclear cells (PBMCs) from MS patients and within B cells isolated from EAE mice. To directly investigate the functional consequences of this B-cell-specific METTL3 reduction in neuroinflammation, we generated B cell-specific METTL3 knockout mice (Mettl3flox/floxCD19Cre). Strikingly, this targeted deletion of METTL3 in B cells markedly exacerbated EAE severity, demonstrated by significantly worsened clinical disease scores, increased spinal cord inflammation, and greater demyelination. Further mechanistic dissection revealed how B-cell METTL3 deficiency drives this exacerbated pathology: it promoted B cell apoptosis, inhibited the differentiation of regulatory B cell (Breg) subpopulations, increased the proportion of pro-inflammatory iNOS+ macrophages, and elevated the production of IL-6, BAFF, and BCMA. In the central nervous system, it promotes neurological damage by affecting axonal function and facilitating the loss of neurons. Collectively, these findings demonstrate that METTL3 functions as a critical negative regulator within B cells, restraining their contribution to neuroinflammation in the EAE model. Importantly, therapeutically relevant overexpression of METTL3 specifically in B cells significantly reduced both the clinical severity and incidence of EAE, underscoring its potential as a novel therapeutic target for MS and similar autoimmune disorders involving pathogenic B-cell responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a6ce86ef87ccf6c54308ad57fa29637a1c3c7500" target='_blank'>
              B cell-specific METTL3 depletion exacerbates experimental autoimmune encephalomyelitis
              </a>
            </td>
          <td>
            Xuzhong Pei, Xiying Wang, Jie Ding, Haojun Yu, Chunran Xue, C. Xie, Yi Chen, Xinyu Lin, Hong Yang, Yangtai Guan
          </td>
          <td>2026-01-03</td>
          <td>Cellular and Molecular Life Sciences: CMLS</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/60b51b9703dbfed647e79713910f273fb5017584" target='_blank'>
              STING–IFN–CH25H lipid axis links innate immune activation to tau pathology
              </a>
            </td>
          <td>
            Hao Chen, Li Fan, M. Wong, Y. Ambaw, Jingjie Zhu, Kendra Norman, Pearly Ye, Nessa R. Foxe, Daphne Zhu, Yuansong Wan, Mahalashmi Srinivasan, S. Mok, Laura Beth J McIntire, Tobias C. Walther, R. V. Farese, Li Gan, Wenjie Luo
          </td>
          <td>2025-12-18</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="Background The COVID-19 pandemic, caused by SARS-CoV-2, has highlighted significant variability in disease severity, ranging from asymptomatic cases to severe acute respiratory distress syndrome. Objective Understanding the immune responses that contribute to this variability, particularly among healthcare workers (HCWs) frequently exposed to the virus, is essential. Materials and methods This was a prospective single-center longitudinal cohort study. We included hospitalized COVID-19+ patients, classified as having mild or moderate-to-severe symptoms, and unvaccinated HCWs with low susceptibility. Peripheral blood mononuclear cells (PBMCs) were collected and analyzed using flow cytometry. We measured the frequencies of key immune subsets, including plasmablasts, plasmacytoid dendritic cells (pDCs), and Natural Killer (NK) cells. SARS-CoV-2 neutralizing antibodies (NAbs) were quantified using pseudotyped HIV particles. Results COVID-19+ patients exhibited a significant increase in plasmablasts, a B-cell subset responsible for producing neutralizing antibodies, which correlated with disease severity (p=0.0082). Conversely, uninfected HCWs had low levels of plasmablasts but significantly higher levels of plasmacytoid dendritic cells (pDCs) (p<0.0001), which produce interferons upon activation by viral antigens. Additionally, HCWs had a higher percentage of CD56bright NK cells than the susceptible patients (p=0.02). Conclusion Our findings suggest that immune dysregulation, characterized by increased plasmablasts and reduced pDC and NK cell responses, contributes to COVID-19 severity. Strong pDC and NK cell responses may confer protection against SARS-CoV-2. These insights into immune responses may inform strategies for therapeutic interventions and vaccine development.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9b2b12f86783468a8a58cf46dfd373285bb90b7e" target='_blank'>
              Contrasting immune responses in COVID-19: insights from healthcare workers and infected patients on plasmablast, pDC, and NK cell dynamics
              </a>
            </td>
          <td>
            Laura Martín-Pedraza, Eulalia Rodríguez-Martín, Erick De La Torre-Tarazona, Elena Moreno, Roberto Pariente-Rodríguez, P. Walo-Delgado, J. García-Pérez, Jorge Díaz, Laura Luna, Mario Rodríguez-Domínguez, Juan Carlos Galán, Claudia Geraldine Rita, Ana Del Amo-de Palacios, Roser Navarro-Soler, María Fons, José Alcamí, Santiago Moreno, L. M. Villar, Sergio Serrano-Villar
          </td>
          <td>2026-01-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Zika virus (ZIKV), a neurotropic virus, poses significant global health challenges because of its ability to cause severe neurological complications and congenital brain abnormalities. Prenatal ZIKV infection impairs early brain development. However, details of the molecular mechanisms driving their virulence remain incompletely understood. Here, we performed comparatively analyses of infection outcomes caused by 2 different ZIKV strains – wild-type (WT) ZIKV versus an attenuated strain (DN-2) – in human cerebral organoids (hCOs) to dissect host responses that could contribute to pathogenicity. Although both viral strains productively infected hCOs with indiscernible gross pathological changes, differences in host responses and subtypes of cells infected discriminate WT ZIKV from DN-2 infections. Single cell RNA sequencing analyses uncovered differently expressed genes (DEGs) that were common to both virus strains, as well as DEGs that were specific to either WT ZIKV or DN-2. For common DEGs, WT ZIKV infections elicited stronger expression of key genes involved in host immune response pathways, such as IFIT2, DDX60, OAS1 and XAF1. Moreover, analyses of WT ZIKV-specific upregulated DEGs uncovered mobilisation of additional innate immune response pathways not found in DN-2. Additionally, while WT ZIKV infected a broad range of cell types in hCOs, DN-2 infections were predominantly limited to radial glial, which are neuroprogenitors essential for neurogenesis. These results highlight that differences in host immune responses and tropism distinguish neurotropic WT ZIKV and attenuated DN-2 infections, underscoring the mechanistic differences involved in pathogenicity. Our study provides further insights into mechanisms used by neurotrophic ZIKV to drive neuropathogenesis during infection of the developing brain.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6d03f6c7701fb82cda454df504a0ff34a1e58052" target='_blank'>
              Comparison of human cerebral organoids infected with wild-type Zika versus attenuated DN-2 virus strains uncovers differences in host immune responses
              </a>
            </td>
          <td>
            Yun Ying Choo, Tuan Zea Tan, S. Zhang, H. Tan, E. Ooi, John Jia En Chua
          </td>
          <td>2025-12-16</td>
          <td>Cell Communication and Signaling : CCS</td>
          <td>0</td>
          <td>73</td>
        </tr>

        <tr id="The polarization state of microglia exerts an influence on neuroinflammation and neural tissue repair after injury. Modulating microglial polarization is emerging as a potential therapeutic strategy for various types of neural injuries and neurodegenerative diseases. However, the causal relationship between microglial polarization and mitochondrial dynamics, which include mitochondrial fusion and fission, remains to be fully clarified. Our study demonstrates that mitochondrial fusion promoter M1 promotes mitochondrial fusion in mouse microglial cells, leading to reduced glycolysis and increased fatty acid oxidation, and this metabolic reprogramming impacts microglial polarization. Additionally, in both cellular and animal experiments, it was observed that knocking down mitochondrial transcription factor A (TFAM) results in increased mitochondrial fission, decreased fatty acid β‐oxidation, enhanced glycolysis, and promotes the polarization of microglia toward the pro‐inflammatory M1 phenotype. In conclusion, our study has, for the first time, provided evidence that TFAM may play a role in the regulation of mitochondrial dynamics. Furthermore, we provide a detailed elucidation of the chronological sequence and underlying causal relationships among mitochondrial dynamics, mitochondrial metabolic reprogramming, and microglial polarization. These findings offer novel targets and strategies for the treatment of various neural injuries and neurodegenerative diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/05037872ff9d9a37d399121d354d551c37363356" target='_blank'>
              TFAM‐Associated Mitochondrial Dynamics and Metabolic Reprogramming Regulate Microglial Polarization: Temporal and Causal Perspectives
              </a>
            </td>
          <td>
            Yuxuan Zhang, Ximeng Wang, Dachuan Li, Xiao Lu, Zhaoyang Gong, Zhidi Lin, Hanqiu Sun, Hongli Wang, Zian Lu, Xiaosheng Ma, Guangyu Xu, Jianyuan Jiang
          </td>
          <td>2026-01-22</td>
          <td>The FASEB Journal</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6d6eba017d5f90627970b16b5a61725ba67c3fc0" target='_blank'>
              Rab27-dependent egress of SARS-CoV-2 via secretory amphisomes
              </a>
            </td>
          <td>
            W. Nijenhuis, Hugo G. J. Damstra, Emma J van Grinsven, Patrique Praest, Mariëlle M.P. van Grinsven, Zahra E. Soltani, D. D. de Jong, J. Symons, G. D. Amatngalim, Frederik J. Verweij, A. Akhmanova, M. Nijhuis, Jeffrey M. Beekman, R. Lebbink, L. Kapitein
          </td>
          <td>2025-12-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>55</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/867efcbe14a63d7bf027c9f54c987f90b3ddddd7" target='_blank'>
              Csf1r-mediated depletion of midbrain microglia prevents dopaminergic neuron loss during chronic colitis
              </a>
            </td>
          <td>
            Rebecca Katharina Kutscherauer, I. Stolzer, E. Neumaier, M. Dedden, Pavel Kielkowski, W. Xiang, Alexander Grotemeyer, Marco Prinz, Takahiro Masuda, K. Knobeloch, V. Rothhammer, Sebastian Zundler, Johannes C. M. Schlachetzki, Jürgen Winkler, Claudia Günther, P. Süß
          </td>
          <td>2026-01-26</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/34649c6562aa2175c877d0871438b8882a670ac3" target='_blank'>
              Integrated single-cell analysis reveals interferon-driven immune signatures in a DENV1 human infection model
              </a>
            </td>
          <td>
            A. Vermeersch, T. Verdonckt, C. Struyfs, E. De Meester, A. Waickman, S.J. Thomas, K. Ariën, O. Lagatie, F. van Nieuwerburgh
          </td>
          <td>2026-01-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="Introduction Matrix metalloproteinases MMP-2 and MMP-9 modulate inflammatory processes at the blood–brain barrier (BBB), but their presence and function in the dura mater remain unclear. We therefore investigated their contribution to immune regulation at this site during neuroinflammation. Methods We analyzed dura mater from naïve and experimental autoimmune encephalomyelitis (EAE) mice using immunofluorescence, gelatin zymography, flow cytometry, and single-nucleus RNA sequencing (snRNA-seq). Comparisons were performed between wild-type (WT) and Mmp9-/- mice to define gelatinase expression, cellular sources, transcriptional alterations, and immune cell dynamics. Results Pro- and activated-MMP-2 and MMP-9 were detectable in naïve dura, with selective upregulation of MMP-9 during EAE. Mmp9-/- mice demonstrated delayed EAE onset but more severe disease at peak. SnRNA-seq revealed that Mmp9 deficiency altered endothelial transcriptional programs, especially in venous endothelial cells, and promoted expansion of granulocyte populations with mature neutrophil signatures. Flow cytometry and immunofluorescence confirmed increased Ly6C⁺Ly6G⁺ neutrophils in Mmp9-/- dura during EAE. Discussion Our findings indicate that MMP-9 regulates immune cell composition and activation within the dura during neuroinflammation. While Mmp9 deficiency delays disease onset, it enhances neutrophil accumulation and inflammatory responses at this CNS border, suggesting a previously unrecognized, potentially anti-inflammatory role for MMP-9 in the dura.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/db959f39888b4f8f3387804147ae4412570e0a00" target='_blank'>
              MMP-9 affects dural cell composition and granulocyte accumulation during neuroinflammation
              </a>
            </td>
          <td>
            Sheng-Hsiang Shen, Hanna Gerwien, Miriam Burmeister, Y. Tsang, I-Na Lu, Anna-Lena Börsch, Tushar Deshpande, Lydia Sorokin, Gerd Meyer zu Hörste
          </td>
          <td>2025-12-11</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7f17946ac3dbb8efa92226c7ce4112035350abc3" target='_blank'>
              STAT1-Mediated Regulation of IL-17A/CEBPB/NF-κB Axis in HIV-1 Infected Human Cerebral Organoids Reveals Therapeutic Targets for Neuroprotection
              </a>
            </td>
          <td>
            Karthick Chennakesavan, Malaroviyam Samikkannu, Shreyan Gupta, Olasunkanmi Israel Tayo, Arpan Acharya, James J. Cai, S. Byrareddy, T. Samikkannu
          </td>
          <td>2026-01-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="The emergence of SARS-CoV-2 led to a global pandemic with severe respiratory symptoms and substantial extrapulmonary manifestations. Increasing evidence suggests significant cardiovascular complications associated with SARS-CoV-2 infection, which are critical factors in morbidity and mortality. In this study, we assessed the viral infectivity and viral niche of SARS-CoV-2 using our clinically-amenable in vitro cardiac spheroids (CSs), which have previously been demonstrated to be an optimal tool to recapitulate the complex cardiac pathophysiology. We examined the expression profiles of cardiovascular-related disease genes and pathways involved in inflammation, interferon responses, and antiviral defence following infection. Genes associated with apoptosis, chemotaxis, fibrosis, and contractile function exhibited substantial increases, implicating these pathways in the cardiac response to SARS-CoV-2. Furthermore, our 3D rendering analyses using confocal imaging revealed cell-specific effects mediated by the virus by colocalising SARS-CoV-2 nucleocapsid protein with each cell type, supporting the ability of CSs to facilitate viral replication and contributing to the observed phenotypes. Additionally, SARS-CoV-2 could only infect intact CSs, whereas it did not infect individual cell types cultured individually. The unique ability of CSs to model SARS-CoV-2 in the heart may potentially mirror the pathophysiological changes observed in COVID-19-induced cardiac complications. Altogether, our results suggest that CSs offer a valuable tool for dissecting direct host-viral interactions and advancing our understanding of SARS-CoV-2-related cardiac injury. Our findings underscore the utility of CSs in revealing the mechanisms of SARS-CoV-2-induced cardiac damage and provide a basis for further studies into the long-term cardiovascular consequences of SARS-CoV-2.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e493a51a3fb6d07e646490a08af4721a5f35f5c7" target='_blank'>
              SARS-CoV-2 infection of 3D in vitro cardiac spheroids models the activation of antiviral, inflammatory, fibrotic, and contractile responses in a dose-dependent manner
              </a>
            </td>
          <td>
            M. Johansen, Clara Liu Chung Ming, P. Hansbro, Carmine Gentile
          </td>
          <td>2026-01-15</td>
          <td>Biofabrication</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Infection rates involving bacterial and viral pathogens have increased precipitously after the COVID-19 pandemic. While it has been speculated that higher infection rates resulted from increased hospitalizations throughout the pandemic or greater use of antibiotics, precisely why rates remain high today has remained unexplained. Mitochondrial dysfunction is known to occur post-COVID and may disrupt immune responses. Within T cells, SARS-CoV-2 infection is linked to low mitochondrial membrane potential, increased mitochondrial apoptosis, and decreased mitochondrial respiration, which together impact cellular activation and function beyond the acute phase of illness. Here, we demonstrate that decreased mitochondrial function in antigen-specific T cells post-COVID may contribute to higher infection susceptibility by metabolically immobilizing T cell memory responses. Using donor-matched peripheral blood samples from 31 COVID-naïve individuals who subsequently contracted COVID-19, we tracked how influenza A (IAV), Staphylococcus aureus (SA), and Varicella-zoster virus (VZV) T cell responses were impacted by COVID-19 infection. We found that gene expression linked to T cell activation decreased but mitochondrial redox pathways increased in CD4 memory T cells post-COVID. However, mitochondrial flux and reactive oxygen species production were limited in a plurality of post-COVID memory T cells after stimulation with IAV, SA, and VZV. Furthermore, we found a disordered relationship between memory T cell mobilization of glycolysis, fatty acid metabolism, and oxidative phosphorylation pathways post-COVID which resulted in diminished use of catabolic pathways including glycolysis and fatty acid oxidation in antigen-specific T cells. Modulation of mitochondrial function with metformin and ubiquinol partially rescued the post-COVID decline in T cell catabolism. Collectively, these findings indicate that COVID-19 infection may have lasting effects on inhibiting T cell memory responses to commonly encountered community-acquired pathogens which can be corrected with commonly available medications. This has significant implications for the clinical care of immunologically vulnerable populations in the post-pandemic era.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/826971fe690f6be31807f55457f0b21244f3d4b9" target='_blank'>
              Post-COVID impairment of memory T cell responses to community-acquired pathogens can be rectified by activating cellular metabolism
              </a>
            </td>
          <td>
            Daniel D. Carroll, Kamacay Cira, Jack Archer, Jason Shapiro, Ue-yu Pen, David Tieri, Lucia Leonor, Neda D. Roofchayee, Samantha S. Yee, Marc Wahab, Igor J. Koralnik, John C. Alverdy, Arjun S. Raman, L. Visvabharathy
          </td>
          <td>2026-01-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="ABSTRACT Canine distemper virus (CDV, species Morbillivirus canis) is a highly contagious pathogen with a broad host range among carnivores. In common with measles virus, alveolar macrophages (AMs) are among the first target cells of infection in the respiratory tract. Therefore, in vitro infections of primary canine AMs were performed with the attenuated Onderstepoort (Ond) and field R252 strain of CDV over a period of 6 days. This showed that AMs are permissive to CDV infection and that such infections are productive with respect to the release of new virus particles. Phenotypic differences were observed over the entire course of the experiment, as higher levels of infection and virus production were observed in CDV R252-infected AMs, while infection with CDV Ond resulted in more prominent cytopathic effects, including syncytium formation. Transcriptome analyses of samples from 1 day post-infection via total RNA sequencing demonstrated further marked differences with respect to the pro-inflammatory response and cell death pathways. CDV Ond-infected AMs exhibited robust induction of pro-inflammatory mediators including type I interferon-related signaling pathways, whereas CDV R252-infected cells showed much weaker expression of these pathways. These transcriptomic differences were further highlighted by the detection of the highest rates of cell apoptosis and lactate dehydrogenase activity in the supernatants of CDV Ond-infected AM cultures over the entire course of the experiment. In addition, transcriptome differences indicate disturbances of homeostatic AM functions associated with CDV infection. These results provide insights into early events in the pathogenesis of CDV infection and mechanisms underlying vaccine strain attenuation. IMPORTANCE Morbilliviruses, including canine distemper virus (CDV) and human measles virus, cause severe systemic disease with respiratory distress, immunosuppression, and neurologic signs. While natural infection in dogs has become rare due to efficient vaccination, outbreaks in wildlife populations can be devastating, and concerns about zoonotic potential of CDV have been raised. The impact of CDV infection on the transcriptome of alveolar macrophages has not been elucidated thus far. Knowledge about early events in CDV pathogenesis and phenotypic consequences of vaccine attenuation is therefore necessary to protect endangered wildlife populations and might furthermore serve as a model for human measles. This study presents the first transcriptomic analyses of primary AMs during the initial phase of morbillivirus infection. These results provide insights into early events in the pathogenesis of CDV infection and mechanisms serving to restrict the spread of an attenuated virus strain. Morbilliviruses, including canine distemper virus (CDV) and human measles virus, cause severe systemic disease with respiratory distress, immunosuppression, and neurologic signs. While natural infection in dogs has become rare due to efficient vaccination, outbreaks in wildlife populations can be devastating, and concerns about zoonotic potential of CDV have been raised. The impact of CDV infection on the transcriptome of alveolar macrophages has not been elucidated thus far. Knowledge about early events in CDV pathogenesis and phenotypic consequences of vaccine attenuation is therefore necessary to protect endangered wildlife populations and might furthermore serve as a model for human measles. This study presents the first transcriptomic analyses of primary AMs during the initial phase of morbillivirus infection. These results provide insights into early events in the pathogenesis of CDV infection and mechanisms serving to restrict the spread of an attenuated virus strain.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3f26cfe0ac9067059119db401d86201bd65190d2" target='_blank'>
              Attenuation of canine distemper virus leads to a potent antiviral innate immune response with restricted infection of alveolar macrophages
              </a>
            </td>
          <td>
            Pauline Pöpperl, E. Chludzinski, M. Stoff, R. Geffers, M. Ludlow, A. Beineke
          </td>
          <td>2025-12-17</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>70</td>
        </tr>

        <tr id="ABSTRACT Middle East respiratory syndrome coronavirus (MERS-CoV) causes a highly lethal respiratory infection for which no vaccines or antiviral therapeutics are currently available. Understanding the immune response is critical for designing effective therapeutics. Here, we comprehensively characterized the dynamics of B-cell responses in severely infected MERS-CoV patients and survivors with SARS-CoV-2 exposure history. Infected patients developed robust neutralizing antibody responses within 1 month of illness, with moderate-to-high cross-neutralization activity against SARS-CoV-2. The enhanced neutralization activity coincided with an increased abundance of specific mutated, class-switched IgG clones. Notably, one such clone was detected at moderate prevalence in both patients, and its expansion was accompanied by high neutralization activity against both viruses. Conversely, MERS-CoV survivors demonstrated higher neutralization activity against MERS-CoV after vaccination, despite minimal changes in antibody titers and limited alterations in B-cell repertoire properties. This suggests that the enhanced neutralization activity may be mediated by the reactivation and expansion of cross-reactive memory B cells targeting conserved epitopes, originally generated in response to the virus that triggered the primary immune response. These findings provide valuable insights into the B-cell repertoire landscape during natural MERS-CoV infection and highlight the potential for identifying broadly neutralizing antibodies in individuals with hybrid immunity. IMPORTANCE This study examines the immune responses of MERS-CoV patients and survivors who have had confirmed exposure to SARS-CoV-2. It offers a unique opportunity to characterize cross-reactive B-cell responses in individuals possessing hybrid immunity to both pathogenic coronaviruses. To our knowledge, no previous studies have examined longitudinal changes in the B-cell repertoire in MERS-CoV patients or survivors before and after SARS-CoV-2 vaccination. Our findings reveal enhanced neutralization activity against both MERS-CoV and SARS-CoV-2 following infection or vaccination, which appears to be associated with distinct patterns of B-cell repertoire dynamics. Notably, the data strongly suggest the presence of potent cross-neutralizing antibody responses, particularly in MERS-CoV patients, driven by dominant B-cell clones. These results underscore the potential for identifying broadly neutralizing antibodies in individuals with hybrid immunity. This study examines the immune responses of MERS-CoV patients and survivors who have had confirmed exposure to SARS-CoV-2. It offers a unique opportunity to characterize cross-reactive B-cell responses in individuals possessing hybrid immunity to both pathogenic coronaviruses. To our knowledge, no previous studies have examined longitudinal changes in the B-cell repertoire in MERS-CoV patients or survivors before and after SARS-CoV-2 vaccination. Our findings reveal enhanced neutralization activity against both MERS-CoV and SARS-CoV-2 following infection or vaccination, which appears to be associated with distinct patterns of B-cell repertoire dynamics. Notably, the data strongly suggest the presence of potent cross-neutralizing antibody responses, particularly in MERS-CoV patients, driven by dominant B-cell clones. These results underscore the potential for identifying broadly neutralizing antibodies in individuals with hybrid immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1207eb36a1ae9d0a38874b4fd9dcc3679243cee7" target='_blank'>
              Dynamics of B-cell response in MERS-CoV patients and survivors with hybrid immunity
              </a>
            </td>
          <td>
            H. Al-Khatib, Fatma H. Ali, H. Zedan, M. Smatti, Peter V. Coyle, Sara Taleb, A. A. Hssain, Asmaa A Al-Thani, H. Yassine
          </td>
          <td>2025-12-16</td>
          <td>mBio</td>
          <td>0</td>
          <td>48</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b09542cf8541c87eb81cd5d350b998bad1880105" target='_blank'>
              Inflammasome activation and oxidative stress in SARS-CoV-2 infection and symptomatic rebound.
              </a>
            </td>
          <td>
            S. Lage, Joseph M. Rocco, Cihan Oguz, Francisco A. Otaizo-Carrasquero, Adam W. Rupert, K. Boswell, Brian P. Epling, Logan Cook, Eduardo Pinheiro Amaral, Elizabeth Laidlaw, Frances Galindo, R. Koup, Princy Kumar, Rita Poon, Glenn W Wortmann, A. Lisco, Maura Manion, I. Sereti
          </td>
          <td>2026-01-20</td>
          <td>The Journal of infectious diseases</td>
          <td>0</td>
          <td>131</td>
        </tr>

        <tr id="Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has a wide range of clinical manifestations modulated by genetic factors. The aim of this study was to identify genetic determinants of severe COVID-19 affecting protein sequence to gain insight into disease pathogenesis. Variants prioritized in two patients requiring lung transplant were tested in the Milan FOGS cohort (487/869 cases/controls), highlighting an independent association between the p.F8S low-frequency variant of interferon alpha receptor 2 gene (IFNAR2) and severe disease (OR = 1.73 [1.24–2.42], p = 0.001), replicated in the COVID-19 Host Genetics Initiative cohort (26,167/2,061,934 cases/controls). In the FOGS cohort, the p.F8S variant was linked to higher circulating IL-6 levels. In keeping, bulk transcriptomic analysis in PBMCs at the peak of infection (n = 57) showed that carriers of the p.F8S variant had upregulation of immune signaling and pathogens response (p < 0.05). Functional flow cytometry experiments in healthy donors (n = 12) revealed that membrane IFNAR2 protein expression was reduced in B lymphocytes, but higher in dendritic cells (p < 0.05). Finally, by interrogating a public scRNAseq resource of PBMC of people with COVID-19, we showed that p.F8S carriers had upregulation of immune pathways specifically in dendritic cells (p < 0.05). These results suggest that the p.F8S variant may influence COVID-19 severity by enhancing adaptive immune response, thereby favoring inflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/26fd134f10d835db7d97829bfbea4ea4fe400a32" target='_blank'>
              IFNAR2 p.F8S Variant Associates with Severe COVID-19 and Adaptive Immune Cell Activation Modulation
              </a>
            </td>
          <td>
            F. Malvestiti, Angela Lombardi, Francesco Gentile, Veronica Torcianti, Elena Trombetta, Alessandro Cherubini, G. Lamorte, Sara Colonia Uceda Renteria, Daniele Marchelli, Lorenzo Rosso, A. Bandera, F. Peyvandi, F. Blasi, Giacomo Grasselli, L. Porretti, Saleh A. Alqahtani, Daniele Prati, Roberta Gualtierotti, Blagoje Soskic, Valentina Vaira, L. Ronzoni, L. Valenti
          </td>
          <td>2026-01-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>57</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7e3390d47a05cc167afea6dd6713ed3857300502" target='_blank'>
              PPARδ activation in microglia drives a transcriptional response that primes phagocytic function while countering inflammatory activation
              </a>
            </td>
          <td>
            Jacob S. Deyell, J. Hasselmann, Linda Stroud, Urmimala Raychaudhuri, Yunzi Guo, Byeonggu Cha, Christopher Karma, Deavin Tendean, Minh-Huy Vu Tran, Anastasia Gromova, Audrey S. Dickey, Mathew Blurton-Jones, Albert R. La Spada
          </td>
          <td>2025-12-19</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/91babd22d3b6b86432a313b4b21fca0bc39e8c82" target='_blank'>
              Single cell RNA sequencing reveals limited effects of Lrrk2 genotype in a mouse model of acute CNS inflammation
              </a>
            </td>
          <td>
            Alice Kaganovich, Liam Horan-Portelance, Natalie Landeck, Dominic J. Acri, Jinhui Ding, R. Langston, Mark R. Cookson
          </td>
          <td>2025-12-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Microglial cells exhibit crucial metabolic adaptations to maintain neural homeostasis. However, their dysregulated activation during infections can lead to neurotoxicity and contribute to the development of neuroinflammatory disorders. Understanding the physiological and metabolic changes of microglia during immune activation is crucial for identifying protective targets against neuroinflammation. This study investigates how the Zika virus (ZIKV) alters microglia metabolism during inflammation, highlighting cellular adaptations that sustain oxidative metabolism linked to cell survival during cellular activation and viral replication. After identifying an enriched abundance of proteins related to oxidative phosphorylation and cellular component organization in the global proteomics of mouse brains following ZIKV exposure, we investigated the relevance of these pathways during in vitro infection of human microglia. ZIKV infection led to cytoskeleton remodeling via β-tubulin reallocation, which characterized an ameboid-like phenotype. Despite the indication of a shift toward increased glycolytic activity due to decreased intracellular glucose, which suggests its consumption, and the accumulation of tricarboxylic acid cycle (TCA) intermediates, ZIKV-infected microglia exhibit enhanced respiratory capacity and an abundance of smaller-sized mitochondria in the perinuclear region. The accumulation of citrate, succinate, and malate, while maintaining mitochondrial function, suggests an important metabolic adaptation that supports biosynthetic pathways and sustains cell viability under stress. Decreased intracellular glutamate abundance supports mitochondrial oxidative metabolism. Pre-treatment with the anti-inflammatory docosahexaenoic acid (DHA) mitigates ZIKV-induced metabolic alterations by reducing pro-inflammatory markers, downregulating viral entry receptors, and lowering microglial activation and viral load. This study reveals that while ZIKV induces cell death in neuronal-like cells, the mitochondrial adaptation observed in microglial infection could be a key to maintaining cell survival throughout neuroinflammation. Our findings elucidate a novel cellular adaptation during ZIKV infection involving β-tubulin reorganization and metabolic dynamics, reflecting microglial flexibility and resistance during neuroinflammation, and demonstrating the therapeutic potential of DHA in mitigating ZIKV-induced pathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6d680f6e601874de149962588421e3e6c0a8d4a6" target='_blank'>
              Zika Virus Reprograms Microglial Mitochondrial Metabolism to Support Immune Activation and Viral Replication: Omega-3 DHA Counteracts Neuroinflammation and Viral Persistence
              </a>
            </td>
          <td>
            Heloísa Antoniella Braz-De-Melo, Fernanda Gomes Lago, Rafael Corrêa, I. Santos, P. Bellozi, R. Almeida, Wagner Fontes, Mariana S. Castro, Aline Maria Araújo Martins, R. M. de Oliveira, Nadia Martins Serpa Rossi, Gabriel Pasquarelli-do-Nascimento, Ana Luiza Gouvea, Paulo Sousa Prado, A. D. de Bem, Sônia Nair Báo, B. M. Ribeiro, S. Rehen, Thomas Christopher Rhys Williams, Gary P. Kobinger, Kelly Grace Magalhães
          </td>
          <td>2026-01-01</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>41</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/687800177db6f90a1dee9be6bba3ed7087d04c6e" target='_blank'>
              Oncolytic Reovirus mediates innate-driven SARS-CoV-2 elimination in the absence of cell toxicity
              </a>
            </td>
          <td>
            Samantha Garcia-Cardenas, Gemma Swinscoe, Amy Moran, Liam Barningham, Graham P. Cook, A. Samson, Sam J. Wilson, Michael Malim, Russell Hughes, Stephen Griffin
          </td>
          <td>2025-12-18</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1a7003e81dc9e785e6c921fda274b93fc77f9d6f" target='_blank'>
              Mechanisms of disrupted neurodevelopment after Zika virus infection in infancy
              </a>
            </td>
          <td>
            V. Edara, Sienna Freeman, M. Sampson, Kathryn Moore, Rebecca Richardson, N. Schoof, Divine Burgess, Michelle Lee, G. Tharp, R. Vlasova, Shane Taylor, Ariana Hodjatzadeh, Yihana Melendez-Alejandro, Samia Abdallah, Esther Ndungu, Ava Mascarenhas, Chao-Hsiung Hsu, Tsang-Wei Tu, M. Styner, M. Suthar, , Steven Bosinger, Mark W. Burke, Steven A. Sloan, J. Raper, A. Chahroudi
          </td>
          <td>2026-01-28</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>69</td>
        </tr>

        <tr id="The COVID-19 pandemic has precipitated a surge in neurocognitive dysfunction, with long-term implications for global health systems and socioeconomic stability. Despite growing clinical recognition of post-COVID cognitive deficits (“brain fog”), the molecular mechanisms driving these impairments remain poorly understood. Our study addresses this critical gap by identifying SARS-CoV-2 nucleocapsid protein (SARS-CoV-2 N protein), a core structural component of the virus, as a novel etiological factor in senescence-mediated cognitive decline. We observed that SARS-CoV-2 N protein caused microglial senescence both in vivo and in vitro. Mechanistically, SARS-CoV-2 N protein-induced metabolic shifting toward glycolysis initiated a cascade of microglial senescence, which propagated cognitive impairment. We found that glycolysis inhibition reduced SARS-CoV-2 N protein-triggered microglial senescence and attenuated cognitive impairment in mice. Disrupted mitochondrial dynamics impaired oxidative phosphorylation capacity, forcing glycolytic reprogramming that ultimately triggered cellular senescence activation. We found that the SARS-CoV-2 N protein promoted excessive mitochondrial dysfunction in microglia, resulting in mitochondrial fragmentation. Inhibition of mitochondrial fission effectively rescued SARS-CoV-2 N protein-induced microglial senescence. In conclusion, our study suggests that the SARS-CoV-2 N protein induces senescence-mediated cognitive impairment by promoting glycolysis in microglia. Therapeutic targeting of glycolysis in SARS-CoV-2 N protein-triggered microglial senescence could be beneficial for treating or preventing cognitive impairment.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/679a7b822ce567d8ac2ac1c2ea01dd417c348cfe" target='_blank'>
              The SARS-CoV-2 nucleocapsid protein induces microglia senescence-mediated cognitive impairment via Glycolysis
              </a>
            </td>
          <td>
            Nan-Shi-Yu Yang, Han-Xi Sha, Chen-Yu Zhang, Hui Chen, Yu-Biao Liu, Jian-Bing Xiong, J. Duan, Jun Zhang, Cha-Xiang Guan, Yong Zhou, Feng Su, W. Zhong
          </td>
          <td>2025-12-12</td>
          <td>Molecular Medicine</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and related sarbecoviruses encode a set of accessory proteins (3a, 3b, 6, 7a, 7b, 8, 9b, and 10) that control host responses to infection and promote virus growth. Of these accessory proteins, 7a is set apart by its intracellular localization near CoV budding sites and its incorporation into secreted virions. To investigate 7a functions during CoV infections under biosafety level 2 conditions, we constructed recombinant mouse hepatitis viruses (rMHVs) (rMHV strain A59) that express sarbecovirus 7a genes. Comparative infections revealed that 7a increased viral replication and viral output in immortalized murine cell cultures and in primary bone marrow-derived macrophages (BMDMs). This proviral effect was independent of a previously reported 7a-mediated interferon antagonizing activity. 7a is a type I transmembrane protein with a short cytoplasmic tail that operates in subcellular trafficking and signal transduction. To further elucidate tail functions, we generated a set of rA59 viruses expressing substitutions in the tail di-lysine motifs. Several substitutions reduced 7a proviral activities; notably, the K119A change in rA59-7a-KRATE eliminated 7a support of virus yield. The K119A change also reduced mouse-adapted SARS-CoV-2 virus yields in infected BALB/c mice. 7a expression was proinflammatory in BMDMs, as measured by cytokine arrays. Cytoplasmic tail substitutions tempered these proinflammatory responses, implying connections with proviral activities. SARS-CoV-2-infected macrophages have been implicated in inflammatory COVID-19, and these findings point to 7a cytoplasmic tails as potential contributors to cytokine-mediated disease. IMPORTANCE This study shows that SARS-CoV-2 accessory protein 7a promotes infection of a phylogenetically distinct embecovirus and, in doing so, elicits proinflammatory and potentially disease-relevant host responses. The proviral and proinflammatory activities were traced in part to a short 7a cytoplasmic tail. The findings localize and highlight a specific proviral component in a sarbecovirus accessory protein. This study shows that SARS-CoV-2 accessory protein 7a promotes infection of a phylogenetically distinct embecovirus and, in doing so, elicits proinflammatory and potentially disease-relevant host responses. The proviral and proinflammatory activities were traced in part to a short 7a cytoplasmic tail. The findings localize and highlight a specific proviral component in a sarbecovirus accessory protein.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5dfa631af078e38f4ca2e53db8a723825ceb2711" target='_blank'>
              A murine coronavirus infection platform identifies proviral and proinflammatory activities of SARS-CoV-2 accessory protein 7a
              </a>
            </td>
          <td>
            Grant M Hawkins, Enya Qing, Julisa Salgado, Pearl Chan, Edward M Campbell, Stanley Perlman, Thomas M. Gallagher
          </td>
          <td>2025-12-16</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Although neurological disease is common in people with human immunodeficiency virus (HIV) (PWH), the contributing factors and underlying inflammatory mechanisms remain challenging to identify. Extracellular vesicles (EVs) constitute a relatively uncharacterized modality of intercellular communication and bioactive cargo transport in the setting of viral infection and pathogenesis. EVs carry inflammatory mediators to areas of the periphery during antiretroviral therapy (ART) suppression but are understudied in the brain. Using a biologically relevant simian–human immunodeficiency chimeric virus with a clade D HIV envelope (SHIV.D)-infected rhesus macaque (RM) model of HIV persistence in the central nervous system (CNS), we investigate circulating EV populations and the protein cargo of myeloid-derived EVs during SHIV infection. Using EV flow cytometry to quantify specific EV subpopulations, we found a significant increase in TMEM119+ microglial EVs and CD171+ neuronal EVs in RM plasma during viremia and ART suppression. Using primary RM monocyte-derived macrophages (MDMs), we determined that MDMs increased EV production after SHIV infection. Whole proteomic analysis of these EVs demonstrated that myeloid EVs isolated from SHIV.D-infected MDMs carried significantly increased levels of neuropathogenic and inflammatory proteins. Altogether, these studies improve our understanding of the contribution of myeloid EVs to neurological disease during SHIV/HIV infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cc3683d7fc86b54ee7352b4c7fdd4e87c4f857ea" target='_blank'>
              SHIV.D Infection Alters Production and Protein Composition of Myeloid-Derived Extracellular Vesicles
              </a>
            </td>
          <td>
            Rachel M. Podgorski, Amir Yarmahmoodi, Stephen Baak, Rebecca Warfield, Jake A. Robinson, Jennifer Roof, Maurizio Caocci, Hossein Fazelinia, L. Spruce, Katharine J. Bar, T. Burdo
          </td>
          <td>2026-01-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="ABSTRACT Immunocompromised patients with prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections may serve as reservoirs for viral evolution, with suboptimal immune responses facilitating the accumulation of adaptive mutations. This study aimed to characterize the drivers of SARS-CoV-2 adaptive evolution in such hosts through genomic surveillance. We retrospectively analyzed 24 patients with long-term positive nasopharyngeal reverse transcription-polymerase chain reaction results (symptom onset duration: 7–14 days on average, 1 HIV-positive patient with >20 days of infection). Most infections (April–May 2022) were caused by Omicron variants (predominantly BA.2). Phylogenetic analysis revealed accelerated viral evolution in patients with diverse underlying diseases (e.g., HIV and esophageal cancer). A total of 78 intrahost single-nucleotide variants were identified, with ORF1ab (53.8%) and the Spike protein coding region (20.5%) being hotspots. Notably, the HIV-positive patient’s virus developed unique mutations: NSP3-T779I, NSP15-A94T, and Spike double mutations N440K and I794T. Functional assays showed that the N440K/I794T double mutation significantly enhanced infectivity in Hela-hACE2 cells (P < 0.05) but reduced immune evasion (50% neutralizing titer increased ~2-fold vs BA.2, P < 0.001). The I794T mutation was later detected in the JN.1.16 strain, suggesting potential evolutionary persistence. Prolonged SARS-CoV-2 replication in immunocompromised hosts, particularly HIV-positive individuals, drives adaptive mutations with altered infectivity and immune evasion. These findings emphasize the need for monitoring such hosts to prevent the spread of potentially transmissible variants. IMPORTANCE This study reveals the characteristics of adaptive mutations and their biological functions of SARS-CoV-2 during long-term infection in immunocompromised patients, emphasizes the importance of close monitoring of the long-term replication of SARS-CoV-2, aiming to timely detect and prevent the spread of newly emerging neutralization-resistant variants in susceptible populations, and provides a key scientific basis for formulating effective public health prevention and control strategies. This study reveals the characteristics of adaptive mutations and their biological functions of SARS-CoV-2 during long-term infection in immunocompromised patients, emphasizes the importance of close monitoring of the long-term replication of SARS-CoV-2, aiming to timely detect and prevent the spread of newly emerging neutralization-resistant variants in susceptible populations, and provides a key scientific basis for formulating effective public health prevention and control strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/925a7a462ba9612099e1dfcb1d328c521716cbac" target='_blank'>
              Impact of prolonged infection on SARS-CoV-2 evolution
              </a>
            </td>
          <td>
            Fang Yan, Qiushi Jin, Yuanguo Li, Xuefeng Wang, Chunling Dong, Xianzhu Xia, Yuwei Gao, Jie Zhang, Zhijun Hou
          </td>
          <td>2025-01-06</td>
          <td>Microbiology Spectrum</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Neuroinflammation is a hallmark of both acute and chronic neurodegenerative diseases and is driven, in part, by activated glial cells, including microglia. A key regulator of this inflammatory response is the NLRP3 inflammasome, an immune sensor that can be triggered by diverse, unrelated stimuli such as pathogen-associated molecular patterns, cellular stress, and mitochondrial dysfunction. Despite progress in targeting NLRP3-mediated immune activation, many drug candidates fail, potentially due to the limited availability of physiologically relevant disease models. The SIM-A9 murine microglial cell line, established in 2014, has emerged as a widely used model for studying neuroinflammation; however, its proteome has not yet been systematically characterized. In this study, we investigated the proteomic landscape of SIM-A9 microglia treated with classical pro-inflammatory stimuli, including lipopolysaccharide (LPS) and extracellular ATP and nigericin (NG), to induce NLRP3 inflammasome activation. Using complementary proteomic approaches, we quantified 4903 proteins and observed significant enrichment of proteins associated with immune and nervous system processes. Differentially expressed proteins were consistent with an activated microglial phenotype, including the upregulation of proteins involved in NLRP3 inflammasome signaling. To our knowledge, this is the first comprehensive proteomic analysis of SIM-A9 microglia. These findings provide a foundational resource that may enhance the interpretation and design of future studies using SIM-A9 cells as a model of neuroinflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/59bd3b9c1de0363b2421f1d539e8f44ae1afeb6f" target='_blank'>
              Characterization of the Proteomic Response in SIM-A9 Murine Microglia Following Canonical NLRP3 Inflammasome Activation
              </a>
            </td>
          <td>
            Nicolas N. Lafrenière, Karan Thakur, Gerard Agbayani, Melissa Hewitt, Klaudia Baumann, J. Sandhu, A. Haqqani
          </td>
          <td>2026-01-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d870ebbff2d4f77ea1c9e4d47b31cd42cc80f053" target='_blank'>
              Bioengineered extracellular vesicles mitigate neuroinflammation by neutralizing pneumolysin and delaying disease onset in experimental pneumococcal meningitis
              </a>
            </td>
          <td>
            Kristine Farmen, Miguel Tofiño-Vian, Doste R. Mamand, Xiuming Liang, Houze Zhou, V. W. Hou, S. El Andaloussi, O. Wiklander, Federico Iovino
          </td>
          <td>2026-01-08</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Neuroinflammation is implicated in the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Amongst potential innate immune mediators of disease, Type I interferon (IFN-I) could play an important role due to its ability to inhibit protein synthesis and affect neuronal synapses and metabolism. These effects could be cell intrinsic or non-cell autonomous mediated by glia or immune cells. We examined IFN-I in rNLS8 mice that have been engineered to express doxycycline suppressible human Transactive response DNA binding protein 43 kDa (hTDP-43) with a defective nuclear localization signal (hTDP-43ΔNLS) regulated by the neurofilament heavy chain (NEFH) promoter. Following induction of hTDP-43ΔNLS in rNLS8 mice, we observed upregulation of IFN-I stimulated genes (ISG) and, specifically, activation of the DNA sensor, cyclic GMP-AMP synthase (cGAS), as determined by mass spectrometry identification of the cyclic dinucleotide, cGAMP, in whole brain. To determine the cellular source of IFN-I, we performed single nucleus RNA sequencing of whole brain. We observed that ISG were most highly upregulated in astrocytes suggesting that astrocytes themselves were largely responsible for IFN-I production and / or response in rNLS8 mice. This observation was confirmed by immunohistochemical and immunofluorescence staining of IFN-I stimulated proteins in astrocytes in the cerebrum, especially in the hippocampus. These results point to a pivotal role of astrocytes in responding to cell damage at a relatively early phase of disease which prior studies have shown is partially reversible.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d3672c44ae4472f3d6ba271aa925d635b19344e3" target='_blank'>
              Neuronal TDP-43 pathology drives astrocytic interferon response in a mouse model of ALS
              </a>
            </td>
          <td>
            Jie An, Nzinga Hendricks, J. Wheeler, Joshua C Hincks, Javier A Ramos Benitez, Jessica M. Snyder, Brian C. Kraemer, Nicole F. Liachko, Keith B. Elkon
          </td>
          <td>2025-12-20</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="ABSTRACT Porcine reproductive and respiratory syndrome virus (PRRSV), a major immunosuppressive pathogen, inflicts substantial economic losses on the global swine industry. Despite extensive research into PRRSV pathogenesis, the mechanisms by which PRRSV induces immune dysfunction in vivo remain incompletely understood. Here, we performed single-cell RNA sequencing on cells isolated from the lung of PRRSV-infected piglets, generating transcriptomic profiles for 46,922 single cells encompassing 15 major cell types. We observed a significant reduction in the number of macrophages in lung tissues, which was primarily attributed to the extensive apoptosis of macrophages induced by PRRSV infection. PRRSV infection triggered aberrant differentiation of macrophage, and the SPP1high macrophage subpopulation was identified as the primary target cells for PRRSV infection. Cell-cell communication analysis revealed that PRRSV infection enhanced ligand-receptor interactions between macrophages and other cell types, associated with inflammatory responses, activation of T cells and B cells, and cell adhesion. In addition, monocytes exhibited a tendency to differentiate into macrophages, potentially compensating for the depletion of macrophages caused by PRRSV infection. Moreover, PRRSV infection caused abnormal development of B cells and incomplete activation of cytotoxic T lymphocytes in the lungs. This study provides a comprehensive characterization of how PRRSV perturbs pulmonary immune cell populations, offering valuable insights into the mechanisms underlying PRRSV-induced lung injury. IMPORTANCE Porcine reproductive and respiratory syndrome virus (PRRSV) has consistently posed a significant and enduring threat to the swine industry. However, the virus-host interactions during in vivo infection in vivo remain poorly understood. In this study, we applied single-cell RNA sequencing to characterize the cellular heterogeneity of lung tissues from PRRSV-infected piglets. Through intracellular viral RNA tracking, we identified SPP1high macrophages as the primary reservoir of PRRSV. Furthermore, we analyzed the cell-cell communication between macrophages and other cell types and investigated the immune responses and heterogeneity of monocytes, T cells, and B cells upon PRRSV infection. Our findings provide a comprehensive single-cell landscape of the complex host-pathogen interplay during PRRSV infection. Porcine reproductive and respiratory syndrome virus (PRRSV) has consistently posed a significant and enduring threat to the swine industry. However, the virus-host interactions during in vivo infection in vivo remain poorly understood. In this study, we applied single-cell RNA sequencing to characterize the cellular heterogeneity of lung tissues from PRRSV-infected piglets. Through intracellular viral RNA tracking, we identified SPP1high macrophages as the primary reservoir of PRRSV. Furthermore, we analyzed the cell-cell communication between macrophages and other cell types and investigated the immune responses and heterogeneity of monocytes, T cells, and B cells upon PRRSV infection. Our findings provide a comprehensive single-cell landscape of the complex host-pathogen interplay during PRRSV infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a411b9a7f498fc257495d61e60998a9d94a15046" target='_blank'>
              Deciphering immune features and cellular heterogeneity in PRRSV infection via single-cell RNA sequencing
              </a>
            </td>
          <td>
            Jianda Li, Yue Liang, Yuyu Zhang, Yulin Xu, Fei Liu, Luogang Ding, Yu Wang, Zhihao Zhang, Zhi Chen, Wenbo Sun, Jiang Yu, Jiaqiang Wu
          </td>
          <td>2025-12-30</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f016d29487af48e626cac97d46f36160ffc4e709" target='_blank'>
              Dual Role of Ninjurin-1 in Myeloid Cell Adhesion and Inflammation in Relapse-Remitting EAE
              </a>
            </td>
          <td>
            Coleen Thompson, Alex Annett, Anastasia Alkhimovitch, Kashish Singh Parihar, Igal Ifergan
          </td>
          <td>2026-01-26</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c37496134da1d54a2727e656c638812c00420ed2" target='_blank'>
              S100A8 aggravates sepsis-associated encephalopathy by promoting PFKFB3-dependent glycolysis and microglial neuroinflammation
              </a>
            </td>
          <td>
            Hongjie Hu, Shu Peng, Jingbo Chen, Dayong Li, Shuhui Wu, Hebin Jiang, Yuru Lu, Yaqin Song, Wei Zhu
          </td>
          <td>2026-01-27</td>
          <td>Inflammation Research</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Pain is a common complication in individuals with HIV, yet the underlying pathogenic mechanisms remain poorly understood. Reactive astrocytes are selectively activated in the spinal dorsal horn of HIV patients experiencing pathological pain, implicating their potential role in pain pathogenesis. However, the specific pathogenic subtype of these reactive astrocytes has not been defined. Here, we identify a distinct subpopulation of pain-associated reactive astrocytes in the lumbar spinal cord of HIV-1 gp120 transgenic mice using single-nucleus RNA sequencing. This astrocyte subpopulation displays transcriptomic features associated with phagocytosis and inflammation and depends on galectin-3 for its formation. Both global and astrocyte-specific heterozygous knockout of Lgals3 (galectin-3) markedly reduce mechanical allodynia in gp120 transgenic mice. These findings reveal a subset of reactive astrocytes that play a role in remodeling the spinal pain circuitry underlying HIV-associated pain. Neuropathic pain is common in HIV patients, but its mechanism is unclear. Here, the authors show that a subpopulation of reactive astrocytes in the spinal cord promotes neuronal loss and drives HIV-associated pain.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/22021c65682652ba28325933340197346e7d7505" target='_blank'>
              Identification of a reactive astrocyte subpopulation during HIV-associated pain pathogenesis in mouse models
              </a>
            </td>
          <td>
            Junying Zheng, Michael S. Spurgat, Mark K Maurelli, Zachary T Watson, Sakib Hossain, Adriana Dibua, Subo Yuan, Xin Liu, Benjamin B. Gelman, Shao-Jun Tang
          </td>
          <td>2025-12-12</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Clinical variability in COVID-19 is partly explained by host genetic factors, including inborn errors of immunity. We investigated a patient with a heterozygous nonsense mutation in the TLR3 gene (p.Trp769*) by generating human-induced pluripotent stem cells (hiPSCs) and differentiating them into lung organoids (hLORGs). TLR3-mutated hLORGs showed reduced basal expression of TLR3 and downstream signaling genes. Following infection with a pseudotyped SARS-CoV-2 virus and live SARS-CoV-2, RNA-Seq and qPCR analyses revealed significant upregulation of fibrinogen genes (FGA, FGG), which are associated with severe COVID-19. Interestingly, TLR3 expression remained inducible upon infection, despite the loss-of-function mutation. Our patient-derived hLORG model recapitulates the pathophysiological features of the patient and provides a platform to investigate host–virus interactions and test targeted therapies for genetically at-risk individuals.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ab1122feba592e78c752f720f21f2f717ed0c328" target='_blank'>
              Modelling severe COVID-19 in TLR3-mutated hiPSCs-derived lung organoids
              </a>
            </td>
          <td>
            A. Latini, P. Spitalieri, F. Centofanti, B. Rizzacasa, Donatella Amatore, G. Grilli, Riccardo De Santis, Lorenzo Vaccaro, V. L. Colona, Giulio Puleri, A. Nardone, M. Biancolella, Elena Campione, L. Sarmati, Paola Rogliani, Davide Cacchiarelli, A. Novelli, Federica Sangiuolo, F. Lista, Giuseppe Novelli
          </td>
          <td>2025-12-26</td>
          <td>Cell Death Discovery</td>
          <td>0</td>
          <td>40</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/13e1f702334b4573a1884e3b676c8b55f48f2598" target='_blank'>
              Diminished EBV-Specific Humoral Immunity is Associated with Neuropsychiatric Long COVID Development up to 12 Months Post-COVID-19 Symptom Onset
              </a>
            </td>
          <td>
            Philip Samaan, P. Budylowski, Victoria Russell, Jeevitha Srighanthan, A. M. Cheung, Mario Ostrowski
          </td>
          <td>2026-01-28</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Abstract Objective Examine the role of T cells in shaping and sustaining humoral immunity to SARS‐CoV‐2 and identify immune factors associated with durable antibody responses. Methods Unvaccinated adults (n = 67) with SARS‐CoV‐2 infection (Wuhan) of any severity were followed longitudinally for up to 14 months. Anti‐Spike (S) binding and neutralising antibodies were measured. Bulk T cell IFNγ and IL‐2 responses were assessed by Fluorospot to multiple viral proteins. S‐specific T‐cell subsets and functions were analysed in detail by flow cytometry in a subset of participants (n = 14), combining activation‐induced markers (AIMs) and cytokines. Correlations between S‐specific T‐cell subsets, their polyfunctionality and antibody levels over time were defined. Results Over 14 months post infection, anti‐S IgG and neutralising antibodies declined significantly but remained detectable in > 85% of participants. Bulk T‐cell IFNγ and IL‐2 responses persisted without significant reduction. However, S‐specific CD4 T cells declined over time. A large proportion of these were peripheral helper T cells (Tph; CXCR5−PD‐1+), which were the main producers of IL‐21 and showed marked polyfunctionality during early convalescence, in contrast to circulating follicular helper T cells (cTfh). The early presence of polyfunctional, IL‐21‐producing Tph strongly correlated with S‐specific IgG and neutralising antibodies early post‐infection and predicted neutralising antibody maintenance a year later. Older age correlated with higher Tph and antibody levels. Conclusion Early S‐specific T‐cell responses—particularly polyfunctional, IL‐21‐producing Tph cells—play a key role in sustaining durable antibody levels post‐infection, offering insights for future vaccine strategies and understanding long‐term immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/63995037b8ae83290f6bb5ffec2deaef5580d4b2" target='_blank'>
              Polyfunctional T peripheral helper cells are associated with the magnitude and durability of antibody responses after COVID‐19
              </a>
            </td>
          <td>
            Katie Tungatt, Gabriela Martins Costa Gomes, Nicole L. Fewings, Aija Stubis, C. Doyle, V. Merheb, A. Aggarwal, K. Byth, Harry Robertson, S. Dervish, Susan Maddocks, Janette Taylor, R. Bull, M. Martinello, F. Brilot, S. Turville, Anthony L. Cunningham, K. Sandgren
          </td>
          <td>2025-01-01</td>
          <td>Clinical & Translational Immunology</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="Sepsis is a life-threatening condition arising from a dysregulated host response to infection, characterized by a complex interplay between pro-inflammatory and anti-inflammatory immune mechanisms. B cells, that are key components of humoral immunity, are essential for antibody production, antigen presentation, and immune modulation. Sepsis is commonly associated with B cell lymphopenia, particularly in severe cases, as evidenced by a marked reduction in circulating B cells in both adult and pediatric patients. However, the mechanisms driving this depletion have not been completely understood, particularly in pediatric sepsis. In this study, we employed single-cell RNA sequencing (scRNA-seq) to profile peripheral blood leukocytes from pediatric patients with sepsis (three with mild and three with severe condition) alongside four healthy controls. Our analysis revealed a broad depletion of immune cells in sepsis, with B cells showing the most pronounced reduction and the strongest capacity to discriminate between mild and severe disease states. Subset-level analysis identified significant loss and transcriptional reprogramming of natural killer-like B cells (ΝΚΒ), MHC IIhighnaïve, and MHC IIlownaïve B cells in severe sepsis, accompanied by signatures indicative of intrinsic and extrinsic apoptosis, disrupted differentiation, and enhanced migratory potential. Importantly, we identified and validated the population of NKB cells in both pediatric and adult cohorts, broadening the known landscape of B cell phenotypes in human sepsis. We also explored intercellular communications, focusing on B cell-neutrophil interactions, given the notable neutrophilia observed, revealing potential crosstalk that may contribute to the overall immune dysregulation in sepsis. Collectively, these findings offer new insights into the cellular and molecular drivers of immune dysfunction in pediatric sepsis, shedding light on B cell depletion as a central feature of disease severity. This work lays the foundation for future diagnostic and therapeutic strategies targeting B cell-mediated immunity in septic children. The study was registered on ClinicalTrials.gov (NCT04103268), with registration date on 2019-09-23, before the first patient was enrolled.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bce54efd110fde03077139b1afa9c1f4e6856c6b" target='_blank'>
              Single-cell analysis of B cell dysregulation in pediatric sepsis stratified by disease severity
              </a>
            </td>
          <td>
            Fahd Alhamdan, Stefano Gianoli, Koichi Yuki, S. Koutsogiannaki
          </td>
          <td>2025-12-31</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="Infection-associated thymic atrophy is common and results in T-cell imbalance and immune dysfunction. Severe dengue, caused by infection with the dengue virus (DV), is associated with perturbation of T cell functions. However, it is unclear whether perturbation of T cell functions is linked to changes in thymic function during dengue infection. Herein, we employed a dengue virus serotype 2 (DV-2)-infected mouse model and Neonatal Thymic Organ Culture (NTOC) to study the impact of DV-2 infection on thymic function. Further, the contribution of infiltrating immune cells, especially myeloid cells, and reactive oxygen species (ROS) in the thymus on DV-2-induced thymic atrophy was studied by depleting Gr-1 + myeloid cells and quenching ROS in mice. We have demonstrated that DV-2 infection caused a massive thymic atrophy, dominated by a loss of CD4+ CD8+ double-positive (DP) thymocytes, reduction in naïve T cells in blood and spleen, a significant increase in the infiltration of myeloid cells, and a reactive oxygen species (ROS) burst in the thymus. Using Neonatal Thymic Organ Culture (NTOC), we confirmed that DV-2 infection alone cannot induce thymic atrophy. Further, we documented that depletion of Gr-1 + myeloid cells, or quenching of ROS using N-acetylcysteine (NAC) during DV-2 infection, partially protected thymic architecture. This protection of thymus function is also reflected in the thymic interstitial fluid proteome profile, where myeloid cells depletion or NAC treatment in DV-2-infected mice confirmed the reversal of protein expression associated with oxidative stress and neutrophil degranulation pathways within the thymus. Further, managing oxidative stress also influenced cytokine production by T cells in the spleen of infected mice. Thus, our study confirms that thymic atrophy does not depend on viremia level but on the interaction between immune cells and the virus, highlighting the contribution of infiltrating myeloid cells and, thus, ROS in DV-2-associated thymic atrophy. Dengue virus serotypes 2 & 3 (DV-2, DV-3) infection, but not serotype 1 (DV-1), leads to thymic atrophy in an experimental mouse model. Thymic atrophy depends not on the viremia level but on the specific host-virus interaction. Myeloid cells abundance and ROS level affect thymic output in severe dengue. The thymic interstitial fluid (TIF) protein profile reflects the atrophied. and non-involuted thymus status. Myeloid cells depletion or ROS quenching reverses the thymic atrophy-associated proteins in the TIF. ROS inhibition modulates the cytokine expression profile of T cells in the splenocytes of DV-2-infected mice.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8942ce52edd462ca76dfcec73d01cf4c11f1f50e" target='_blank'>
              Depletion of myeloid cells in AG129 mice reduces the infection-mediated oxidative stress and restrains dengue virus-induced thymic atrophy
              </a>
            </td>
          <td>
            B. Kusuma, Surender Rawat, Oindrila Saha, Sakshi Nimesh, Srikanth Sadhu, Amit Awasthi, T. K. Maiti, Arup Banerjee
          </td>
          <td>2025-12-06</td>
          <td>Cell Communication and Signaling : CCS</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/92b1464e350c468b0e960f74f8db814fa5f708d3" target='_blank'>
              Molecular signature of COVID-19 prior to its exacerbation by multi-omics survey
              </a>
            </td>
          <td>
            Tomoyuki Suzuki, Yoshihiro Kita, Keisuke Yanagida, Kenji Maeda, T. Hashidate-Yoshida, Hiroki Nakanishi, Takayo Ohto-Nakanishi, J. Terada-Hirashima, Yoshie Tsujimoto, Masayuki Hojo, H. Mitsuya, Takao Shimizu, Hideo Shindou
          </td>
          <td>2025-12-30</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0b1d9f79a0aea2296171fb92a1b3d1203b20d46c" target='_blank'>
              IgA-driven neutrophil activation underlies severe dengue disease after primary Zika virus infection in humans
              </a>
            </td>
          <td>
            Jaime A. Cardona-Ospina, Vicky Roy, Dorca E Marcano-Jiménez, S. Bos, Elias M. Duarte, J. V. Zambrana, Agamjot Bal, Boyeong K An, A. G. Dias, Julia A. Zhiteneva, J. Huffaker, C. Montenegro, G. Kuan, M.J. Ramos-Benitez, Á. Balmaseda, G. Alter, Eva Harris
          </td>
          <td>2026-01-01</td>
          <td>Nature Immunology</td>
          <td>1</td>
          <td>67</td>
        </tr>

        <tr id="Influenza is an acute respiratory infectious disease caused by the influenza virus, which has been circulating in humans for over a century. In contrast, COVID-19, caused by the novel SARS-CoV-2, emerged recently in December 2019. Following nearly four years of pandemic, the acute phase of SARS-CoV-2 has transitioned towards an endemic state, suggesting a trend of long-term coexistence with humans. Concurrent or sequential coinfection with influenza and SARS-CoV-2 has been clinically observed to exacerbate pulmonary pathology and systemic inflammation in affected individuals. This review discusses the impact and elucidates the potential underlying mechanisms by which influenza and SARS-CoV-2 coinfection aggravates local lung injury and systemic host responses, aiming to inform improved prevention and clinical management strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2322642c46c964d010a337ffc642b56652fa15cc" target='_blank'>
              Local and systemic host responses to influenza and concurrent or sequential SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Tong Zhu, Liying Wang, Chaoying Yan
          </td>
          <td>2026-01-21</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Alzheimer’s disease (AD) presents with a sex bias in which women are at higher risk and exhibit more rapid cognitive decline and brain atrophy compared to men. Microglia play a significant role in the pathogenesis and progression of AD and have been shown to be sexually differentiated in health and disease. Whether and how microglia contribute to the sex differences in AD remains to be elucidated. Herein, we characterized the sex differences in amyloid-beta (Aβ) plaque pathology and microglia-plaque interaction using the 5xFAD mouse model and revealed microglial transcriptomic changes that occur in females and males. Despite women with symptomatic late-onset AD being in the post-menopausal stage, metabolic and pathological changes are seen prior to menopause. For this reason, and because Aβ pathology develops decades prior to clinical presentation, we focused on two hormonally distinct stages of the female rodent estrous cycle (proestrus and diestrus). Our results showed that Aβ plaque morphology is sexually distinct, with females having greater plaque volume and lower plaque compaction compared to males of the same age. Neuritic dystrophy was also increased in female 5xFAD mice, independent of estrous cycle stage. While microglia transcriptomes were not overtly different at the proestrus or diestrus stages, female 5xFAD microglia upregulated genes involved in glycolytic metabolism, antigen presentation, disease-associated microglia, and microglia neurodegenerative phenotype compared to males, some of which have been previously reported. In addition, we found a novel female-specific enhancement of IFN signaling in microglia, as evidenced by a striking proportion of differentially expressed type 1 interferon genes characteristic of interferon-responsive microglia (IRM). Finally, we validated our transcriptomic results at the protein level and observed that female 5xFAD mice had an enrichment in Aβ+ IRMs compared to males. Collectively, we show that there are sex-specific alterations in Aβ plaque morphology and that endogenous hormonal fluctuations across the estrous cycle do not overtly affect Aβ pathology or microglial transcriptomic profiles. Furthermore, our study identifies a novel sex-specific enhancement of interferon signaling in female microglia responding to Aβ, which may constitute a new therapeutic target for personalized medicine in AD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4995ad110fd928d03a9ee384dbf57ef7115e5bfb" target='_blank'>
              Microglial interferon signaling and Aβ plaque pathology are enhanced in female 5xFAD Alzheimer’s disease mice, independent of estrous cycle stage
              </a>
            </td>
          <td>
            L. Calcines-Rodríguez, N. Noyes-Martel, J. L. Becker, S. K. Nguyen, M. Osabutey, L. A. Trojanczyk, A. Majewska, M. K. O'Banion
          </td>
          <td>2025-12-27</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="Long COVID (LC) is a long-term debilitating disease of which the exact pathophysiology is unknown. A dysregulated immune response resulting in hyperresponsive immune cells is hypothesized as a key mechanism in the development of LC. Several studies suggest that acute infections can leave lasting epigenetic changes, which result in heightened immune reactivity. Upon stimulation, these primed immune cells may exhibit exaggerated responses. This form of epigenetic memory can contribute to altered immune dynamics, particularly in response to induction of type I Interferons (IFN-I) pathway activation using a viral mimic. Therefore, we investigated if LC patients exhibit a hyperresponsive response towards viral mimics in comparison with healthy controls (HC). PBMCs of two distinct LC cohorts, characterized by a different disease course and duration, were collected and transfected using Lyovec with the cGAS and RIG-I agonists G3-YSD and 3p-RNA followed by measurement of IFN-I bioactivity with a reporter cell line. Transfection of PBMCs of LC patients with the cGAS and RIG-I agonists resulted in increased IFN-I bioactivity in comparison with HC. Unsupervised hierarchical clustering revealed two distinct clusters, each predominantly composed of either patients or HC. In addition, a moderate correlation between RIG-I stimulation with 3p-RNA and fatigue severity scores was found. These data show a hyperresponsive phenotype of immune cells of LC patients upon stimulation with viral mimics. The current availability of biologicals and small molecule inhibitors that interfere with aberrant IFN-I pathway activation underscores the importance of pursuing future investigations into this phenomenon.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a860b1f890cd6919e6ed4f49c16018a6906fcd8a" target='_blank'>
              Exaggerated IFN-I Response in Long COVID PBMCs Following Exposure to Viral Mimics
              </a>
            </td>
          <td>
            Bart Humer, J. Berentschot, C. V. van Helden-Meeuwsen, L. Bek, Maaike de Bie, Tobias M Defesche, Chantal A Boly, Manon Drost, M. Hellemons, W. Dik, M. Versnel
          </td>
          <td>2025-12-10</td>
          <td>Journal of Clinical Immunology</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1a6c6fb0d7fc812c84dff6e5379a1c49e11b27d9" target='_blank'>
              Targeting HMGB1 in Microglia Alleviates Neuroinflammation and Modulates the Pro-/Anti-inflammatory Balance of Microglia/Macrophages in Experimental Autoimmune Encephalomyelitis
              </a>
            </td>
          <td>
            Yuzhen Li, Haoyu Wang, Siyu Yang, ·. E. Du, Jiapei Dai, Fang Zheng, Jiawen Lei, Huoying Chen, Yan Sun, Yuzhen Li, Ke Lei
          </td>
          <td>2026-01-01</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/71d5ba039c8b0bb25394b26c19a0184e39b35b47" target='_blank'>
              Modelling ferroptosis in a human microglial line by sequential exposure to iron and GPX4 inhibition
              </a>
            </td>
          <td>
            Renaud Bussiere, Nikhil Tulsian, Cecilia Wieder, Dewi McConnaughie, Evie Tynan, Andrew Lowe, Esther Cheow, Matthew Choo, Jill Richardson, James A. Duce, 
          </td>
          <td>2026-01-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Microglial dysfunction has emerged as a critical factor in the Alzheimer’s Disease (AD), with innate immune dysregulation driving pathological progression. This growing understanding has shifted attention toward the therapeutic modulation of glial response as a means to restore immune balance and promote neuronal resilience. Increasing attention has also focused on small-molecules capable of reprogramming microglia toward a reparative, surveillance-competent phenotype that enhances Amyloid-β (Aβ) clearance while limiting detrimental neuroinflammation. In this context, we previously reported that Sulfavant A (SULF A), a novel synthetic sulfolipid, binds to Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) and activates myeloid cells without inducing inflammatory hallmarks. The immunomodulatory properties of SULF A were characterized using biochemical, molecular, and cell biological approaches in primary murine microglia. The small modulatory molecule SULF A was synthetically produced in our laboratory. Functional assays included quantitative analyses of phagocytosis using standard beads and fluorescently labeled Aβ peptides, designed and synthesized considering tag emission and fiber aggregation. Aβ aggregation was characterized using biophysical and biochemical methods to ensure well-defined assemblies in microglial assays. To assess translational relevance, SULF A was evaluated at two distinct time points, before and after Aβ plaque deposition, in Tg2576 transgenic mice, a well-established AD model, to determine its neuroprotective potential and therapeutic efficacy. We demonstrate that the small-molecule TREM2 ligand SULF A functions as an immunomodulator that reprograms microglia toward a reparative phenotype. It promotes a ramified and polarized microglial morphology associated with enhanced cellular motility, phagocytic capacity and clearance of neurotoxic Aβ peptides. SULF A upregulates arginase expression, downregulates inducible Nitric Oxide Synthase (iNOS), and redirects microglial metabolism toward tissue-protective functions. This phenotypic shift is characterized by increased TREM2 turnover and upregulation of CD68 and CCL2, without triggering classical inflammatory hallmarks. In vivo, SULF A enhances plaque‑associated microglial recruitment, reduces plaque burden, preserves midbrain dopaminergic neurons, and improves cognitive and motivational performance in Tg2576 mice. We propose that SULF A is a promising therapeutic small molecule that restores microglial homeostasis via an inflammation-sparing mechanism. It enhances amyloid clearance, preserves vulnerable neurons, and improves cognitive function in vivo. These findings support SULF A as a disease-modifying approach that extends beyond conventional plaque-targeting strategies in AD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9aba401534af5fd0dcfbf2afe013207ee3a9d0dd" target='_blank'>
              Microglial clearance, neuroprotection and cognitive recovery via a novel synthetic sulfolipid in Alzheimer’s disease
              </a>
            </td>
          <td>
            Carmela Gallo, Lucia Verrillo, E. Manzo, Emma Cauzzi, Livia La Barbera, Giuseppina Sabatino, Maria Luisa De Paolis, Michele Francesco Maria Sciacca, Giusi Barra, Elisa Peroni, O. Monasson, Mario dell’Isola, Dalila Carbone, Annalisa Nobili, Marcello Ziaco, Laura Fioretto, Marinella Pirozzi, G. d’Ippolito, Daniela Castiglia, Andrea Soluri, Genoveffa Nuzzo, Danilo Milardi, M. Miano, Marcello D’Amelio, Angelo Fontana
          </td>
          <td>2025-12-13</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="The upper respiratory epithelium protects the airway from microbial exposure, environmental irritants, and viral pathogens such as influenza A virus (IAV). Situated at the airway–gastrointestinal junction, the larynx must integrate this barrier function with fine neuromuscular control under constant immune stimulation. Clinical syndromes such as post-viral vagal neuropathy—marked by chronic cough, throat clearing, dysphonia, and vocal fatigue—highlight critical gaps in our understanding of how the larynx and upper airway remodel after viral injury. To address this, we employed mouse models integrating genetics, imaging, and single-cell transcriptomics to dissect IAV-induced injury and repair in the upper respiratory tract. IAV infection displayed regionally restricted tropism toward ciliated, secretory, neuroendocrine, and basal epithelial cells, eliciting rapid clearance, acute neutrophil invasion, and a sustained intraepithelial population of cytotoxic CD8+ natural killer T (NKT)-like cells. Single-cell analysis revealed injury-induced Myc expression in KRT5+ basal progenitors, which activated a proliferative repair program and an epithelial–immune communication circuit centered on a MYC-dependent CXCL10–CXCR3 axis. Basal-specific Myc deletion preserved viral replication and clearance but blunted injury-induced proliferation, skewed lineage differentiation, and impaired CD8+ NKT cell recruitment. These findings define a coordinated epithelial–immune program governing post-IAV mucosal restoration and offer mechanistic insight into persistent upper airway sequelae.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/561fc69832beac4c1e41655e3f435bfb03fefa41" target='_blank'>
              Oncogene c-Myc Regulates Upper Respiratory Epithelial Repair for Host Immunity During Acute Influenza Infection
              </a>
            </td>
          <td>
            Alexander G. Foote, Le Xu, J. Verheyden, Belle Pan, Nikita Katoch, Xin Sun
          </td>
          <td>2025-12-23</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection causes not only acute respiratory illness but also dysregulated immune responses, including autoimmunity and hypersensitivity reactions, which can worsen outcomes. SARS-CoV-2 infection, known publicly as COVID-19 disease, has presented a complex clinical landscape ranging from asymptomatic infection to SARS and multi-organ failure. Beyond direct viral damage, the pathogenesis of COVID-19 is heavily driven by immune dysregulation, which causes allergic-type reactions. Nutritional status and immunonutrition further modulate these processes and play a critical role. Vitamins C and D are essential for immune competence, with vitamin C serving as an antioxidant that supports barrier integrity and leukocyte function. In contrast, vitamin D regulates innate and adaptive responses. The intake of essential nutrients could be a strategic approach to bolster the innate and adaptive immune systems, aiming to prevent infection and mitigate disease severity. Saliva and oral health are increasingly recognized as central to COVID-19 immunopathology, both as diagnostic media and as immunological barriers. This review synthesizes recent findings on autoimmune phenomena, hypersensitivity reactions, immunonutrition, and oral health in SARS-CoV-2 infection, highlighting mechanisms and clinical implications.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9cd7d982a49e201c0783b28ad3d1e949e2b88e75" target='_blank'>
              Immune Dysregulation and Nutrition in SARS-CoV-2 Infection: An Integrated Review with Oral Health Perspectives
              </a>
            </td>
          <td>
            Bernadeth Vindi Januarisca, Imme Kris Wicaksono, Cindy Karina Hartono, Ivan Djuarsa
          </td>
          <td>2026-01-31</td>
          <td>International Journal of Science and Research Archive</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Dogs play a major role in sustaining transmission of Leishmania infantum to people, thus prevention and treatment of canine leishmaniosis (CanL) to reduce transmission represents an unmet public health need. Although advances have been made in understanding how immunopathology correlates to infectiousness as CanL progresses, the immune mechanisms underlying transition between disease stages and terminal decline remain ill-defined. To address this knowledge gap, we generated a comprehensive atlas of peripheral immune cells from control dogs and naturally-infected dogs using single-cell RNA sequencing. The LeishDog Atlas captures the cellular and transcriptional complexity underlying CanL, tracing shifts in immune composition and gene expression across progressive, well-defined disease stages. Notably, we identified distinct myeloid, CD4+ and CD8+ T cell phenotypes and transcriptional states associated with disease progression. This resource provides a valuable framework for understanding systemic immune dysregulation in CanL, including determinants of T cell exhaustion and myeloid cell activation, and establishes a foundation for comparative, translational, and mechanistic studies of CanL immunopathology and transmissibility.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8412687f28e64e4d6b2558529c494e2ee4440eca" target='_blank'>
              A single-cell transcriptomic atlas of peripheral blood immune cells spanning progressive canine leishmaniosis
              </a>
            </td>
          <td>
            Danielle P. Uhl, Daniel J. Holbrook, Max C Waugh, S. Dey, Najmeeyah Brown, Karen I. Cyndari, Jacob J. Oleson, Paul M. Kaye, Christine A. Petersen
          </td>
          <td>2025-12-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating but poorly-understood disease. ME/CFS symptoms include immune system effects alongside incapacitating fatigue and post-exertional disease exacerbation. Symptom severity can range from mild to severe and whilst symptoms can fluctuate, few people fully recover. Immunological profiles of people living with ME/CFS were analysed by flow cytometry, focusing on cytotoxic cells, to determine whether people with mild/moderate (n = 43) or severe ME/CFS (n = 53) expressed different immunological markers. Flow cytometry data were tested for normality and the two clinical groups were compared by t-test or Mann-Whitney U-test as appropriate. People with mild/moderate ME/CFS had increased expression of cytotoxic effector molecules alongside enhanced proportions of early-immunosenescence cells, determined by the CD28-CD57- phenotype, indicative of persistent viral infection. In contrast, people with severe ME/CFS had higher proportions of activated circulating lymphocytes, determined by CD69+ and CD38+ expression, and expressed more pro-inflammatory cytokines, including interferon-γ, tumour necrosis factor and interleukin-17, following stimulation in vitro, indicative of prolonged non-specific inflammation. These changes were consistent across different cell types including CD8+ T cells, mucosal associated invariant T cells and Natural Killer cells, indicating generalised altered cytotoxic responses across the innate and adaptive immune system. These immunological differences likely reflect different disease pathogenesis mechanisms occurring in the two clinical groups, opening up opportunities for the development of prognostic markers and stratified treatments.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a1e6b2fa3ad265819948a6a86e70aa620144d602" target='_blank'>
              Abnormal T-Cell activation and cytotoxic T-Cell frequency discriminate symptom severity in myalgic encephalomyelitis/chronic fatigue syndrome
              </a>
            </td>
          <td>
            Ji-Sook Lee, E. Lacerda, Caroline C. Kingdon, Ella Abken, Giada Susannini, H. Dockrell, L. Nacul, J. Cliff
          </td>
          <td>2025-12-10</td>
          <td>Journal of Translational Medicine</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/648fff5e794cabf595a6a989b3a6fca738f1f3d2" target='_blank'>
              MAPKAP Kinase 2 Orchestrates Memory T Cell Inflation in Cytomegalovirus Infection
              </a>
            </td>
          <td>
            Eleni Panagioti, Xueyang Yu, Yi Wen Kong, Kristina Makakova, Noe B. Mercado, Sean E. Lawler, Michael B. Yaffe, Charles H. Cook
          </td>
          <td>2026-01-20</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="HIV-associated neurocognitive disorder (HAND) is characterized by glial activation and neuroinflammation emerging from HIV infection. Moreover, methamphetamine (METH) is a highly addictive psychostimulant whose use is linked to high HIV prevalence, significantly worsening clinical outcomes for people living with HIV and hastening onset of systemic illness. Overall, pathologies associated with HIV infection/METH use comorbidity include neuroinflammation, neurotoxicity, synaptodendritic damage, and resulting cognitive dysfunction. However, mechanisms underlying this neuropathogenesis remain elusive due to the scarcity of human brain-specific experimental model systems. Therefore, we created a next-generation three-dimensional (3D) human brain model derived from human induced pluripotent stem cells (hiPSCs). Specifically, this 3D in vitro cerebral assembloid model integrates functional microglia derived from hiPSCs with cerebral organoids. Microglia are key contributors to HAND symptoms associated with HIV/METH comorbidity. We show that the presence of microglia in this assembloid model allows productive infection with HIV, which is enhanced by METH exposure, resulting in increased glial activation, inflammatory responses (namely IL-1β and IL-6 release), and neurotoxicity marked by neuronal cell death and synaptic protein loss. Importantly, in this model, we observed markedly decreased levels of the microglial receptor TREM2, which is implicated in microglial functions including phagocytosis, apoptosis and inflammatory responses following HIV infection and METH treatment. Analysis of our model showed that decreased TREM2 function may lead to HIV- and METH-associated pathological changes. Overall, our assembloid model could be a valuable tool for future analyses of HIV/METH/CNS interactions and mechanisms underlying HAND, which could lead to novel therapeutic approaches to decreasing the CNS viral reservoir.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ffac3d500bac8bf3422011ef75e52fe379d437e3" target='_blank'>
              Investigation of CNS damage following HIV infection and methamphetamine exposure using human iPSC-derived microglia and 3D cerebral assembloid models
              </a>
            </td>
          <td>
            S. Tiwari, Gulshanbir Baidwan, S. Trescott, Shweta Jakhmola, N. Coufal, Tariq M. Rana
          </td>
          <td>2025-12-10</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the third highly pathogenic coronavirus to emerge in humans in recent decades. Although primarily a respiratory virus, SARS-CoV-2 can invade the central nervous system (CNS), leading to severe neurological manifestations such as stroke, encephalopathy, and memory loss. However, the mechanisms by which neural cells control SARS-CoV-2 infection remain poorly understood. Here, we demonstrate that SARS-CoV-2 and its Nucleocapsid (N) and Spike (S) proteins induce classical NLRP3 inflammasome activation in astrocytes. Notably, astrocytes lacking NLRP3 or caspase-1 exhibit higher viral loads, indicating a crucial role of the NLRP3 inflammasome in astrocyte-mediated viral control. Similarly, gasdermin-D (GSDMD)-deficient astrocytes display increased susceptibility to infection, although their LDH release remains unaffected, suggesting that pyroptosis is not required for viral restriction. Instead, GSDMD deficiency leads to markedly reduced IL-1β secretion, and exogenous IL-1β rescues the impaired antiviral response in NLRP3-, caspase-1-, and GSDMD-deficient astrocytes. Our findings reveal that astrocytes autonomously control SARS-CoV-2 infection via the NLRP3-GSDMD-IL-1β axis, underscoring their active role in the neuroimmune response to viral infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/136f69bd7deca72975cec306cf3a4c28e3a9afc4" target='_blank'>
              NLRP3 inflammasome activation in astrocytes restricts SARS-CoV-2 through gasdermin-D-driven IL-1β release
              </a>
            </td>
          <td>
            I. S. de Farias, Márcia Duarte-Barbosa, Natalia Salazar, Robert Andreata-Santos, Victoria Weise L. de Lucena, J. Maricato, R. Gazzinelli, L. M. R. Janini, K. Bortoluci
          </td>
          <td>2026-01-20</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ebd7c1c95a72fa42446be74525f1dfe8c58ae064" target='_blank'>
              Decoding acute neuroinflammatory states from the 3D architecture of in vitro microglia
              </a>
            </td>
          <td>
            Anthoula Chatzimpinou, Johanna Huber, Xenia Podlipensky, J. Cairns, Ayse Erozan, Jian-Hua Chen, V. Loconte, M. Le Gros, Carsten Hopf, Carolyn A Larabell, V. Weinhardt
          </td>
          <td>2025-12-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1ebef12370aba49b0c9a0e8c7f942ab6de71a9e9" target='_blank'>
              Pharmacological intervention targeting neuroimmune axis in the aging hypothalamus prevents age-associated physiological decline
              </a>
            </td>
          <td>
            Min-Jong Seok, Na-Kyung Lee, In-Seop Sim, Jumi Kim, Kelvin Pieknell, T. Stein, Jung-Hee Lee, Hoon Ryu, Seung-Hyup Song, J. Seong, Il-Yong Kim, Eun Ha Ko, Yanuar Alan Sulistio, Sang-Hun Lee
          </td>
          <td>2026-01-12</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>56</td>
        </tr>

        <tr id="Background and Objectives Interleukin-9 (IL-9) is an immune molecule with multiple roles in a variety of cell types. IL-9–induced cell responses are mediated by the IL-9 receptor (IL-9R). Recent evidence demonstrates that expression of IL-9R in post mortem brain tissues of patients with multiple sclerosis (MS) is associated with a protective, anti-inflammatory role of IL-9 in MS. In this study, we investigated the expression of IL-9R in cells resident in the CNS of patients with MS. We found that astrocytes express IL-9R, indicating their expected responsiveness to IL-9. Astrocytes play a critical role in MS, where the inflammatory environment turns them into reactive cells, which actively contribute to the disease. The transcription factor nuclear factor-kB (NF-kB) regulates the response of reactive astrocytes and their potential pathogenic activities during CNS inflammation. Methods To address the role of IL-9 in proinflammatory astrocytes, we used 3 different human in vitro models: (1) human astrocytoma cell line (U-373 MG), (2) primary normal human astrocytes, and (3) induced pluripotent stem cell–derived astrocytes. We used interleukin-1β for their conversion into proinflammatory astrocytes. Results We found that IL-9 contributes to the switch of astrocytes from an inflammatory to an anti-inflammatory profile by downregulating NF-kB activation. Moreover, we demonstrated that IL-9 inhibits granulocyte-macrophage colony-stimulating factor (GM-CSF) expression driven by NF-kB. Discussion Because GM-CSF production by astrocytes is linked to microglial activation and CNS inflammation, these results indicate that IL-9 regulates the astrocyte-microglia axis and has potential therapeutic anti-inflammatory implications in MS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/68caea23e18c5a4cd499ee0619116e5884afc207" target='_blank'>
              Interleukin-9 Regulates NF-kB-Mediated Activation of Astrocytes in Multiple Sclerosis Brain
              </a>
            </td>
          <td>
            Miriam Cinotti, Susanna Amadio, Daniele Tidei, Gloria Donninelli, Costanza Stacchiotti, Veronica De Paolis, Emanuela Colombo, Anthea De Angelis, F. Ruffini, Gianvito Martino, Cinthia Farina, Chiara Parisi, C. Volonté, Elisabetta Volpe
          </td>
          <td>2026-01-13</td>
          <td>Neurology® Neuroimmunology & Neuroinflammation</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="

 During the COVID-19 pandemic, it became evident that an infection with SARS-CoV-2 is associated with an increased predisposition for thrombembolic events. Recent studies suggest an excessive neutrophil extracellular trap (NET)-formation in response to SARS-CoV-2, which is considered a hallmark in immunothrombosis. A better understanding of the (dys)regulation of NET-formation in COVID-19 may provide the basis for new therapeutic strategies.



 We conducted a pilot study with a total of 84 patients in three groups matched in a 1:1:1 fashion: Group 1: patients with acute ischemic stroke (AIS) or transient ischemic attack (TIA) and SARS-CoV-2 infection, Group 2: patients with AIS and no SARS-CoV-2 infection and Group 3: patients with SARS-CoV-2 infection and no AIS or TIA. Venous blood samples were collected from all patients and subsequently analyzed for NET-specific markers, NET regulators (Deoxyribonuclease (DNase) activity) and a panel of cytokines.



 Citrullinated histone3 (H3cit) and elastase levels were higher in groups with SARS-CoV-2 infection (Groups 1 and 3) compared to patients without ((group 1: H3cit = 2.9 (1.11–6.89) ng/mL, elastase = 312.1 (162–435.4) ng/mL and group 3: H3cit = 3.31 (2.03–7.97) ng/mL and elastase = 433.1 (281–783.8) ng/mL) vs. group 2: H3cit = 1.17 (0.61–2.15) ng/mL), elastase = 195.1 (91.99–386.9) ng/mL). No relevant differences were found regarding other measured NET-marker (myeloperoxidase, LL-37). DNase activity was lower in group 1 (6.12 (4.97–6.78) pmol/mL/min) compared to both other groups (group 2: (7.16 (5.88–7.85) pmol/mL/min) (p=0.018) and group 3 (7.19 (5.52–8.54) pmol/mL/min) (p=0.013).



 This pilot data suggest that a disturbed regulation of NETs in patients with SARS-CoV-2 infection may play a role in SARS-CoV-2 associated cerebral ischemia. These results highlight the importance of further investigating the role of NETs in immunothrombosis in the context of viral infections, to better understand its potential as a target for therapeutic strategies.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/02ea051bb7193e24e5a7fbf922a5dd16ac43e2d3" target='_blank'>
              Disturbed regulation of immunothrombosis in cerebral ischemia associated with SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Richard Plem, N. de Buhr, Rabea Imker, Silke Akhdar, Marita Meurer, Christine S. Falk, Johanna Ernst, M. Gabriel, J. Keil, Verena Kopfnagel, Thomas Illig, Karin Weissenborn, Sabine Blaschke, Isabel Bröhl, Christoph Römmele, Gerrit M. Grosse, R. Schuppner
          </td>
          <td>2026-01-29</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="T lymphocyte dysfunction is closely associated with immunosuppression in sepsis, whereas the underlying mechanisms are not fully understood. In this study, we established a mouse model of cecal ligation and puncture (CLP)-induced sepsis and observed immunometabolic alterations in splenic T cells. Serum energy metabolites related to glycolysis and the tricarboxylic acid (TCA) cycle were imbalanced. Splenic T cells from septic mice showed a shift in subset distribution, with decreased naïve T cells and increased effector populations, along with concurrent activation and exhaustion phenotypes. Notably, mitochondrial mass and mitochondrial membrane potential were significantly diminished in both CD4+ and CD8+ T cell, correlated with increased programmed cell death protein 1 (PD-1) expression. Transmission electron microscopy further confirmed mitochondrial morphological alterations in CLP-derived CD3+ T cells. Furthermore, seahorse assays demonstrated impaired metabolic reprogramming capacity in activated CLP splenic CD3+ T cells, with suppressed glycolytic and oxidative phosphorylation responses. This impairment was coupled with reduced fold-increases in mitochondrial mass and mitochondrial membrane potential levels upon activation in both CD4+ and CD8+ T cell compared to controls. Clinically, peripheral T cells from septic patients showed elevated CD69 and PD-1 expression, a significant increase in CD39 and a decrease in CD73, increased mitochondrial mass and decreased mitochondrial membrane potential, particularly in those with septic shock. Our findings provide several layers of T cell dysfunction in sepsis, linking subset redistribution, an exhausted phenotype, mitochondrial impairment, and reduced proliferative capacity, suggesting that future therapeutic interventions aiming to reverse sepsis-induced immunosuppression may require a combinatorial approach.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e08abe28f3c28414caf3aa09b75259bdbaacb3ca" target='_blank'>
              T cell immunometabolic dysfunction in a mouse model of cecal ligation and puncture-induced sepsis
              </a>
            </td>
          <td>
            Xiaojun Liu, Liting Mai, Peiyu Li, Zhong Chen, Zhijian Yu
          </td>
          <td>2025-12-09</td>
          <td>BMC Immunology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d82b0101e16002e72922cc003dc674661bb12d26" target='_blank'>
              Ischemic injury triggers a protective microglial phenotype in models of Aβ pathology
              </a>
            </td>
          <td>
            Michael Candlish, Jan Hofmann, Desirée Brösamle, Annika Haessler, Murphy DeMeglio, Angelos A. Skodras, Georgi Tushev, Eloah S. De Biasi, Stefan Günther, R. Wiegandt, Heidi Theis, Elena De Domenico, Nina Hermann, K. P. R. Nilsson, Marc Beyer, Mario Looso, M. Windbergs, Sigrun Roeber, Jochen Herms, J. Neher, Andreas G. Chiocchetti, Jasmin K. Hefendehl
          </td>
          <td>2025-12-11</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="ABSTRACT Dengue, transmitted by Aedes mosquitoes, can progress to severe symptoms like hemorrhagic fever and shock syndrome. While the virus and host immune response contribute to severity, other factors, such as small extracellular vesicles (sEVs), may play a role. sEVs mediate intercellular communication by transferring cellular components; however, their role in vivo infection remains unclear. We isolated and characterized sEVs from DENV-infected C6/36 mosquito cells, finding that they interact with mammalian cells and internalize the content. Using sEVs populations (with a size between 100 and 200 nm), we demonstrated enhanced infection in in vitro and in vivo murine models, including immunocompetent and immunosuppressed mice, which developed severe dengue-like symptoms. Our study reveals that sEVs from DENV-infected mosquito cells contribute to dengue pathogenesis, inducing severe symptoms in in vivo models, highlighting their potential role in disease progression and severe outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1b112d4c25a9bca215f1fe39fd264d1f9a35b89e" target='_blank'>
              Small extracellular vesicles from DENV2-infected C6/36 cells show viral infection in vitro and in vivo
              </a>
            </td>
          <td>
            C. D. Cordero-Rivera, Magda L Benítez-Vega, S. Palacios-Rápalo, José De Jesús Bravo-Silva, Ricardo Jiménez-Camacho, Jonathan Hernández-Castillo, Marcos Pérez-García, C. N. Farfán-Morales, L. A. De Jesús-González, J. Reyes-Ruíz, J. F. Osuna-Ramos, Fernando Medina-Ramírez, D. Talamás-Lara, Raymundo Cruz-Pérez, Arturo Reyes-Sandoval, R. D. del Ángel
          </td>
          <td>2026-01-27</td>
          <td>Emerging Microbes & Infections</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="Tuberculous meningitis (TB meningitis), the deadliest form of Mycobacterium tuberculosis infection, leads to mortality and severe neurological disability despite standard therapy. Brain injury and microglial activation are major determinants of outcome, yet the mechanisms linking infection, inflammation and neuronal injury remain poorly understood. Extracellular vesicles (EVs), key mediators of cell-to-cell communication, have been investigated in pulmonary TB but their role in TB meningitis remains unexplored. We used our young rabbit model of TB meningitis to isolate pure, intact EVs from brain tissue (i.e., brain-derived EVs) from infected and uninfected rabbits and used nanoflow cytometry, transmission electron microscopy and protein quantification to characterize the EVs. Comparative proteomic profiling was performed by liquid chromatography-tandem mass spectrometry (LC-MS/MS), followed by in silico pathway, cell-type and protein-protein interaction analyses using DAVID, Enrichr, and STRING databases. We found that EV isolation from fresh and frozen tissue was equivalent and demonstrated that M. tuberculosis infection activated EV biogenesis. Despite preserved vesicle morphology, EVs from infected brain showed a significant proteomic shift characterized by enrichment of TB host defense, microglial and immune activation, metabolic excitotoxicity, and neuronal injury. These proteome dysregulations suggest that infection reprograms brain EV cargo toward proinflammatory and metabolic stress responses while depleting neuronal and mitochondrial components. Collectively, these data demonstrate that M. tuberculosis infection alters the cargo and abundance of brain-derived EV, highlighting their potential as biomarkers and mediators of host-pathogen interactions in TB meningitis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f3f466a8b6bbef99c55e8bb31d40feefddd8931f" target='_blank'>
              Tuberculous meningitis alters the proteomic landscape of brain-derived extracellular vesicles
              </a>
            </td>
          <td>
            Blanca V. Rodriguez, Nerketa N. L. Damiba, Nicole Beaubien, Daisy Puca, D. B. Foster, Samarjit Das, Elizabeth W. Tucker
          </td>
          <td>2025-12-08</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="This review explores the interplay between SARS-CoV-2 and HIV-1 infections within the human brain, highlighting the significant neurological implications of these viral infections. SARS-CoV-2 can infect the central nervous system (CNS), with evidence of the virus detected in various brain regions, including the hypothalamus, cerebellum, and olfactory bulb. This infection is linked to microglial activation and neuroinflammation, which can lead to severe neurological outcomes in affected individuals. Autopsy studies revealed microglial changes, including downregulation of the P2RY12 receptor, indicating a shift from homeostatic to inflammatory phenotype. Similar changes in microglia are found in the brains of people with HIV-1 (PWH). In SARS-CoV-2, the correlation between inflammatory cytokines, such as IL-1, IL-6, and MCP-1, found in cerebrospinal fluid and brain tissues, indicates significant neurovascular inflammation. Astrogliosis and microglial nodules were observed, further emphasizing the inflammatory response triggered by the viral infections, again in parallel to those found in the brains of PWH. Epidemiologic data indicate that although SARS-CoV-2 infection rates in PWH mirror those in People without HIV (PWoH) populations, Long-COVID prevalence is markedly higher among PWH. Evidence of overlapping cognitive impairment, mental health burden, and persistent neuroinflammation highlights diagnostic complexity and therapeutic gaps. Despite plausible mechanistic synergy, direct neuropathological confirmation remains scarce, warranting longitudinal, biomarker-driven studies. Understanding these interactions is critical for developing targeted interventions to mitigate CNS injury and improve outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5a0ebece59d92a56c77aa4f6d9df14d6fa82e5c4" target='_blank'>
              Synergy of SARS-CoV-2 and HIV-1 Infections in the Human Brain
              </a>
            </td>
          <td>
            Rajnish S. Dave, Howard S. Fox
          </td>
          <td>2026-01-01</td>
          <td>Pathogens</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Post-Acute Sequelae of COVID-19 (PASC), or “long COVID,” describes persistent symptoms following recovery from SARS-CoV-2 infection. Early identification of circulating biomarkers predictive of PASC is critical for prognosis and therapeutic development yet remains poorly defined. To address this gap, we conducted a longitudinal, multi-omics analysis of blood samples from COVID-19 patients (n = 75), stratified by acute disease severity and PASC status. We integrated targeted multiplex assays, untargeted proteomics (LC-MS), and whole blood flow cytometry to define immune and vascular signatures associated with PASC. We found that individuals who went on to develop PASC exhibited a distinct phenotypic signature between 1 and 35 days post-infection, such as significantly elevated plasma Factor-IX, Tissue factor, and tPA, which reflected hyperactivation of immunothrombotic pathways. Similarly, pathway enrichment analysis revealed ongoing neutrophil degranulation, platelet activation, and extracellular matrix remodeling—indicating unresolved inflammation and immunothrombosis which persisted beyond 77 days post-symptom onset. Unlike prior studies using single biomarkers or limited timepoints, our study offers a comprehensive longitudinal analysis combining proteomic and cellular data to define a durable immune-vascular signature specific to PASC. This integrative approach reveals insights into PASC pathogenesis and highlights candidate biomarkers with potential utility in early risk stratification. Our findings underscore the critical role of chronic immune and endothelial dysfunction in long COVID and point toward actionable targets for intervention. This investigation links biorepository human samples with clinical symptoms and lays the foundation for precision diagnostics and therapeutic strategies aimed at improving long-term outcomes in COVID-19 survivors (NCT04603677).">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1c8423d9fefb3d644864a26f8dbc02503abeb9ee" target='_blank'>
              Blood pro-thrombotic analytes and platelet activation are associated with post-acute sequelae of COVID-19
              </a>
            </td>
          <td>
            Luke A Whitcomb, K. Berry, S. LaVergne, Nicole Natter, Bridget Baxter, Sangeeta Rao, M. Tipton, Marina A. Gritsenko, Karl K. Weitz, Vince Gerbasi, L. Bramer, P. Piehowski, Tracy L. Webb, Marcela Henao-Tamayo, Adam J. Chicco, J. Dunn, Taru S. Dutt, Elizabeth P. Ryan
          </td>
          <td>2025-12-10</td>
          <td>BMC Infectious Diseases</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f07503d0b86a50035590b1eaaf023d9368332643" target='_blank'>
              Specific deletion of interleukin-1 beta in microglia improves acute outcome and modulates neurogenesis after ischemic stroke
              </a>
            </td>
          <td>
            Alba Grayston, Margarida Baptista, Kelly Wemyss, Ruby Taylor, Grace Cullen, Syeda S Jafree, Nadim Luka, Joshua R. Cox, Joanne E. Konkel, David Brough, S. Allan, E. Pinteaux
          </td>
          <td>2025-12-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>41</td>
        </tr>

        <tr id="While it is clear that inflammation contributes to Parkinson’s disease (PD) and prevalence is higher in males, sex remains an underexplored determinant of immune responses in PD. Using the 3KL transgenic mouse model, which expresses three E to K α-synuclein mutations, we investigated how sex and age shape peripheral and central immunity and behavior in synucleinopathy. Male and female 3KL mice were aged to 8- and 14-months. At these ages animals underwent motor and cognitive assessment, followed by assessment of the peripheral immune response using flow cytometry and analysis of microglial transcriptional profiles by bulk RNA sequencing. Male 3KL mice exhibited earlier onset and greater severity of motor and cognitive impairments, which was linked to a pro-inflammatory peripheral immune profile marked by increased cytotoxic CD8⁺ T cells and IFNγ-producing CD4 Th1 cells. In contrast, female mice displayed delayed symptom onset, preserved cognition, along with early elevations in regulatory IL-10⁺ CD4 and γδ T cells. RNA sequencing of microglia revealed broad sex differences at 8 months. Males demonstrated early upregulation of microglia neurodegenerative signatures, MHC class I/II signaling, ceramide signaling, and pronounced lipid dysregulation, while females showed upregulation of microglial pathways related to protein, metabolic, and neuronal maintenance, including phagosome formation, docosahexaenoic acid signaling, and synaptogenesis pathways. Microglial transcriptional differences were nearly absent by 14 months, suggesting sex-specific trajectories converge during late-stage disease, which is concurrent with a decrease in estrogen in aged female mice. Together, these findings reveal distinct immune signaling in male and female 3KL mice and identify coordinated changes in T cell and microglial responses that may contribute to sex differences in PD vulnerability and progression. This work underscores the importance of incorporating sex as a biological variable in neurodegeneration research and provides mechanistic insight into immune-mediated modulation of synucleinopathy. Parkinson’s disease (PD) affects millions of people worldwide and is more common in men than women. Scientists believe that differences in the immune system may help explain this, but little is known about how sex and age shape these responses during the disease. In this study, we used a mouse model of PD that develops symptoms similar to those seen in people, including problems with movement and memory. We compared male and female mice at two ages: middle age (8 months) and older age (14 months). We looked at both behavior and how the immune system in the body and brain responded. Male mice showed earlier and more severe movement and memory problems. Their immune systems were more inflammatory, with high levels of aggressive immune cells. Female mice were protected for longer, performing better on memory tests, and had more “regulatory” immune cells that help keep inflammation in check. When we studied microglia, the immune cells of the brain, we found striking sex differences. In males, microglia turned on genes linked to nerve cell damage and inflammation. In females, microglia activated genes that support brain health. These differences were strongest at 8 months but faded with age, coinciding with the natural drop in estrogen in older females. Overall, our results show that sex strongly shapes the immune response in PD. Understanding these differences may lead to more personalized approaches to treatment and prevention. Male 3KL mice exhibited earlier and more severe motor and cognitive decline, linked to a pro-inflammatory peripheral immune profile. Female mice showed delayed symptom onset and preserved cognition, associated with early increases in regulatory IL-10⁺ CD4 and γδ T cells. Microglial RNA sequencing revealed broad sex differences at 8 months: males upregulated neurodegenerative and lipid dysregulation pathways, while females upregulated protein maintenance, phagosome formation, DHA signaling, and synaptogenesis. These sex-specific microglial transcriptional programs diminished by 14 months, coinciding with decreased estrogen in aged females. Findings identify coordinated differences in T cell and microglial responses that may underlie sex-specific vulnerability and resilience in Parkinson’s disease. Male 3KL mice exhibited earlier and more severe motor and cognitive decline, linked to a pro-inflammatory peripheral immune profile. Female mice showed delayed symptom onset and preserved cognition, associated with early increases in regulatory IL-10⁺ CD4 and γδ T cells. Microglial RNA sequencing revealed broad sex differences at 8 months: males upregulated neurodegenerative and lipid dysregulation pathways, while females upregulated protein maintenance, phagosome formation, DHA signaling, and synaptogenesis. These sex-specific microglial transcriptional programs diminished by 14 months, coinciding with decreased estrogen in aged females. Findings identify coordinated differences in T cell and microglial responses that may underlie sex-specific vulnerability and resilience in Parkinson’s disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/40c18f0c8c2558267619fc6e940cf9ae9e6d0f16" target='_blank'>
              Sex-dependent immune activation shapes disease progression in a model of Parkinson’s disease
              </a>
            </td>
          <td>
            Leah C. Beauchamp, Lily A Palumbo, Toby B Lanser, Mariam Baig, Laura M. Cox
          </td>
          <td>2025-12-24</td>
          <td>Biology of Sex Differences</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="As a first line of defence for the central nervous system (CNS), microglia play a critical role in maintaining homeostasis within the brain. Upon detection of damage or threats, activated cells release factors to communicate and potentiate immune responses. This activation also increases activity of the kynurenine pathway (KP) and alters expression of key KP enzymes such as indoleamine 2,3-dioxygenase (IDO-1) and kynurenine 3-monooxygenase (KMO), both major contributors in the pathology of several neurodegenerative and psychiatric disorders. This study investigated the impact of pro-inflammatory stimuli on the C20 human microglial cell line, focussing on the regulation of KMO and IDO-1 expression, and the production of cytokines. Additionally, we explored whether the anti-inflammatory effects of dexamethasone (DEXA) influenced these outcomes. This additional characterisation of a physiologically relevant human microglial cell line offers a novel and reliable platform for investigating human-specific microglial biology and function. C20 were challenged for 24 hours with cytokines or lipopolysaccharide (LPS). Gene expression was measured by RT-qPCR and excreted cytokines were quantified using a multiplex array. Our results showed up-regulation of IDO-1 and KMO transcripts, and increased release of pro- and anti-inflammatory cytokines. Notably, these effects were significantly dampened by pre-incubation with DEXA. Furthermore, transcriptomic analyses supported these data by highlighting TNF-α-activated enriched pathways, as well as those down-regulated in samples co-treated with DEXA. This study contributes to the understanding of key mechanisms regulated in human microglia by immune challenges and supports the crucial role of synthetic glucocorticoids (GCs) in moderating the microglial immune response induced by pro-inflammatory signals. These data support the use of GCs as possible therapeutic interventions for diseases associated with neuroinflammation, particularly those with altered KP metabolism.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/52d0499ab0c59fa1b0cba53d288ecb025258b527" target='_blank'>
              Glucocorticoid Treatment Dampens Kynurenine Pathway Activation and Cytokine Release in Immune Stimulated Human Microglia
              </a>
            </td>
          <td>
            Martina Esposito Soccoio, Robert P. Mason, Julien Devilliers, Roberto Feuda, Mary E. W. Collier, F. Giorgini
          </td>
          <td>2026-01-01</td>
          <td>International Journal of Tryptophan Research: IJTR</td>
          <td>0</td>
          <td>42</td>
        </tr>

        <tr id="Respiratory syncytial virus (RSV) causes severe lower respiratory tract infections in infants, immunocompromised individuals, and older adults. Although vaccines and monoclonal antibodies have recently become available, understanding RSV pathogenesis remains essential for next-generation therapeutic strategies. RSV attachment glycoprotein G mediates virus binding through a CX3C-like chemokine motif, and its secreted soluble form (sG) possesses immunomodulatory properties. We showed that recombinant sG binds TLR2, inducing proinflammatory mediators. In vitro, sG pretreatment of airway epithelial cells enhanced viral replication upon infection, indicating functions beyond canonical receptor binding. We demonstrated that RSV sG can activate MyD88-NF-κB signalling in uninfected cells via TLR2, leading to NLRP3 upregulation and ROS accumulation. Subsequent RSV infection provides the second signal for caspase‑1 activation and pyroptosis, preconditioning neighbouring cells for inflammasome-dependent lysis and viral egress. Targeting the sG-TLR2 interface could reduce inflammatory damage and viral spread, providing a rationale for CX3C motif-directed interventions and NLRP3 inhibitors during infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/de3f8c6ed6b1b520a0dd678872b0d48aa913aa50" target='_blank'>
              The soluble G protein of respiratory syncytial virus promotes viral dissemination via TLR2-mediated NLRP3 priming and pyroptosis
              </a>
            </td>
          <td>
            Robert Meineke, Ayse Agac, Marie-Christin Knittler, A. Osterhaus, M. Ludlow, G. Rimmelzwaan
          </td>
          <td>2026-01-27</td>
          <td>npj Viruses</td>
          <td>0</td>
          <td>96</td>
        </tr>

        <tr id="ABSTRACT During the COVID-19 pandemic, multiple SARS-CoV-2 variants emerged, each with distinct pathogenicity and transmissibility. This study investigated the role of the viral spike (S) protein in disease progression, focusing on the highly virulent S variant. The Delta S protein exhibited enhanced cleavage efficiency at the S1/S2 junction, resulting in partial dissociation of the S1 subunit, with detectable levels of extracellular S1. Unexpectedly, transient expression of Ancestral and Delta S protein induced by a recombinant vesicular stomatitis viral vector caused mild pulmonary inflammation, neutrophil activation, microthrombosis, and ~40% mortality in transgenic K18-hACE2 mice between 8 and 16 days, similar to post-COVID sequelae. The diseased mice displayed splenic atrophy and systemic inflammation, with elevated serum IGFBP-1 and CXCL13 levels. Consistent with the animal findings, serum samples from long COVID patients showed significantly elevated IGFBP-1 levels. CXCL13 levels were particularly elevated in patients with more severe long COVID symptoms. Notably, treatment with the antiplatelet agent aspirin significantly reduced both mortality and weight loss in mice exposed to Delta S protein expression. These findings suggest that SARS-CoV-2 S protein-associated coagulation and systemic inflammation during infection may contribute to the development of post-acute sequelae of COVID-19. IMPORTANCE Our study investigates the distinctive pathogenic properties of the SARS-CoV-2 spike (S) protein from highly virulent variants, with a particular focus on its delayed pathological effects in mice. Using a vesicular stomatitis virus (VSV) vector to transiently express the Ancestral and Delta variant S proteins in K18-hACE2 mice, we observed minimal acute symptoms initially; however, approximately 40% of the mice developed mild pulmonary inflammation, neutrophil activation, and microthrombosis, leading to death between 8 and 16 days post-infection. This delayed pathology was accompanied by elevated circulating levels of CXCL13 and IGFBP-1. Consistent with these findings, serum samples from long COVID patients also showed significantly increased IGFBP-1 levels, while CXCL13 levels were particularly elevated in individuals with more severe long COVID symptoms. These findings provide important observational evidence that may guide future mechanistic studies on long COVID and inform the development of potential therapeutic approaches. Our study investigates the distinctive pathogenic properties of the SARS-CoV-2 spike (S) protein from highly virulent variants, with a particular focus on its delayed pathological effects in mice. Using a vesicular stomatitis virus (VSV) vector to transiently express the Ancestral and Delta variant S proteins in K18-hACE2 mice, we observed minimal acute symptoms initially; however, approximately 40% of the mice developed mild pulmonary inflammation, neutrophil activation, and microthrombosis, leading to death between 8 and 16 days post-infection. This delayed pathology was accompanied by elevated circulating levels of CXCL13 and IGFBP-1. Consistent with these findings, serum samples from long COVID patients also showed significantly increased IGFBP-1 levels, while CXCL13 levels were particularly elevated in individuals with more severe long COVID symptoms. These findings provide important observational evidence that may guide future mechanistic studies on long COVID and inform the development of potential therapeutic approaches.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/df20b77bf296aeeec28956534f7acfcfef3b6afd" target='_blank'>
              SARS-CoV-2 spike protein expression drives post-acute coagulopathy
              </a>
            </td>
          <td>
            Chih-Feng Tien, En-Ju Lin, Wei-Hsiang Tsai, W. Tsai, Ming-Yu Chen, Yu-Siang Su, Hangshen Wu, Yueh-Tzu Chiu, Wan-Ju Tung, Yi-Ping Kuo, Yu-Wen Su, Hsin-Wei Chen, Feng-Jui Chen, Tsung-Hsien Chuang, Hsiang-Tsui Wang, Guann‐Yi Yu
          </td>
          <td>2026-01-21</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5d5581192995f28d24b781c1e7c2e69bf2aa53d8" target='_blank'>
              Systems Immunology of Long Covid: Insights from the STOP-PASC Clinical Trial
              </a>
            </td>
          <td>
            E. Maestri, W. J. Kwon, H. Zheng, T. Prestwood, H. Hedlin, J. W. Liang, H. McCann, B. Shaw, L. Tian, B. Jones, R. Lu, G. Wiley, E. Haraguchi, O. Wirz, J. Afaghani, B. Lam, D. F. D. Mahmood, N. A. Phillips, M. M. S. Sim, J. P. Wood, J. R. Heath, S. D. Boyd, J. Guthridge, U. Singh, H. Bonilla, P. Jagannathan, P. Utz, L. Geng, P. Khatri
          </td>
          <td>2025-12-05</td>
          <td>None</td>
          <td>0</td>
          <td>61</td>
        </tr>

        <tr id="Rationale: Microglia cells as niche homeostasis monitor with rapid responses to acute ischemic stroke (IS). T-cell intracellular antigen 1 (TIA1), a core component of stress granules (SGs), is involved in cellular stress responses such as hypoxia, but its roles and mechanisms in regulating microglial responses during IS remain unclear. Methods: To evaluate the function of microglial TIA1 in IS, we established a mouse model of IS by using photothrombotic method. Furthermore, conditional knockout (CKO) of Tia1 in microglia mice (Tia1Cx3cr1-CKO mice) was generated and then Tia1Cx3cr1-CKO IS mice and their littermate controls (Tia1f/f IS mice) were used as experimental subjects. The behavioral tests, immunostaining, Laser speckle contrast imaging (LSCI), TTC staining, Nissl staining, quantitative real-time PCR (qPCR) and Western blotting were used to assess the effects of microglial Tia1 deletion in IS progression. In vitro, we utilized the microglia cell line (HMC3 cells) and primary cultured microglia to establish an OGD model, and generated stable TIA1-knockdown or TIA1-overexpressing HMC3 cell lines, and employed a co-culture system of HMC3 and N2a cells to further explore the roles of microglial Tia1 signaling in IS. Through RNA sequencing (RNA-seq) of control HMC3 cells and Tia1-knockdown HMC3 cells, we investigated in depth the role and molecular mechanism of TIA1-mediated insulin-like growth factor 2 (IGF2) signaling pathway in microglia during IS progression. Results: Microglial TIA1 was significantly upregulated in mice during the acute phase of IS. Microglial Tia1 knockout suppressed microglial pro-inflammatory responses, enhanced anti-inflammatory responses, promoted phagocytic clearance of infarct debris, alleviated neuronal death, and improved motor deficits in post-IS mice. In vitro, TIA1 promoted pro-inflammatory responses to exacerbate neuronal cell death and inhibited phagocytic ability of microglia cells after OGD. Mechanistically, Tia1 deletion in microglia impaired SG formation, reduced sequestration of Igf2 mRNA into SGs, upregulated IGF2 expression, and IGF2 signaling enhanced anti-inflammatory responses and phagocytic capacity while suppressing pro-inflammatory activation in microglia. Conclusions: These findings identify a previously unrecognized function of microglial TIA1 in modulating microglia homeostasis and sustaining pro-inflammatory responses via SGs-mediated Igf2 mRNA sequestration after IS, providing a novel therapeutic target for IS treatment.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3c49ebe9a677699ef9a47459f8285f2c82861161" target='_blank'>
              Microglial TIA1-mediated stress granules promote neuroinflammation and aggravate neuron loss in mice after ischemic stroke by inhibiting IGF2 signaling
              </a>
            </td>
          <td>
            Yiming Qian, Hong Yu, Jianhong Dong, Jinyuan Liu, Jiaqi Han, Tianwen Zheng, Wei Zhang, Lipei Wang, Zhihui Huang, Ying Wang
          </td>
          <td>2026-01-01</td>
          <td>Theranostics</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Introduction Coronavirus disease 2019 (COVID-19) has been widely associated with intense systemic inflammation, endothelial injury, and a high incidence of thrombotic complications, which together contribute to disease severity and poor clinical outcomes. While endothelial dysfunction, dysregulated cytokine production, and oxidative stress are recognized features of severe COVID-19, the direct impact of circulating factors from infected individuals on endothelial cell behavior remains insufficiently characterized. Here, we examined how serum from patients with severe COVID-19 and from convalescent individuals modulates endothelial activation, inflammatory responses, and oxidative stress using human umbilical vein endothelial cells as an in vitro model. Methods Venous blood samples were collected from individuals with severe COVID-19 (n = 13), convalescent patients (n = 11), and healthy volunteers (n = 7) during the initial phase of the COVID-19 pandemic. Human umbilical vein endothelial cells (HUVEC) were maintained in culture and exposed to 15% serum from each study group after a period of serum deprivation. The expression of genes associated with endothelial activation, thrombosis, inflammation, and oxidative stress was analyzed by quantitative real-time PCR at defined time points. In addition, the endothelial secretory profile was evaluated in cell culture supernatants using multiplex bead-based immunoassays. Statistical analyses were performed using one-way ANOVA followed by appropriate post hoc tests, receiver operating characteristic (ROC) curve analysis to assess the discriminatory capacity of biomarkers, and multivariate linear regression to identify factors associated with disease severity. Results and discussion We investigated the role of the endothelium in modulating the cytokine storm in severe COVID-19. HUVEC were stimulated with serum from patients with severe COVID-19, convalescent individuals, and healthy volunteers. Stimulation with serum from severe cases induces significant increases in VCAM1, F3, PROCR, IL6, IL12A, NFE2L2, HMOX1, GPX1, and GSR expression within 60 minutes. Antioxidant genes SOD1 and CAT were upregulated later, after 120 minutes. HUVEC stimulated with severe COVID-19 sera showed increased levels of sICAM-1, sVCAM-1, P-selectin, sE-selectin, PECAM-1, tissue factor, thrombomodulin, and a broad range of cytokines and growth factors, such as IL-1α, IL-1Ra, IL-5, IL-6, IL-10, IL-12(p40), IL-18, IL-27, TNF-α, TGF-α, FGF-2, G-CSF, M-CSF, FLT-3L, fractalkine, eotaxin, MIG, IP-10, MIP-1β, MDC, GROa and PDGF-AB/BB. In contrast, convalescent sera induced fewer markers, specifically IL-12(p40), IL-18, FGF-2, MIP-1β, MDC, GROa, and PDGF-AB/BB, while HV sera induced significant increases in IL-12(p40), IL-27, TNF-α, VEGF, MDC, eotaxin, and GROa. ROC curve analysis revealed that P-selectin and MIP-1β levels clearly distinguish severe cases from HV. When comparing severe and convalescent groups, we observed increases in IL-27, TGF-α, sVCAM-1, IL-1α, and G-CSF levels. Furthermore, Multivariable logistic regression analysis associated disease severity with decreased IL-10 and increased MIP-1β, sICAM-1, and P-selectin. Conclusion These findings suggest that HUVEC serves as a promising biological sensor for detecting inflammatory responses in COVID-19 patients and shows the crucial role of the endothelium in sustaining the cytokine storm that contributes to patient severity and mortality.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/60fcceeacb96bb3cf6d83c4dae27c5972db20b1d" target='_blank'>
              Assessing the endothelium’s role in COVID-19 severity using the HUVEC model
              </a>
            </td>
          <td>
            S. S. Santana, S. Yahouédéhou, Corynne Stéphanie Ahouéfa Adanho, Jéssica Rebouças Silva, Hayna Malta Santos, C. Barbosa, T. N. Pitanga, Valéria Matos Borges, Vitor Fortuna, I. Lyra, Marilda Souza Gonçalves
          </td>
          <td>2026-01-08</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Since the emergence of SARS-CoV-2 in late 2019, substantial efforts have been made to understand its mechanisms of pathogenicity. Although angiotensin-converting enzyme 2 (ACE2) has been identified as the main receptor for viral entry, the complexity of the host immune response to different Spike protein conformations and variants remains poorly understood. Using zebrafish larvae as an in vivo model, we show that the monomeric S1 domain of the Omicron variant triggers a potent proinflammatory response characterized by elevated Nfkb activity and increased expression of key cytokines, despite reduced recruitment and expansion of neutrophils and macrophages. Notably, monomeric S1 Omicron also promotes neutrophil cell death, suggesting an alternative mechanism of immune modulation. In contrast, the trimeric form of the Spike protein fails to induce significant inflammation or emergency hematopoiesis, likely due to its efficient neutralization by endogenous Ace2. Our results revealed that both zebrafish and human ACE2 exert a dual anti-inflammatory role: indirectly through the production of angiotensin-(1-7), and directly by binding and neutralizing the trimeric Spike. These results provide new insights into variant-specific immune responses and the multifaceted role of ACE2 in modulating SARS-CoV-2-induced cytokine storm syndrome.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a0ca72bd55ea95e6ec10136fbdf6de706bf156d6" target='_blank'>
              Dual role of ACE2 in regulating inflammation triggered by Omicron S1 and other SARS-CoV-2 Spike variants
              </a>
            </td>
          <td>
            Annamaria Pedoto, Juan M Lozano-Gil, María Ocaña-Esparza, Ana M Conesa-Hernández, S. Candel, M. Cayuela, Victoriano Mulero, S. D. Tyrkalska
          </td>
          <td>2026-01-06</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects millions of people worldwide and often leads to fatal heart damage. The course of CD is influenced by how the immune system is tuned, which can protect the host and favor parasite persistence. Interleukin-33 (IL-33) is an alarmin released upon tissue injury that signals through the ST2 receptor, exerting context-dependent regulatory or pathogenic effects. However, the role of the IL-33/ST2 axis in T. cruzi-induced myocarditis remains unclear. Here, using ST2-deficient (ST2–/–) and wild-type (WT) female mice infected with the T. cruzi Y strain, we investigated its contribution to cardiac inflammation, tissue damage, and parasite burden. We found that ST2 signaling was not essential for controlling parasitemia, but its deficiency led to early onset myocarditis, disorganized fibrosis, and distinct electrical conduction. This severe immunopathology was driven by a remodeling of the cardiac immune landscape, with ST2–/– mice exhibiting an influx of IFN-γ-producing monocytes and a shift in resident and monocyte-derived macrophages toward a pathogenic, pro-inflammatory phenotype. Likewise, the cardiac T cell compartment, including both conventional and γδ T cells, was skewed toward an inflammatory, IFN-γ-driven profile. However, infected ST2-deficient mice also displayed higher cardiac parasite burden and impaired nitric oxide production, indicating a dysfunctional response in parasite control. Together, these findings demonstrate that the IL-33/ST2 axis limits early systemic inflammation, orchestrates cardiac immune response, and protects against immunopathology and electrical remodeling during T. cruzi experimental infection. Targeting this pathway may offer therapeutic potential for preventing cardiac damage in CD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c31dfa372eb0f6f0a367ba1d3efbe2085386b350" target='_blank'>
              IL-33/ST2 Signaling Protects the Heart by Restraining Inflammation and Parasite Burden during Trypanosoma cruzi Experimental Infection
              </a>
            </td>
          <td>
            M. E. Cardozo, T. M. Cirilo, Jorge Lucas Nascimento Souza, J. B. R. Rihs, Isabela de Brito Duval, Fernando Bento Rodrigues Oliveira, Mayra Ricci, Laura Lis de Oliveira Santos, Livia Fernanda Dias Santana, Luiza Pinheiro Silva, C. Amorim, Ana Rafaela Antunes-Porto, Izabela da Silva Oliveira, Ana Laura Grossi de Oliveira, Luisa Vitor Braga do Amaral, Gabriela Gomes Monteiro Lemos, Getúlio Mota E Silva Junior, Ivan Lobo Sousa Marques, M. P. Reys, G. Cassali, Artur Santos-Miranda, L. Magalhães, L.L. Bueno, F. S. Machado, R. Fujiwara
          </td>
          <td>2025-12-09</td>
          <td>ACS Infectious Diseases</td>
          <td>0</td>
          <td>41</td>
        </tr>

        <tr id="ABSTRACT Cryptococcus neoformans, the etiological agent of cryptococcal meningitis (CM) is a globally distributed environmental yeast that mainly causes infections in immunocompromised individuals. Particularly in low-resource countries, the mortality rate of CM can reach 81% and accounts for ~19% of HIV/AIDS-related deaths each year. In immunocompromised individuals, once inhaled, C. neoformans escapes from the lungs and disseminates with special predilection for the central nervous system (CNS). Once in the brain, C. neoformans interacts with microglia, the tissue-resident macrophages of the CNS. Previous studies indirectly showed that microglia are ineffective at controlling this fungal infection. The mechanisms underlying this fungal survival and proliferation within the CNS, however, remain unclear. In this study, we use and validate the C20 immortalized human microglia cell line to study cryptococcal-microglia interactions. We show that microglia have limited phagocytic activity that is specific to C. neoformans and partly dependent on cryptococcal antiphagocytic proteins that alter cell size and cell wall structure. We also show that human microglia respond to cryptococcal strains differently than peripheral macrophages. Further, we show that human microglia are ineffective at killing phagocytosed C. neoformans, and that this could be due to the ability of this yeast to disrupt phagosome maturation and induce phagosome membrane damage in these cells. These findings provide us with fundamental knowledge regarding cryptococcal pathogenesis in the CNS, specifically the insight into how C. neoformans is recognized by microglia under different conditions and demonstrate the usefulness of C20 cells to further study how this yeast survives and replicates within the CNS environment. IMPORTANCE While Cryptococcus neoformans is acquired through inhalation, the fatal pathology of cryptococcal infection occurs when the yeast disseminates to the central nervous system (CNS) and causes cryptococcal meningitis. Microglia are the first immune cells that C. neoformans will encounter once it reaches the CNS, and they are the largest population of macrophages in the brain. While microglia are professional phagocytes, they are unable to control C. neoformans infection. The mechanisms behind uncontrolled growth of C. neoformans within the CNS remain understudied, partly due to incomplete knowledge regarding microglia-cryptococcal interactions. This study provides fundamental knowledge into these interactions and establishes a powerful model to specifically study how C. neoformans is recognized by microglia and how cryptococcal phagosomes mature in these phagocytes. This work opens new avenues of research to further our understanding of cryptococcal-host interactions, which can be leveraged to develop more effective therapeutics for cryptococcal meningitis. While Cryptococcus neoformans is acquired through inhalation, the fatal pathology of cryptococcal infection occurs when the yeast disseminates to the central nervous system (CNS) and causes cryptococcal meningitis. Microglia are the first immune cells that C. neoformans will encounter once it reaches the CNS, and they are the largest population of macrophages in the brain. While microglia are professional phagocytes, they are unable to control C. neoformans infection. The mechanisms behind uncontrolled growth of C. neoformans within the CNS remain understudied, partly due to incomplete knowledge regarding microglia-cryptococcal interactions. This study provides fundamental knowledge into these interactions and establishes a powerful model to specifically study how C. neoformans is recognized by microglia and how cryptococcal phagosomes mature in these phagocytes. This work opens new avenues of research to further our understanding of cryptococcal-host interactions, which can be leveraged to develop more effective therapeutics for cryptococcal meningitis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1a71a917e2126a4d0bc8f93cc6a70aeac3072e40" target='_blank'>
              Use of a human immortalized microglia cell line to study recognition, phagocytosis, and intracellular survival of Cryptococcus neoformans
              </a>
            </td>
          <td>
            Robbi L. Ross, Kassandra Arias-Parbul, Zane M. Douglass, Katrina L. Adams, F. Santiago-Tirado
          </td>
          <td>2026-01-30</td>
          <td>mSphere</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="ABSTRACT The recently identified alphacoronavirus swine acute diarrhea syndrome coronavirus (SADS-CoV) has a high fatality rate in neonatal piglets. Currently, no vaccines or treatment strategies for SADS-CoV infection are available. The stimulator of interferon genes (STING) pathway plays a critical role in initiating innate immune responses against RNA viral infections; however, its role in host defense against SADS-CoV infection remains unexplored. We assessed the pathogenicity of SADS-CoV in 3-day-old, 7-day-old, and 3-week-old mice, revealing striking age-dependent susceptibility—a pattern mirroring clinical observations in piglets. Additionally, SADS-CoV infection activated the STING-dependent pathway, which resulted in significant interferon responses in infected mice. In vitro experimental findings confirmed that STING pathway activation inhibited SADS-CoV replication by modulating the NF-κB and IRF3 signaling pathways and mediating the production of inflammatory cytokines, which underscores the importance of the STING pathway in antiviral defense mechanisms. In vivo studies revealed that the STING inhibitor C176 significantly promoted viral replication, whereas activation of the STING pathway using the STING agonist diABZI increased antiviral immune responses and reduced viral replication. Notably, diABZI protected mice from SADS-CoV infection by reducing viral replication through mechanisms involving both type I interferon-dependent and -independent pathways. These results represent the first demonstration of the in vivo therapeutic efficacy of pharmacological STING activation against SADS-CoV. These findings demonstrate that the STING pathway serves as a critical regulator of host defense against SADS-CoV and suggest that STING-targeted intervention has therapeutic potential. IMPORTANCE Swine acute diarrhea syndrome coronavirus (SADS-CoV) is an emerging zoonotic pathogen with significant implications for veterinary and public health; it has a high mortality rate in piglets and the potential for cross-species transmission. Currently, there are no approved vaccines or specific antiviral agents available for this pathogen. In this study, we demonstrated that the stimulator of interferon genes (STING) pathway serves as a critical mediator of host defense against SADS-CoV infection. STING activation inhibits viral replication by coordinating interferon responses and modulating NF-κB/IRF3 signaling, and its inhibition exacerbates infection. Importantly, pharmacological activation of the STING pathway using the agonist diABZI significantly inhibited viral replication in vivo in a STING-dependent manner, with contributions from both type I interferon-dependent and -independent antiviral mechanisms, highlighting its therapeutic potential. These results advance our understanding of antiviral defense strategies against SADS-CoV and identify STING pathway regulation as a viable therapeutic approach for this emerging pathogen. Swine acute diarrhea syndrome coronavirus (SADS-CoV) is an emerging zoonotic pathogen with significant implications for veterinary and public health; it has a high mortality rate in piglets and the potential for cross-species transmission. Currently, there are no approved vaccines or specific antiviral agents available for this pathogen. In this study, we demonstrated that the stimulator of interferon genes (STING) pathway serves as a critical mediator of host defense against SADS-CoV infection. STING activation inhibits viral replication by coordinating interferon responses and modulating NF-κB/IRF3 signaling, and its inhibition exacerbates infection. Importantly, pharmacological activation of the STING pathway using the agonist diABZI significantly inhibited viral replication in vivo in a STING-dependent manner, with contributions from both type I interferon-dependent and -independent antiviral mechanisms, highlighting its therapeutic potential. These results advance our understanding of antiviral defense strategies against SADS-CoV and identify STING pathway regulation as a viable therapeutic approach for this emerging pathogen.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a05a2e5279a634fa785ee9b0dff3bb87703a347f" target='_blank'>
              STING agonist diABZI confers protection against swine acute diarrhea syndrome coronavirus in neonatal mice by activating antiviral immunity
              </a>
            </td>
          <td>
            Yuying Li, Wei Chen, Xinyu Zhang, Jiyong Zhou, Yanqing Hu, Yi-min Zhou, Tian Lan, Haixin Huang, Lu-lu Xie, Yan Qin, Lin Zhou, Wen-chao Sun, HuiJun Lu
          </td>
          <td>2025-12-29</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Trisomy 21 increases the risk of severe outcomes and mortality in hospitalized individuals with Down syndrome (DS) following SARS-CoV-2 infection. Using data from the Brazilian Epidemiological Surveillance Information System Influenza (SIVEP-Gripe), we analyzed 102,767 hospitalized COVID-19 patients (1,115 DS and 101,652 non-DS, NDS). DS patients had a higher prevalence of comorbidities and required ventilatory support, ICU admission, and intubation more frequently than NDS patients (p < 0.001). Mortality was 4.5 times higher in DS patients aged 0–30 years (26.3% vs. 5.9%, p < 0.001) and remained 2.22 times higher after adjusting for comorbidities. DS patients over 30 years also exhibited a 22% increase in mortality (PR 1.22, p < 0.001). Gene expression analysis of pre-pandemic monocytes and T cells from DS individuals revealed upregulated pathways linked to SARS-CoV-2 infection, including interferon signaling and cytokine interactions. This baseline immune dysregulation may contribute to severe COVID-19 outcomes in DS patients. Identifying these altered pathways could inform targeted therapeutic strategies to improve immune homeostasis and clinical outcomes. To the best of our knowledge, this is the first study integrating nationwide clinical outcomes with pre-pandemic immune transcriptomic data to mechanistically explain the heightened COVID-19 severity in individuals with DS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5f7075222f6b4bba193e24822c99a19b4d8bb480" target='_blank'>
              Elevated mortality and upregulated SARS-CoV-2-associated pathways in innate and adaptive immune cells from individuals with Down syndrome
              </a>
            </td>
          <td>
            Daniella Balduino Victorino, J. Malheiros, Felipe ten-Caten, Victor Hugo Cardoso Betta, Felipe Farinha Saad Barbosa, K. Ghneim, Fernanda Caroline Coirada, Fernanda Romano Bruno, Giuliana Xavier de Medeiros, Cassia Silveira, Christina Gavegnano, Robert Balderas, Ana Claudia Brandao, Edward Yang, Helder Nakaya, Gabriela A. Wagner, L. Covolan, Susan Pereira Ribeiro
          </td>
          <td>2026-01-05</td>
          <td>PLOS One</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="Long COVID (LC) or Post-Acute Sequelae of SARS-CoV-2 infection (PASC) syndrome represents a widespread health challenge that necessitates the development of novel diagnostic approaches and targeted therapies that can be readily deployed. Immune dysregulation has been reported as one of the hallmarks of LC, but the extent of LC immune dysregulation in patients over time remains unclear. We therefore assessed SARS-CoV-2-specific antibody responses, peripheral immune cell profiles, autoantibody profiles and circulating cytokines for up to 6 months in participants with a SARS-CoV-2 infection who either convalesced or developed LC. Compared to convalescent, LC participants with a broad range of LC phenotypes exhibited persistently elevated IgG titers for SARS-CoV-2 Envelope and Nucleocapsid proteins over the 6 months of study duration. In contrast, the IgG responses to Spike protein were significantly lower in the LC cohort with predominantly IgG1 and IgG3 class-switched bias. Using CyTOF analysis we show elevated numbers of circulating T follicular helper cells (cTFH) and mucosa-associated invariant T cells (MAIT), which also correlated with high anti-Envelope IgG titers. Persistent immune activation was accompanied by augmented serum cytokine profiles with LIF, IL-11, Eotaxin-3, and HMGB-1 in LC participants, who also demonstrated significantly higher rates of autoantibodies. These findings highlight the persistence of immune dysregulation in LC, underscoring the need to explore targeted therapies addressing viral persistence, dysregulated antibody production, and autoimmunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c4f9def96ecd7623891e3f4b4f5c72c22acebf31" target='_blank'>
              Persistent Immune Dysregulation during Long COVID is Manifested in Antibodies Targeting Envelope and Nucleocapsid Proteins
              </a>
            </td>
          <td>
            Jalees Rehman, Marcin Kwissa, Manikannan Mathayan, Satyajeet S. Salunkhe, Velavan Bakthavachalam, Zijing Ye, Mark A. Sanborn, Samantha Condo, Aditi Upadhye, Athulith Nemakal, Haoyang Wang, James Chan, Justin M. Richner, Sanjib Basu, Richard Novak, Jeffrey R. Jacobson, Balaji B Ganesh, Martha Cerda, Hassan Brim, Nathaniel Erdmann, Bruce Levy, Gailen D. Marshall, Grace A. McComsey, Torri Metz, Megumi Okumura, M. Peluso, Tiffany Walker, Paul Utz, Jerry A. Krishnan, Bellur S. Prabhakar
          </td>
          <td>2026-01-08</td>
          <td>Research Square</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Coronavirus disease 2019 (COVID-19) pneumonia is prevalent in the elderly infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); however, the mechanisms underlying its age-dependent pathogenesis remain unclear. In this study, we established a mouse-adapted SARS-CoV-2 strain infected Nr4a3-Tocky mouse model to examine T-cell dynamics associated with disease severity. Nr4a3-Tocky mice allow the analysis of the dynamics and induction of antigen-reactive T cells following antigen recognition in vivo using fluorescent Timer protein. SARS-CoV-2-infected adult mice exhibited transient body weight loss and recovery, whereas aged mice developed severe pneumonia. BALF viral RNA was comparable between 1–4 days post-inoculation (d.p.i.), but declined in adults at 5 d.p.i. Aged mice displayed stronger inflammation as indicated by scRNA-seq, and higher levels of inflammatory cytokines (TNF-α, CCL2, CXCL10 and IL-6) in BALF correlated with weight loss. Timer analysis revealed induction of antigen-reactive T cells in the adult lungs at 5 and 8 d.p.i., which inversely correlated with disease severity. Additionally, S-specific IFN-γ ⁺ CD8 ⁺ T cells were detected at 5 d.p.i. in adults, whereas detection of antigen-specific T cells was delayed in aged mice. These results suggest that the coexistence of age-related lung inflammation and delayed induction of antigen-specific T cells is linked to more severe pneumonia, while earlier T-cell responses are associated with improved viral control and milder disease. In this study, we utilized a novel mouse model enabling characterization of antigen-reactive T cells in the local tissue, and investigated inflammatory responses in the lung together with lung-infiltrating virus-specific T cells, finding the dynamics of these immunological parameters associated with the age of the mice. Our analysis provides new insights into understanding how age-related T-cell dysfunction is associated with the severity of SARS-CoV-2 pneumonia.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/26d80e657921afbee11ed57efcbb48ed233ef470" target='_blank'>
              Dynamics of lung-infiltrating virus-specific T cells associated with age-dependent SARS-CoV-2 pneumonia severity
              </a>
            </td>
          <td>
            Rise Kurokawa, Chatherine Silas Mtali, Innocent John Daniel, Thorbjorg Einarsdottir, Omnia Reda, Nobuko Irie, Wajihah Sakhor, Koki Niimura, Mitsuyoshi Takatori, Kenji Sugata, C. A. Tye, Yorifumi Satou, Masahiro Ono, Takushi Nomura
          </td>
          <td>2026-01-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Cognitive dysfunction associated with type 1 diabetes (T1D) is closely linked to the accumulation of amyloid-beta (Aβ) oligomers. However, the role of microglia and their underlying molecular mechanisms in this process remain unclear. Triggering receptor expressed on myeloid cells 2 (TREM2), a microglial receptor critical for clearing neurotoxic Aβ and maintaining metabolic homeostasis, is dysfunctional in Alzheimer’s disease. Here, we investigated TREM2-mediated microglial dysfunction in diabetic neurodegeneration. To investigate the role of TREM2-mediated microglial dysfunction in Aβ clearance and cognitive impairment in T1D. A total of 204 male C57BL/6J mice, aged 6–8 weeks, were used in this study. We performed single-nucleus RNA sequencing (snRNA-seq) on 59,356 cells from the prefrontal cortex and hippocampus. Aβ pathology was evaluated by western blot, immunofluorescence and ELISA. TREM2 knockout mice and the murine microglial cell line BV2 were used to study the role of TREM2 in cognitive function and Aβ clearance. T1D mice exhibited progressive memory deficits and prefrontal Aβ oligomer accumulation (36–50 kDa), with region-specific microglial activation. SnRNA-seq identified ten microglial subpopulations, with Trem2-enriched clusters (M1/M2/M3/M5) showing impaired phagocytosis and metabolic dysregulation. TREM2 knockout exacerbated cognitive deficits and Aβ accumulation in T1D mice. Mechanistically, TREM2 regulated microglial migration, phagocytosis of Aβ oligomers, and mitochondrial integrity under high-glucose conditions, potentially via the mTOR signaling pathway. These findings establish TREM2 as a critical regulator of microglial Aβ clearance in T1D, operating mitochondrial and phagocytic programs via mTOR and highlighting its therapeutic potential for diabetic neurodegeneration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/504f67391ce0f3646645568c2d0f2a018f2f44cc" target='_blank'>
              Cognitive dysfunction in type 1 diabetes: role of TREM2 in microglial activation and Aβ pathology
              </a>
            </td>
          <td>
            Yue Wang, Ruyue Wang, Yimeng Liu, Zhaohui Wang, Hongyan Ding, Xinyi Wei, Aikeda Aihemaitijiang, Minghan Sun, Li Zhao
          </td>
          <td>2026-01-02</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Background/Objectives: The molecular cascades involved in the induction and maintenance of neuroinflammation resulting from chronic compression of the cervical spinal cord in the setting of degenerative cervical myelopathy (DCM) have yet to be defined. Here, we determined the role of the fractalkine receptor, CX3CR1, during the neuroinflammatory response in a novel mouse model of DCM and demonstrated the relevance of this mechanism with human DCM tissue. Methods: Using our murine DCM model alongside the CX3CR1-knockout mice and a neutralizing antibody of CX3CR1 in wild-type mice, we examined protein, neurobehavioural and immunohistochemical readouts. The animal data were then complemented with immunohistochemical results from human post-mortem spinal cord tissue from individuals with DCM. Results: Humans and mice with DCM exhibited an up-regulation of CX3CR1 as well as markers of activated microglia/macrophages in the cervical spinal cord. Knockout and neutralization of CX3CR1 hindered microglia/macrophage activation and accumulation at the site of spinal cord compression. DCM mice exhibited decreased body speed and increased stance phase duration, which mirrors human DCM gait deficits. Strikingly, both CX3CR1 deficiency and CX3CR1 neutralization alleviated these gait deficits in DCM mice. Conclusions: Collectively, these data provide strong evidence that CX3CR1 plays a critical role in the secondary injury of neural structures in the setting of DCM. Further, targeting of CX3CR1 represents a promising therapeutic strategy to enhance neurological outcomes in DCM.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2268c228ba1fc9b9436b04f3da83f5c32be4049e" target='_blank'>
              An Examination of the Role of CX3CR1 in the Pathobiology of Degenerative Cervical Myelopathy: Evidence from Human and Mouse Tissue
              </a>
            </td>
          <td>
            Wen Ru Yu, Spyridon K. Karadimas, James Hong, Sarah Sadat, S. Brockie, Pia M. Vidal, T. Kiehl, Noah Poulin, A. Andreopoulou, J. Kallitsis, Michael G. Fehlings
          </td>
          <td>2025-12-22</td>
          <td>Journal of Clinical Medicine</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="Organ transplant recipients are at high risk of developing chronic infection when exposed to hepatitis E virus (HEV), which can rapidly progress to liver fibrosis and cirrhosis. Macrophages play a key role in the response to the infection and disease progression. However, the interactions amongst immunosuppressants, macrophages, the course of HEV infection and activation of inflammatory response remain unclear. In this study, we generated M0, M1 and M2 macrophages from the human THP‐1 cell line. These macrophages were then infected with HEV and treated with different immunosuppressants. We visualised viral infection using laser confocal microscopy, and quantitatively analysed viral replication and inflammatory responses by bulk sequencing, RT‐qPCR, ELISA and Western blotting. We found that the M1 inflammatory macrophages exhibited the highest, while M2 macrophages had the lowest levels of viral RNA. Genome‐wide transcriptome analysis indicated that viral, inflammation and immunity‐related pathways were predominantly upregulated by HEV infection. Dexamethasone exerted potent inhibitory effects on inflammatory response in macrophages. Mycophenolic acid (MPA) demonstrated inhibitory effects on viral replication, IL‐1β and TNF‐α expression, whereas mTOR inhibitors had the opposite effects, and tacrolimus showed no clear effect. In conclusion, immunosuppressants can differentially affect HEV replication and the subsequent inflammatory responses in macrophages.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/eac70274038702e260d9f4da11346625f1871599" target='_blank'>
              The Differential Effects of Immunosuppressants on Hepatitis E Virus Replication and the Triggered Inflammatory Responses in Macrophages
              </a>
            </td>
          <td>
            Jiahua Zhou, Kuan Liu, P. Boor, Qiuwei Pan, I. Ayada
          </td>
          <td>2025-12-16</td>
          <td>Journal of Viral Hepatitis</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Background: Immune aging is a complex process involving various cellular changes, such as a myeloid bias, decreased functional activity of immune cells, accumulation of senescent cells, and alterations in serum levels of bactericidal humoral factors. As believed, these changes contribute to increased susceptibility of older adults to infectious diseases. Myeloid cells are considered the first line of defense against bacterial invasion. However, it remains unclear whether the protective functions of myeloid cells diminish in active older adults and whether potential age-related changes are evolutionarily conserved across primates. Methods: In this study, myeloid cell populations from peripheral blood and bone marrow of cynomolgus macaques and human peripheral blood were analyzed across a broad age range for phenotypic and functional characteristics, e.g., E. coli phagocytosis, secretion of proinflammatory factors, genetic instability, and signs of cellular aging. Results: Despite minor interspecies phenotypic differences in granulocyte populations, both the quantity and functions of myeloid cells were remarkably stable during aging in both species. Myeloid cells maintained genetic stability, and high SA-β-Gal activity was observed, likely reflecting metabolic traits rather than age-related changes. Importantly, a predominant and age-independent role of humoral factors, rather than cellular mechanisms, was identified in the initial control of bacterial infection. Conclusions: These findings suggest that innate immune functions remain stable for a long time during aging in both species.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d8a987a1816f32ee1e3963ce13efb0c477c73470" target='_blank'>
              Stability of Myeloid Cell Phenotype and Function Across a Broad Age Range in Humans and Cynomolgus Monkeys, and a Dominant Contribution of Humoral Factors in the Control of Bacterial Infection
              </a>
            </td>
          <td>
            Elena V. Lysakova, Marina Y. Burak, Ilya Larin, Sergey A. Chuvpilo, Victor S. Laktyushkin, A. Shumeev, Igor E. Pismennyi, Vladimir Y. Toshchakov, M. Bobrov, S. Rybtsov
          </td>
          <td>2025-12-29</td>
          <td>Biomedicines</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="mRNA vaccines have shown high efficacy against SARS-CoV-2, yet orchestration of innate and adaptive responses in infection-naïve individuals remains incompletely characterized. Understanding these dynamics in people without prior infection is essential for defining baseline immune trajectories and providing a reference for future studies. We conducted a longitudinal study in SARS-CoV-2-naïve adults who received two doses of the BNT162b2 vaccine. Peripheral blood was analyzed by flow cytometry to quantify monocyte, NK, T, and B cell subpopulations, and serum cytokines were measured by multiplex assays. Data were evaluated with Z-score normalization and paired comparisons. Monocyte subsets segregated into two groups: one with progressive decline and another with transient activation. NK cells displayed multiphasic activation, particularly after booster. CD4+ and CD8+ T cells differentiated toward central and effector memory phenotypes, while B cells showed evidence of germinal center engagement followed by memory refinement. Cytokine fluctuations, including interferon-related signals, paralleled cellular dynamics. The booster was associated with re-engagement of innate components and amplification of adaptive responses. BNT162b2 vaccination in naïve individuals induces a coordinated sequence in innate and adaptive compartments, culminating in memory T and B cells. These findings align with current literature and provide trajectories to inform immune monitoring and optimization strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ec63f2d70eca68584542e62e194ff95891698efb" target='_blank'>
              Primary immune trajectories following a single BNT162b2 vaccination scheme in SARS-CoV-2-naïve individuals.
              </a>
            </td>
          <td>
            Miguel Leonardo Méndez Rodríguez, A. Ponciano-Gómez, Myriam Campos-Aguilar, Wilfrido David Tapia-Sánchez, Carlos Leonardo Duarte-Martínez, Jesús Salvador Romero-Herrera, Sandra Olivas-Quintero, A. Saucedo-Campos, Jaciel Ivan Lopez-Sanchez, A. René Méndez-Cruz, Rafael Jiménez-Flores, Héctor Romero-Ramírez, Leopoldo Santos-Argumedo, V. Rosales-García, Vianney Ortiz-Navarrete
          </td>
          <td>2026-01-13</td>
          <td>European journal of microbiology & immunology</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a80bbb3790bf37a49652e840f00b66c360bfe299" target='_blank'>
              Monomeric C-reactive Protein Exacerbates Neuronal Injury and Enhances Microglial Activation after Global Cerebral Ischemia in Mice
              </a>
            </td>
          <td>
            Gaowei Pan, Xiaoling Liu, Xiaoyue Zhang, Hao Gao, Ting Xu, Kemin Li, Lei Wang, Shangrong Ji, Ting Li, Shengxiang Zhang
          </td>
          <td>2025-12-29</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="ABSTRACT Extracellular vesicles (EVs) are key mediators of maternal–foetal communication, regulating placental function and foetal development through the transfer of bioactive molecules. Although placental EVs play a crucial role in placental function during pregnancy, their contribution to foetal development, notably foetal brain, remains poorly understood. Human cytomegalovirus (HCMV) is the most common virus transmitted in utero and a leading cause of infectious brain malformations. Although certain central nervous system lesions caused by HCMV are explained, the neuropathogenesis of congenital infection remains poorly understood. In this study, we demonstrate that EVs from healthy placentas promote neurogenesis. However, EVs from HCMV‐infected placentas lose this neurogenic potential, impairing differentiation and migration of neural stem cells, perturbations that may contribute to the neurodevelopmental defects observed in congenital HCMV infections. miRNA profiling revealed profound infection‐induced changes, including the incorporation of viral miRNAs and dysregulation of host miRNAs involved in neurogenesis. These findings highlight the critical role of placental EVs in foetal brain development and their contribution to HCMV neuropathogenesis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/18b8199a60a8db1a80f8fc1ceb44252f69b8e30c" target='_blank'>
              Placental Extracellular Vesicles Exhibit Reduced Neurogenic Potential Linked to Changes in Their miRNA Landscape Upon HCMV Infection
              </a>
            </td>
          <td>
            Charlène Martin, Hélène Martin, M. Bergamelli, Lhorane Lobjois, Lucie Franco, Emma Bordes, Alexandra Benchoua, Stéphanie Balor, D. Kantar, Etienne Coyaud, Frédéric Martins, Alexandre Favereaux, Cécile E Malnou
          </td>
          <td>2026-01-01</td>
          <td>Journal of Extracellular Biology</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="There are multiple reports of elevated inflammation in patients with major depression. It is, however, unclear whether these reported perturbations in immune functions in depression affect the general functionality of the peripheral immune system. Here, using single-cell RNAsequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) extracted from blood samples collected prior to a flu vaccination administration/immunization (at baseline), we found downregulated T cell and B-cell-associated gene expression repertoire coupled with a selectively upregulated plasmablast, CD14 classical monocytes, and natural killer (NK) proliferating cell-associated gene expression in 9 depressed patients (6 females) compared to 5 healthy controls (5 females), as well as in association with depression ratings. Our cell type proportion analysis revealed shifts in immune cell populations, specifically reduced numbers of CD4+ T and CD8+ T proliferating cells, plasmablasts, and NK cells in individuals with depression compared with controls. In contrast, we found increased numbers of CD14 classical and CD16 monocytes as well as doublet cells in depressed individuals compared with controls. Although our baseline and flu vaccine challenge did not show marked differences in peripheral immune markers measured by a multiplex cytokine assay, our results suggest impaired innate and adaptive immune responses at the transcriptomic and cellular population levels in depressed patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c2cf073f7c3882ea32b466937ec788669b0a8b86" target='_blank'>
              Immune System Alterations in Depression across Baseline and Flu Vaccine Challenge
              </a>
            </td>
          <td>
            D. Arasappan, Alyssa Marron, Sina Sanei, Mbemba Jabbi
          </td>
          <td>2025-12-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0d58d659e01646033f54b4d5e7e8ed88c2867fb7" target='_blank'>
              Microglia Mitochondrial Metabolism in Neurological Diseases
              </a>
            </td>
          <td>
            Jin Wang, Yikun Gao, Qing Chen, Xiaoxing Xiong, Sen Miao, Xuemei Chen, Youjia Tang, Lijuan Gu
          </td>
          <td>2026-01-01</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bd34010aa1ea1210d34d9e69c2b56f53fe420294" target='_blank'>
              TLR3 Activation of Microglia-Containing Cerebral Organoid Induces Antiviral Factors against HIV-1 Infection
              </a>
            </td>
          <td>
            Qianhao Xiao, Xu Wang, Priyanka Sarkar, Xiao-Long Wang, Li Song, Binhua Ling, Wenhui Hu, Wen-Zhe Ho
          </td>
          <td>2025-12-19</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c515ee3e9e86703752ec072206a806bfdf0f76b3" target='_blank'>
              SLAMF1-peptide mediated epigenetic priming reprograms innate immune responses in sepsis
              </a>
            </td>
          <td>
            Sindre Ullmann, Birgitta Ehrnström, Jørgen Stenvik, S. Pinto, Yashwanth Subbannayya, Victor Boyartchuk, I. Mestvedt, Mahamaya Dhaware, Siddhesh S. Kamat, L. Ryan, Hilde Vagle, T. Dahl, B. Halvorsen, J. K. Damås, T. Espevik, Maria Yurchenko
          </td>
          <td>2025-12-29</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>72</td>
        </tr>

        <tr id="The long-term immunological effects of prior Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in people living with Human Immunodeficiency Virus (HIV) remain poorly understood. This study aimed to characterize plasma proteomic alterations associated with previous SARS-CoV-2 infection in HIV-infected individuals and to identify potential biomarkers and affected pathways. High-throughput liquid chromatography–tandem mass spectrometry (LC–MS/MS) was performed on plasma obtained from three groups: HIV-infected individuals with documented prior SARS-CoV-2 infection, HIV-monoinfected individuals, and healthy controls. A total of 13,675 proteins were identified. Hierarchical clustering and sparse partial least squares discriminant analysis revealed distinct proteomic profiles in the prior-SARS-CoV-2 group. Ten proteins with the highest discriminatory power—PRR11, TEX14, METTL9, NMD3, PXT1, CRISP2, MELK, SPF27, GCP6, and GTPBP8—were associated with cell cycle regulation, RNA processing, apoptosis, mitochondrial function, and cytoskeletal organization. Subcellular localization indicated predominant nuclear and cytoplasmic involvement, suggesting alterations in transcriptional regulation and intracellular structural dynamics. These signatures imply that preceding SARS-CoV-2 exposure may compound HIV-associated immune dysregulation and disrupt cellular homeostasis. The findings offer novel molecular insights into the persistent biological impact of SARS-CoV-2 in the context of HIV and identify candidate proteomic biomarkers with potential utility for risk stratification and targeted intervention in immunocompromised populations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0e603a3eec42ec77b104560dc9bb5835ed1851d4" target='_blank'>
              Plasma proteomic signatures in HIV-infected individuals post-SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Chayanin Chanthara, Janya Khattiya, S. Roytrakul, C. Akekawatchai, Narumon Phaonakrop, Nattamon Niyomdecha
          </td>
          <td>2025-12-09</td>
          <td>BMC Infectious Diseases</td>
          <td>1</td>
          <td>42</td>
        </tr>

        <tr id="ABSTRACT In the context of COVID-19, macrophages are primarily responsible for sensing and responding to the virus, significantly influencing disease outcomes. They are involved in early pathogen recognition, immune activation, and tissue repair. Heterogeneity and phenotypic plasticity of macrophages are dynamically shaped by microenvironmental cues, including metabolites, hypoxia, and pathogen-derived signals. Notably, emerging evidence underscores that cellular metabolism, particularly in macrophages, dictates immune responses to viral infection. This metabolic-immune crosstalk critically determines COVID-19 severity, ranging from viral clearance to hyperinflammation or fibrosis. In this review, we systematically dissect how cell-intrinsic metabolic nodes and extrinsic factors modulate macrophage effector functions, while illustrating the complications associated with macrophage metabolic dysregulation in SARS-CoV-2 infection. These mechanistic insights provide a rational foundation for therapeutic strategies targeting macrophage metabolism to rebalance immune responses and mitigate COVID-19 complications.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8a2e1bb8d0dab5824b185f810e0cd5ef78deac45" target='_blank'>
              Metabolic control of macrophages in coronavirus disease 2019
              </a>
            </td>
          <td>
            Li An, Houxi Xu, Qiaoling Fan, Mengjiang Lu, Dongdong Sun
          </td>
          <td>2025-12-23</td>
          <td>Virulence</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Introduction Airborne particulate matter (PM), particularly fine (PM2.5) and coarse (PM10) particles, is a major environmental health concern linked to increased respiratory morbidity and mortality. During the COVID-19 pandemic, epidemiological studies suggested that PM exposure may worsen SARS-CoV-2 infection outcomes; however, cellular mechanisms underlying this association remain incompletely understood. Here, we investigated how pre-exposure to PM2.5 and PM10 impacts SARS-CoV-2 infection dynamics in Calu-3 human epithelial cells. Methods Calu-3 cells were pre-exposed to PM for 72 h prior to infection with either the wild-type Wuhan strain or the more virulent Delta variant for additional 48 h. Viral infection, receptor expression, apoptosis and cytokine responses were assessed. Results PM10, but not PM2.5, enhanced Delta variant infection, increasing the proportion of infected cells by 13.7% and viral titers by 2.6-fold compared with controls. This enhancement was not attributable to changes in ACE2 receptor expression or viral entry efficiency but instead impaired antiviral defenses. PM10 pre-exposure suppressed apoptosis and reduced the expression of pro-inflammatory cytokines including IFN-γ, IP-10, and TNF-α during Delta infection. Discussion These findings suggest that PM10 compromise epithelial antiviral response by dampening apoptotic cell clearance and inflammatory responses, thereby creating a cellular condition more permissive to viral replication. Our study provides a mechanistic basis by which particulate air pollution may amplify SARS-CoV-2 pathogenicity in a variant-specific manner. These results underscore further validation in physiologically relevant systems and highlight the potential public health implications of air pollution during viral pandemics.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ac9a796dc8ff736d95d72734234fedf3e2cf1ff5" target='_blank'>
              Particulate matter exposure potentiates SARS-CoV-2 delta variant infection by suppressing epithelial antiviral responses
              </a>
            </td>
          <td>
            Supasek Kongsomros, Jiraporn Paha, Phayungsap Prasara-a, Sopita Visamol, Pinnakarn Techapichetvanich, Apisada Jiso, Kwanchanok Uppakara, Ardythe L. Morrow, Alexander W. Thorman, S. Chutipongtanate, Phisit Khemawoot, A. Thitithanyanont
          </td>
          <td>2026-01-05</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="The COVID-19 pandemic has profoundly affected societies around the world. Although the emergency phase of coronavirus disease 2019 (COVID-19) has ended, the threat it poses remains persistent. This review aims to clarify the mechanisms of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection to support effective management of the disease. A central focus is the host cellular response to the viral infection, with particular emphasis on the role of cytokines. Cytokines play a dual role in antiviral defense: they contribute to the inhibition of viral replication and facilitate the clearance of pathogens, yet dysregulated cytokine responses can result in severe immunopathology. Interferons (type I, type II, and type III) and other cytokines are pivotal in activating intracellular antiviral mechanisms and in orchestrating the recruitment of immune cells through extracellular signaling. Effective immune responses to viral infections are governed not only by primary immune cells—such as dendritic cells, T lymphocytes, and B lymphocytes—but also by the local cytokine milieu shaped by infected and neighboring cells. Given the presence of endogenous inhibitors and autoantibodies in vivo, it is essential to evaluate the functional activity of cytokines in clinical samples. We propose a novel approach to quantify biologically active cytokine levels.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/549a84778c011cc8c3e8f33bdfcaf598bd26756a" target='_blank'>
              Host Responses to SARS-CoV-2 with an Emphasis on Cytokines
              </a>
            </td>
          <td>
            Hideki Hayashi, Yoshinao Kubo, Yoshimasa Tanaka
          </td>
          <td>2026-01-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e1ef193e4ddeac0c1d6e0a6d600cf0e2aaf662ba" target='_blank'>
              Systemic administration of PD-L1 blocking antibodies leads to removal of senescent microglia
              </a>
            </td>
          <td>
            Yuliya Androsova, A. Kertser, Hannah Partney, Bar Nathansohn, Angham Ibraheem, Miguel Abellanas, T. Croese, T. Salame, H. Akiva, V. Krizhanovsky, Michal Schwartz
          </td>
          <td>2025-12-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8e82b97b13d456a0dff65f4dc3232b454a383edd" target='_blank'>
              Explainable AI multiomics analysis reveals shared and divergent host responses in COVID-19 and influenza.
              </a>
            </td>
          <td>
            Yan Zhang, Lining Zhang, Zehong Zhang, Yuxi Lin, Zexu Jiang, Fulong Yu
          </td>
          <td>2026-01-27</td>
          <td>NPJ digital medicine</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="AIMS
Patients with cardiovascular disease (CVD) have an increased risk of developing severe respiratory infections, including COVID-19. However, the underlying molecular mechanisms are not completely understood. It has been previously shown that cardiovascular disease predisposes to an altered responsiveness to subsequent inflammatory triggers by an imprinted epigenetic memory in innate immune cells. Therefore, we hypothesized that patients with preexisting atherosclerotic cardiovascular disease (ASCVD) and COVID-19 display a dysregulated inflammatory response compared to patients without ASCVD due to epigenetically altered immune cells leading to increased disease severity.


METHODS AND RESULTS
Single-cell RNA sequencing revealed a dysregulated myeloid immune response with hyperinflammatory and immunosuppressive features in patients with ASCVD and moderate COVID-19. Assay for Transposase-Accessible Chromatin sequencing and in-vitro experiments with isolated monocytes infected with SARS-CoV-2 showed epigenetic priming of monocytes from patients with ASCVD towards increased expression of inflammatory mediators and type I interferon signalling. In a German nationwide cohort (NAPKON), using multiplex cytokine assays, enzyme-linked immunosorbent assays, and bulk-RNA-sequencing, we confirmed that patients with ASCVD display an exaggerated inflammatory response during moderate COVID-19.


CONCLUSIONS
This study demonstrates that patients with ASCVD show a dysregulated myeloid immune response in moderate COVID-19 disease. Mechanistically, epigenetic imprinting sensitizes myeloid cells of patients with ASCVD to an exaggerated type I interferon-associated immune response.


TRANSLATIONAL PERSPECTIVE
This study evaluates the underlying molecular mechanisms of worse outcomes of patients with atherosclerotic cardiovascular disease during respiratory infections, specifically COVID-19. Patients with atherosclerotic cardiovascular disease present with a dysregulated hyperinflammatory, type I interferon-driven immune response already during moderate COVID-19. This not only explains a major risk factor for severe COVID-19 but might also enable targeted therapies for this specific risk group.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/417901a925ab6ef7f438ab3c6409b92a5127c60d" target='_blank'>
              Atherosclerosis licenses for an exceeding immune response in COVID-19 disease by interferon priming in circulating myeloid cells.
              </a>
            </td>
          <td>
            J. Leberzammer, W. Abplanalp, Katharina Grikscheit, Emmanouil G. Solomonidis, S. Glaser, B. Schuhmacher, Maximilian Merten, Gligorije Jeremijev, A. Wilken-Schmitz, Lara Korth, David John, S. Günther, C. Kuenne, Mario Looso, C. Valasarajan, V. Beneš, Ferris Jung, Vivianne Niehaus, Gabriele Anton, Christoph Stellbrink, C. Römmele, S. Göpel, Soni S Pullamsetti, J. Vehreschild, M. Vehreschild, S. Ciesek, D. Leistner, Andreas M. Zeiher, S. Dimmeler, S. Cremer
          </td>
          <td>2025-12-13</td>
          <td>Cardiovascular research</td>
          <td>0</td>
          <td>160</td>
        </tr>

        <tr id="After antigen encounter, long‐lived antibody‐secreting cells (ASC) secrete high‐affinity circulating antibodies. In addition, memory B cells (MBC) are quickly reactivated upon antigen re‐exposure and predominantly generate shorter‐lived ASCs. Studies have suggested that MBC can differentiate into ASCs without recognizing their cognate antigen, a process known as “bystander activation”. This antigen‐independent reactivation of MBC could help maintain circulating antibody levels, thereby protecting against future infections. To elucidate whether SARS‐CoV‐2 mRNA vaccination leads to bystander activation of B cells, the dynamics of antibody concentrations against six pathogen‐specific antigens not encountered during the sampling period were analyzed over time. Deep profiling of antigen‐specific B cell responses was simultaneously performed using multiparameter high‐dimensional spectral flow cytometry. Antibody concentrations against tetanus toxoid (TT), respiratory syncytial virus (RSV), and influenza hemagglutinin (HA) unexpectedly increased 6 weeks after the first SARS‐CoV‐2 vaccination. Deep profiling of B cell differentiation stages demonstrated a short‐term increase in influenza‐specific IgG+ DN3 B cells, RSV‐specific IgG+ CD11c+ activated B cells, and TT‐specific IgG+ MBC following vaccination. In this study, we demonstrated at both the antibody and cellular levels that SARS‐CoV‐2 mRNA vaccination transiently activates distinct early activated B cell compartments directed against influenza HA, RSV, and TT.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f900c073d1085623f61904044b055568f8e6e7fd" target='_blank'>
              SARS‐CoV‐2 mRNA Vaccination Leads to Transient Humoral and B Cell Bystander Responses in Adults
              </a>
            </td>
          <td>
            Lisan H Kuijper, L. Kummer, Laura Fernandez Blanco, K. Straten, M. Claireaux, A. Bos, Miranda C Dieker-Meijer, T. Jorritsma, M. Duurland, M. Steenhuis, Juan J. Garcia Vallejo, Koos P. J. Dam, E. Stalman, L. Wieske, S. Tas, L. Boekel, Gert-Jan Wolbink, T. Rispens, T. Kuijpers, F. Eftimov, M. J. Gils, A. ten Brinke, S. M. Ham
          </td>
          <td>2026-01-01</td>
          <td>European Journal of Immunology</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="HIV infection induces chronic immune activation, predisposing people living with HIV (PLWH) to early immunosenescence. It is essential to understand the mechanisms behind the senescence‐associated secretory phenotype (SASP). This study investigates the role of extracellular vesicles (EVs) in peripheral immunosenescence in HIV infection associated with SASP modulation. Biological and in silico analyses were performed to explore the crosstalk between EVs, miR‐21‐5p, and SASP. Plasma EVs from PLWH were isolated and used to stimulate peripheral blood mononuclear cells (PBMCs) to evaluate their potential to induce SASP. Mononuclear cells were transfected in vitro to induce the production of EVs carrying specific miR‐21‐5p and assess their role in SASP induction. Inflammatory and senescence markers were analyzed using an immunoassay, flow cytometry, and RT‐qPCR. Biological verifications revealed that plasma EVs from PLWH predominantly induce SASP and drive IL‐6 production in HIV‐uninfected PBMCs. We confirmed that miR‐21‐5p expression was increased in plasma EVs from chronically infected PLWH on antiretroviral therapy (ART). Furthermore, we demonstrated that EVs overexpressing miR‐21‐5p induced SASP, specifically increasing IL‐6 levels. SASP‐associated cytokines were associated with PLWH with impaired CD4 T cell recovery and a higher prevalence of CD8+ and CD4+ CD57+ T cells. We also corroborate that IP‐10, IFN‐γ, and IL‐6 could be potential biomarkers for identifying PLWH at greater risk of immunosenescence. Our findings provide insights into EVs driving SASP/IL‐6 release, and this effect becomes more evident in EVs that carry miR‐21‐5p. This finding highlights a potential mechanism by which EVs and IL‐6 contribute to peripheral immunosenescence in HIV‐uninfected cells.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f1bc4a970f60b48815517c9643841b0d3b2b62ec" target='_blank'>
              Extracellular Vesicles Favor Early Peripheral Immunosenescence Through Modulation of the Senescence‐Associated Secretory Phenotype in HIV Infection
              </a>
            </td>
          <td>
            R. Castro, H. Gravina, Fabrícia Heloísa Cavicchioli Sugiyama, Yann Lamarre, Caroline Fontanari, B. Powell, Olesia Gololobova, Zhaohao Liao, Fausto Almeida, Simone Kashima, Kennith W. Witwer, F. Frantz
          </td>
          <td>2025-12-08</td>
          <td>Aging Cell</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="The mechanisms of the chronic inflammatory response in smoking-induced chronic obstructive pulmonary disease (COPD) remain unclear, with limited understanding of T cell responses to smoke exposure in lung tissue and circulation. We characterized the alterations in T cells associated with smoke exposure using single-cell RNA sequencing, TCR sequencing, and flow cytometry-based validation. Our experiments show significant recruitment of T cells within the airways, exhibiting a multifaceted immune profile, augmented TCR clonal diversity, and a prolonged CDR3 length. Notably, smoke-induced γδ T cells, particularly clonally expanded γ6δ4 T cells with high Il17a expression, accumulate in smoke-induced airway inflammation. Despite arising in inflammation, these cells function in a protective manner: γδT17 deficiency worsens smoke-induced lung injury, whereas adoptive transfer of γδT17 cells restores tissue protection in smoke-exposed lungs over time. Here, we show γδT17 cells as a potential target for addressing smoke-induced immune dysfunctions, providing alternative avenues for early prevention and treatment of COPD. T cells have been shown to have a function in chronic lung inflammation in COPD. Here the authors characterise the single cell transcriptional profile of T cells after smoke inhalation in mouse models showing changes in TCR repertoire and Il17a expression in γδ T cells, suggesting smoke-associated γδ T cells are involved in COPD inflammation and implicating γδT17 cells as a possible target for early prevention and treatment of COPD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c72bfc4278bed289c335fdcb150aff219f94dd9e" target='_blank'>
              Comprehensive profiling of smoke-induced T cells in mice implicates clonal γδT17 cells as a hallmark of COPD
              </a>
            </td>
          <td>
            Xinyue Mei, Junxiang Wang, Yuan Wang, Li Cheng, Xiaoyu Wang, Xinyuan Liu, Ge Bai, Jiaying Zhong, Mingzhu Huang, Suyin Huang, Peiyu Huang, Jieda Cui, Yu Liu, Qianmei Wen, Ruiting Sun, Erkang Yi, Fan Wu, Xiaohui Wu, Ziqing Yuan, Q. Wan, Xiaoyang Zheng, Yujie Zuo, Jingwei Zhang, Leqing Zhu, Yumin Zhou, Zhongfang Wang, Pixin Ran
          </td>
          <td>2025-12-08</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Helminth-mediated immunomodulation has been extensively studied in animal models, demonstrating its potential as both a prophylactic and therapeutic option for inflammatory lung diseases. However, its role in attenuating respiratory virus-induced inflammation remains largely unexplored. In this study, we examined whether pre-existing infection with the helminth Trichinella spiralis confers protection against pulmonary pathology induced by respiratory syncytial virus (RSV) infection in mice. Mice with prior T. spiralis infection exhibited reduced pulmonary inflammation and lower viral titers in the lungs compared with RSV-infected controls. Transcriptomic profiling of lung tissue us-ing RNA sequencing identified 407 differentially expressed genes. Among these, enrichment was observed in categories associated with the Gene Ontology (GO) terms “inflammatory response” (GO:0006954) and “defense response to virus” (GO:0051607). Selected genes from these categories were further validated by quantitative real-time PCR. Validation confirmed that co-exposure to T. spiralis and RSV resulted in attenuated expression of inflammation-related genes. Collectively, these findings demonstrate that pre-existing T. spiralis infection can alleviate virus-induced pulmonary pathology and inflammation, highlighting its potential as a novel therapeutic approach for respiratory inflammatory diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ec4ed0767158627001f0445feca2b7dc07b32823" target='_blank'>
              Transcriptomic profiling reveals
 Trichinella spiralis
 -mediated attenuation of respiratory syncytial virus-induced inflammation in mice
              </a>
            </td>
          <td>
            Ki-Back Chu, Fu-Shi Quan
          </td>
          <td>2026-01-22</td>
          <td>Parasites, Hosts and Diseases</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a49c865b1c705b9bfe6bc7d206d36d45188ef570" target='_blank'>
              Neural CXCR4 contributes to neuroimmune modulation of atherosclerosis in a cardio-metabolic Ldlr⁻/⁻ mouse model
              </a>
            </td>
          <td>
            Yaqi Sun, R. Tom, Anna Götz, Sebastian Cucuruz, Annette Feuchtinger, Dominik Lutter, Y. Jansen, C. Weber, Yvonne Döring, Cristina García Cáceres, A. Kapurniotu, J. Bernhagen, T. Müller, Susanna M. Hofmann
          </td>
          <td>2025-12-18</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>39</td>
        </tr>

        <tr id="Although the SARS-CoV-2 pandemic no longer poses a global emergency, the virus continues to diversify and acquire immunoevasive properties. Understanding the molecular pathways that shape SARS-CoV-2 pathogenesis has become essential. In this paper, we summarize the most recent current evidence on how the spike protein structurally evolves, on changes in key non-structural proteins, such as nsp14, and on host factors, such as TMPRSS2 and neuropilin-1. These changes, together, shape viral entry, replication fidelity and interferon antagonism. Given the emerging Omicron variants of SARS-CoV-2, recent articles in the literature, cryo-EM analyses, and artificial intelligence-assisted mutational modeling were analyzed to infer and contextualize mutation-driven mechanisms. It is through these changes that the virus adapts and evolves, such as optimizing angiotensin-converting enzyme binding, modifying antigenic surfaces, and accumulating mutations that affect CD8+ T-cell recognition. Multi-omics data studies further support SARS-CoV-2 pathogenesis through convergent evidence linking viral adaptation to host immune and metabolic reprogramming, as occurs in myocarditis, liver injury, and acute kidney injury. By integrating proteomic, transcriptomic, and structural findings, this work presents how the virus persists and dictates disease severity through interferon antagonism (ORF6, ORF9b, and nsp1), adaptive immune evasion, and metabolic rewiring. All these insights underscore the need for next-generation interventions that provide a multidimensional framework for understanding the evolution of SARS-CoV-2 and guiding future antiviral strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/470c3ee53d5264abc99bc0f49675bd9d3f08a23a" target='_blank'>
              Molecular Aspects of Viral Pathogenesis in Emerging SARS-CoV-2 Variants: Evolving Mechanisms of Infection and Host Response
              </a>
            </td>
          <td>
            Sofia Teodora Muntean, A. Cozac-Szőke, A. Tinca, Irina-Bianca Kosovski, Silviu Vultur, Mara Vultur, O. Cotoi, Anca-Ileana Sin
          </td>
          <td>2026-01-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9a6289ef0537be46b46de88cbd93f3087a718d09" target='_blank'>
              Unraveling the Dual Immunomodulatory and Immunogenic Roles of the Central Conserved Cysteine-Rich Region in Respiratory Syncytial Virus G Protein
              </a>
            </td>
          <td>
            J. Gutman, AL Paletta, F. Birnberg-Weiss, CA Prato, A. Boudgouste, CJ Goldin, S. Sastre, A. Byrne, P. Pakci, FP Polack, J. Dvorkin, A. Zeida, MT Caballero, GC Fernández, MV Tribulatti, D. Alvarez-Paggi, SA Esperante
          </td>
          <td>2025-12-10</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1babe6054c4059128d610e6cfbc8906c8e8c1b18" target='_blank'>
              IFNγ-Driven Inflammatory Responses in the Nasal Mucosa Drive Influenza Virus Shedding and Transmission
              </a>
            </td>
          <td>
            Stacey Bartlett, Hedy L. Rocha, Leon L. Hsieh, Stephen T. Yeung, Chan Wang, Grace O. Ciabattoni, Cynthia A. Loomis, Huilin Li, B. tenOever, M. Ortigoza
          </td>
          <td>2026-01-07</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>64</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/077d61a2f5398bd9d9325e4f8f0c44e0a25878aa" target='_blank'>
              Flu Virus Infection in Juvenile Mice Leads to Lifelong Multi-Organ Damage and Parkinsonian Pathological Changes in Aging
              </a>
            </td>
          <td>
            Ruina You, Cuicui Liu, Xun Liu, Xinglian Wang, Zhuoya Xu, Qian Huang, Guolin Dong, Chaoqun Liang, Na Wang, Zhichao Miao, Taijiao Jiang, Dayan Wang, Lei Deng, Yousong Peng
          </td>
          <td>2025-12-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), remains a major public health threat, particularly in vulnerable populations. SARS-CoV-2 spike proteins interact with the human angiotensin-converting enzyme 2 (ACE2) receptor, together with accessory molecules that facilitate viral entry, through its spike receptor-binding domain (RBD). Although ACE2 is the primary receptor required for viral replication, its expression patterns do not fully correlate with viral distribution or tissue pathology. Moreover, SARS-CoV-2 has been shown to infect cells and tissues lacking detectable ACE2 expression. Viral entry via ACE2-independent pathways may also confer resistance to some monoclonal antibodies (Abs) targeting the spike RBD that block ACE2-mediated binding. These observations highlight the potential significance of ACE2-independent entry factors in SARS-CoV-2 infection, particularly in vaccinated individuals with Abs directed against ACE2-dependent viral entry. In this review, we discuss the emerging roles of ACE2-independent entry factors in SARS-CoV-2 infection and the immune responses. These factors include CD147, AXL, CD169/Siglec-1, CD209L, CD209, CLEC4G, ASGR1, LDLRAD3, TMEM30A, TMEM106B, transferrin receptor 1, GPR78, integrin α5β1, KREMEN1, LFA-1, and CD4. While ACE2 remains central to viral replication, ACE2-independent entry appears sufficient to elicit immune responses. Therefore, future investigations are warranted to elucidate the roles of ACE2-independent mechanisms in immune-mediated pathology and viral evolution, independent of immune pressure targeting ACE2-mediated entry in previously infected or vaccinated individuals.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/416f126df60ac30115fcfb6b97329efa70fd8c23" target='_blank'>
              ACE2-independent entry factors for SARS-CoV-2 infection and immune activation
              </a>
            </td>
          <td>
            Yiyu Sun, L. Wong, Theresa L. Chang
          </td>
          <td>2025-12-22</td>
          <td>mBio</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Exaggerated immune responses to respiratory viruses may contribute to increased morbidity in older adults. To investigate virus-specific immune activation in this population, we developed an ex vivo whole blood stimulation model using samples from 30 healthy individuals aged ≥65 years. Whole blood was stimulated with UV-inactivated influenza A virus (IAV), respiratory syncytial virus (RSV), and SARS-CoV-2, and the expression of 22 immune-related genes was assessed by quantitative RT-PCR array. All three viruses elicited responses with marked variability across individuals, as well as differences in the magnitude and distribution of cytokine expression across stimuli. RSV stimulation was associated with relatively higher expression of inflammatory mediators, while IAV and SARS-CoV-2 induced greater expression of Type I interferon. SARS-CoV-2 also led to an increased expression of regulatory cytokines. Although individual responses varied, correlation analysis indicated coordinated gene expression within functional categories, and Uniform Manifold Approximation and Projection (UMAP) showed distinct grouping of cytokine responses by virus and function. These findings describe differential immune mRNA expression profiles in response to viral stimuli in older adults and may support future studies aimed at understanding age-related differences in host–virus interactions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/186205a878f8f030c29402ed3fafa2c9c330cedb" target='_blank'>
              Distinct Cytokine Landscapes Induced by Influenza a Virus, RSV, and SARS-CoV-2 in Older Adults (65+) Using an Ex Vivo Whole Blood Stimulation Model
              </a>
            </td>
          <td>
            A. Palmieri, I. Schiavoni, Eleonora Olivetta, P. Leone, Alessandra Fallucca, Anita Muglia, A. Carfì, A. di Paola, G. Onder, Giorgio Fedele
          </td>
          <td>2026-01-27</td>
          <td>Pathogens</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="Post-COVID cardiac complications have emerged as a significant and persistent clinical concern, yet their underlying mechanisms remain poorly understood. Animal models can act as proxies to investigate the pathophysiology of the human, post-acute sequelae of SARS-CoV-2 infection (PASC). The aim of this experimental study was to evaluate the expression of inflammatory biomarkers in cardiac tissue 28 days after SARS-CoV-2 infection in a female hACE2 mouse model, with a focus on chemokine-mediated immune activation. Twelve female C57BL/6 hACE2 mice were infected with the Omicron variant (BA.1.17 lineage) of SARS-CoV-2, and eleven non-infected mice served as controls. Cardiac tissue was analyzed via Western blot for markers of innate immune activation (TLR4, MyD88, NF-κB) and pro-inflammatory cytokines (IL-6, IL-18, IL-1β, TNF-α, CD11d). Cardiac tissue injury markers (iNOS, PAI-1 and Connexin43) were also analyzed. Compared to non-infected mice, cardiac tissue from infected mice showed significantly higher expression of IL-6 (p = 0.028), indicating an inflammatory state, and CD11d (p = 0.016), suggesting an inflammatory stage accompanied by sustained activation of chemokine-mediated inflammatory signaling. No significant differences in TLR4 (p = 0.340), MyD88 (p = 0.410), NF-κB p65 (p = 0.780), IL-18 (p = 0.548), IL-1β (p = 0.455), and TNF-α (p = 0.125) expressions were observed Similarly, no changes in cardiac damage markers (iNOS: p = 0.4684; PAI-1: p = 0.5345; Connexin 43: p = 0.2879) were found. The results of this experimental study would support the hypothesis of persistent low-grade inflammation as a contributor to post-COVID cardiac sequelae in females that is not accompanied by severe tissue damage, as also observed in clinical studies. This study also reinforces the need for studies evaluating the functional and structural evolution of the myocardium after an acute SARS-CoV-2 infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8c71f525771ab829c5b8bbcdcdb88fac1b05cc46" target='_blank'>
              Cardiac Tissue Damage in a Female Animal Post-COVID Model: Relevance of Chemokine-Mediated Inflammation
              </a>
            </td>
          <td>
            Silvia Flaj-Prados, Esperanza Herradón Pliego, Carlos Goicoechea Garcia, Eva M. Sánchez-Robles, L. Arendt-Nielsen, C. Fernández‐de‐las‐Peñas, Visitación López-Miranda
          </td>
          <td>2025-12-01</td>
          <td>Viruses</td>
          <td>0</td>
          <td>87</td>
        </tr>

        <tr id="COVID-19 patients experience dynamic changes in immune and cellular function over time, similar to that in sepsis. However, there is insufficient research investigating, at the gene expression level, the mechanisms that become activated or suppressed over time as patients deteriorate or recover. This has potential prognostic and therapeutic implications. In this longitudinal study, 300 whole blood samples were analyzed from 128 adult patients throughout their COVID-19 hospitalization. Transcriptome sequencing (RNA-Seq), differential gene expression analysis, pathway enrichment, and drug-gene set enrichment analysis were performed to elucidate key mechanisms for therapeutic targeting during six distinct disease phases through the COVID-19 trajectory. Adaptive immune dysfunction, inflammation, and metabolic dysregulation were most pronounced during phases with higher disease severity. Hemostatic dysregulation was present early and persisted throughout the disease course, in contrast to an early antiviral response and late heme metabolism activity. Drug-gene set enrichment analysis predicted repurposed medications for potential use, including platelet inhibitors, antidiabetic medications, and dasatinib. Disease phases had distinct transcriptional signatures and were highly correlated to previously developed sepsis endotypes, indicating that severity and disease timing were significant contributors to heterogeneity observed in COVID-19 sepsis. These findings provide an opportunity for better prognostication of patients and potential time-dependent personalized treatments.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/730bda77c6f77da1330b66ac6126520d39d7c77d" target='_blank'>
              Longitudinal gene expression analysis in COVID-19 sepsis highlights dynamic immune, cellular, and metabolic dysfunction in high severity patients
              </a>
            </td>
          <td>
            Andy An, Arjun Baghela, Peter Zhang, Travis M. Blimkie, Jeff Gauthier, Daniel E Kaufmann, E. Acton, Amy H. Lee, Roger C. Levesque, Robert E. W. Hancock
          </td>
          <td>2025-12-19</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Melioidosis is an emerging infectious disease caused by the intracellular bacterial pathogen, Burkholderia pseudomallei. Infection of humans and animals can occur through multiple routes of bacterial entry resulting in life-threatening pneumonia and/or bacteremia. B. pseudomallei is inherently resistant to multiple antibiotics and mortality rates are high despite therapeutic intervention. Development of an effective vaccine could protect at-risk individuals, such as those who reside in highly endemic areas, military personnel, diabetics, and travelers. Despite decades of pursuit, no candidate vaccine for melioidosis has advanced beyond pre-clinical testing in rodent models. Here, we demonstrate that an outer membrane vesicle (OMV) vaccine prevents pulmonary disease in non human primates (NHP) using survivability, biotelemetry, and clinical pathology assessments. Using two independent serologic assays, we demonstrate that vaccination in rhesus macaques is associated with systemic and mucosal IgG and IgA to OMV surface proteins and polysaccharides. We also show that NHP immune sera promotes opsonophagocytosis by macrophages and that human sera responses to several key OMV antigens are associated with survival in melioidosis. Collectively, these results attest to the potential efficacy of the OMV vaccine and lay the groundwork for its advancement to human phase 1 clinical trials. Currently, there is no licensed vaccine for Burkholderia pseudomallei, the causative agent of melioidosis. Here, the authors evaluate the efficacy and safety of an outer-membrane vesicle vaccine in macaques and demonstrate that it prevents lung pathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9442780e25db91fb83d5580e3649220051e4adc7" target='_blank'>
              An outer membrane vesicle vaccine prevents lung pathology in a macaque model of pneumonic melioidosis
              </a>
            </td>
          <td>
            Sarah M Baker, E. Settles, K. Celona, Austin B Shannon, Christpher Davitt, Kalen Hall, Aarti Jain, R. D. de Assis, A. E. Gregory, P. Felgner, Celeste Woerle, M. Mayo, Bart J Currie, W. Wimley, James B. McLachlan, Heesik Yoon, Chinh T Dao, Janice Moser, Dereck Pociask, Paul Keim, K. Russell-Lodrigue, Chad J. Roy, L. Morici
          </td>
          <td>2025-12-09</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>56</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/291cd1612c50d00cdb88e4ebcedd78749a7bb740" target='_blank'>
              Pathology and viral evolutionary dynamics in a hamster model of persistent SARS-CoV-2 infection.
              </a>
            </td>
          <td>
            Wanting Wei, M. Kuroda, Yanan Liu, S. Iida, Sangam Kandel, Heather Machovech, Yuichiro Hirata, Tadaki Suzuki, K. Koelle, Zhongde Wang, T. C. Friedrich, Yoshihiro Kawaoka, P. Halfmann
          </td>
          <td>2026-01-08</td>
          <td>Communications biology</td>
          <td>0</td>
          <td>57</td>
        </tr>

        <tr id="Abstract Background: Human enteric species F adenoviruses are a leading cause of diarrhoea-associated paediatric morbidity and mortality worldwide. The cellular immune response (antigen-specific cytotoxic T cells and secreted cytokines) to human adenovirus (HAdV) infection is known to ameliorate symptoms and is critical for viral clearance. We hypothesized that the capsid proteins (hexon and penton) of HAdV-F40 and 41 (F40, F41) are evolving to escape cellular immune responses. Major histocompatibility complex (MHC) binding of viral peptides is a key step in the presentation of peptide–MHC complexes which activate the T-cell receptor and the cytotoxic T-cell response. Methods: Using global HAdV genomic data, we predicted MHC–peptide binding within the hexon and penton proteins of F40 and F41. We focused on MHC Class I alleles common in the UK and Kenya and identified predicted MHC Class I epitopes. Eight predicted epitope pairs from the F41 hexon were synthesized as 15-mer peptides, comparing the wildtype (1970 F41 reference) to the variant (2019–22) sequences. Cellular interferon gamma (IFN-γ) responses to these epitopes were measured in healthy donors using FluoroSpot assays. Results: We identified multiple predicted Class I epitopes shared between HAdV species C and F, but also unique to species F, and epitopes unique to each genotype. We show that IFN-γ and IL-2 (interleukin 2) peripheral blood mononuclear cell (PBMC) responses to HAdV-F are ubiquitous among healthy adult donors from Cambridge, UK. Among predicted Class I epitopes within the F41 hexon, 11/16 peptides elicited donor positive IFN-γ responses from healthy donor PBMC (at least one epitope from seven out of eight peptide pairs). Conclusions: The hexon and penton proteins of HAdV-F-40 and F41 are predicted to contain a number of genotype-specific, but conserved, Class I epitopes which could be used to inform future vaccine design. Using the hexon of F41 as a case study, we show that predicted T-cell epitopes in emergent strains are able to elicit an inflammatory cytokine response from healthy donor PBMC. The role of T-cell recognition in driving enteric adenovirus evolution deserves further consideration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0650b83da6b365958f0d11b971f63f80b43f06d1" target='_blank'>
              Viral diversity influences T-cell responses to enteric human adenoviruses F40 and F41
              </a>
            </td>
          <td>
            Holly M. Craven, Jennifer P Hoang, Rookmini Mukhopadhyay, A. Lambisia, Benjamin A C Krishna, Benjamin J. Ravenhill, C. Agoti, C. Houldcroft
          </td>
          <td>2025-12-18</td>
          <td>Virus Evolution</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/43bca2de8a56fce85ec0fb9fafcd995828afcdf9" target='_blank'>
              “Bifidobacterium longum-reactive T helper cells as marker for intestinal barrier impairment in ICU patients with sepsis”
              </a>
            </td>
          <td>
            Lea-Maxie Haag, Markus Müller, J. Ziegler, M. Lehmann, Julia Hecker, R. Glauben, M. Heimesaat, Friederike Compton, B. Siegmund
          </td>
          <td>2025-12-24</td>
          <td>Gut Pathogens</td>
          <td>0</td>
          <td>53</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/267292fcda51fe6aa716329edd7ebaab70e35171" target='_blank'>
              Structural mimics of SARS-CoV-2.
              </a>
            </td>
          <td>
            Natasha Killassy, Patrick Arbuthnot, M. B. Maepa
          </td>
          <td>2026-01-22</td>
          <td>Infection</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="Spinal cord injury (SCI) causes irreversible motor and sensory dysfunction. Initial mechanical injury breaches the blood-spinal cord barrier (BSCB), triggering a rapid influx of neutrophils. However, previous studies on neutrophils after SCI have been relatively limited, the function and heterogeneity of neutrophils need further study. Here, we identified 3 distinct neutrophil subclusters post-SCI using scRNA-seq in SCI mouse models. Additionally, elevated levels of CD177+ neutrophils may aggravate inflammation and neuronal impairment based on our data from SCI patients and mice models. Further in vivo and in vitro assays indicate that CD177+ neutrophils induce pro-inflammatory polarization of macrophages and microglia via neutrophil extracellular traps (NETs) formation in a peptidyl arginine deiminase 4 (PAD4) and reactive oxygen species (ROS)-dependent manner thus inducing neuronal apoptosis. Additionally, bone marrow transplantation from Cd177 knockout (KO) to Cd177 wild-type (WT) mice improved functional recovery post-SCI. These findings elucidate the role of CD177+ neutrophils in SCI-related inflammation and highlight their potential as therapeutic targets.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0cffc735f3e28fe7714468bd124b9861f5e56bb5" target='_blank'>
              Neutrophil extracellular traps released by CD177+ neutrophils aggravated inflammation and neuronal impairment post-SCI
              </a>
            </td>
          <td>
            Siming Dai, Ziyang Zheng, Chengxi Zhang, A. Xue, Hao Liu, Yin Li, Shenyu Wang, Haofei Ni, Jiaxi Li, Siqi Li, Jian Chen, Guoyong Yin, Shujie Zhao
          </td>
          <td>2025-12-07</td>
          <td>Cell Communication and Signaling : CCS</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="

 Multisystem inflammatory syndrome in children (MIS-C) is a severe condition that arises 4–6 weeks after SARS-CoV-2 exposure, marked by persistent fever, mucocutaneous symptoms, cardiac involvement, and shock. Natural killer (NK) cells are thought to contribute during the acute phase due to their antiviral and immunoregulatory roles, but their phenotype during recovery is not well defined. An expansion of TCR Vβ21.3+ T cells has been observed during acute MIS-C, though their long-term presence and significance remain unclear.



 Peripheral blood mononuclear cells (PBMCs) were collected from 4 healthy pediatric controls, 4 febrile (non-COVID) controls, 4 children with acute COVID-19, 9 with acute MIS-C, 8 MIS-C convalescents (6–12 months), and 6 long-term MIS-C convalescents (4 years). TCR Vβ21.3 expression was analyzed using a T cell panel (CD3, CD4, CD8, CD27, CD45RA, TCR Vβ21.3). NK cell phenotype was assessed after co-culture with K562 cells using markers including CD56, CD3, CD16, CXCR6, Ki67, NKG2D, NKG2C, and CD158.



 NK cells from acute MIS-C patients showed decreased CD57, CD158, and CD107a, along with increased NKG2D expression. Clustering analysis revealed a unique NK cell population exclusive to acute MIS-C, defined by absent CD107a and elevated CXCR6 and Ki67. Most alterations resolved within 6–12 months, except CD158, which remained low even after 4 years. TCR Vβ21.3+ T cells persisted for up to a year but were undetectable at 4 years.



 MIS-C triggers a transient NK phenotype marked by reduced cytotoxicity and increased activation, suggesting a hyperactivated or dysregulated immune profile. Persistent downregulation of the inhibitory receptor CD158 may indicate prolonged NK activation. TCR Vβ21.3+ T cells appear to be short lived. Further long-term studies with larger cohorts are needed to validate these findings.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1c63e6c5c161a67863c64ce2aea0e118e09c3073" target='_blank'>
              Tracking NK and Memory T Cell Dynamics in Children Affected by Multisystem Inflammatory Syndrome (MIS-C)
              </a>
            </td>
          <td>
            Natalia González, Camila Astudillo, Yazmin Espinosa, Paz Cerda-Castro, Juan Pablo Araya, Grace Ayleen Silva, Martín Felipe Hernández, M. C. Poli, Emma Rey-Jurado
          </td>
          <td>2025-12-22</td>
          <td>Journal of Human Immunity</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="ABSTRACT Thrombomodulin (TM) is a membrane protein with significant roles in coagulation hemostasis and immune response. Its soluble form (sTM) has recently emerged as a key biomarker for severe invasive bacterial infections, including Necrotizing Soft Tissue Infections (NSTI). While various mechanical, chemical, and enzymatic mechanisms have been linked to TM shedding, this study investigates the direct impact of bacterial stimuli on soft tissue cells as primary sources of TM release. We stimulated organotypic models, composed of fibroblast and endothelial cells, with NSTI clinical isolates and found that while Group A Streptococcus and Escherichia coli had minimal effect on TM release, Staphylococcus aureus infection triggered a significant increase of sTM levels. We further assessed whether the secreted proteins of S. aureus led to higher TM levels by increased expression, increased cell toxicity, or direct cleavage of TM from the endothelial cell membrane. To investigate these mechanisms, we performed in vitro stimulations of endothelial monolayers with secreted proteins of two S. aureus isolates differing in their agr-system functionality. Our results indicate that S. aureus agr-regulated proteins induce TM shedding by direct cleavage from the cell membrane, an effect that was inhibited by metalloproteinase inhibitors. Stimulation with the pore-forming protein α-toxin showed similar results, suggesting a potential involvement of ADAM10 in TM cleavage. Additionally, we observed that other agr-regulated proteins can cleave TM directly. Altogether, this study reveals a pathogen-specific mechanism for TM release during S. aureus invasive infection, contributing to its elevated plasma levels and providing deeper insights into the pathophysiology of NSTI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8317351e5214a59c2c7b069984a0672c0c8381b9" target='_blank'>
              Staphylococcus aureus toxins mediate endothelial Thrombomodulin release during severe invasive infections
              </a>
            </td>
          <td>
            Lisa Seidner, Emi Tanaka, Olivia Engstrand, Sara Nilsson, Anna Bergonzini, Lara Kaland, Monica Novello, Mattias Svensson, A. Norrby-Teglund, L. M. Palma Medina
          </td>
          <td>2025-12-17</td>
          <td>Virulence</td>
          <td>0</td>
          <td>56</td>
        </tr>

        <tr id="Backgrounds Asthma is a chronic inflammatory disease affecting airways, usually starting in childhood. Its cause remains unclear. Objective We aim to elucidate the role of immune dysregulation in the pathogenesis of pediatric asthma. Methods In this study, we used single-cell RNA sequencing to analyze peripheral blood mononuclear cells (PBMCs) from three pediatric asthma patients and four age-matched healthy controls to investigate the cellular etiology of childhood asthma. Results The overall expression patterns of PBMCs from the three asthma patients indicate that both innate and adaptive immunity are imbalanced and abnormally activated in childhood asthma. Analysis of hematopoietic stem and progenitor cells (HSPCs) expression profiles further reveals that HSPCs from asthma patients tend to express immunity-related genes earlier. The cell developmental trajectories observed in asthma patients show an abnormal immune cell development pattern. Dysregulated lymphoid lineage development is observed in all three patients but there is no identical abnormal pattern for each patient. Pseudo-time analysis of gene expression demonstrates that JUN, a gene controlling cell cycle progression, is repressed in asthma patients while SPI1, an essential gene for lymphoid lineage development along with six inflammatory response related genes (S100A8, S100A9, S100A12, IL7R, IL32, and CCL5), exhibit various aberrant expression trajectories in asthmatic individuals. S100A8, S100A9, S100A12, and RETN are universally upregulated in various cell types of asthma patients. The analyses of cell-cell communication further elucidate the contributory roles of dendritic cells and CD14+ monocytes in the development and heterogeneity of asthma, as they exhibit increased reception and transmission of annexin and resistin signals in the asthma group. The resistin protein-protein interaction network analysis further suggests that SQSTM1, HSPA5 and A2M might serve as the potential therapeutic targets in childhood asthma. Conclusions Our scRNA-Seq analyses unveil childhood asthma as a complex disease with immune-related heterogenicities, characterized by dysregulated lymphoid cell development, a common feature that may offer a novel research direction for comprehensively understanding the key molecular mechanisms underlying childhood asthma.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7ac839354a116b4d2e6b2ef7d374214851cf6652" target='_blank'>
              Single-cell RNA sequencing unraveled immune-related expression heterogeneity and lymphoid cell development dysregulation in childhood asthma
              </a>
            </td>
          <td>
            Danying Zhu, Guang Li, Lang Yuan, Zeyu Zeng, Na Dong, Chao Wang, Ming Chen, Lijian Xie, Guohui Ding, Libing Shen, Xiaoyan Dong
          </td>
          <td>2026-01-02</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Introduction A global outbreak of Mycoplasma pneumoniae pneumonia (MPP) emerged following the Corona Virus Disease 2019 (COVID-19) pandemic. Different altitudes significantly impact community-acquired pneumonia (CAP). Whether there are differences in the immune responses of children with MPP at different altitudes is unknown. Methods This study collected bronchoalveolar lavage fluid (BALF) from children with MPP in Nanjing (altitude, 20 m) or Qinghai (altitude, 4,058.40 m) for transcriptome sequencing analysis to investigate pulmonary immune responses in children with MPP at different altitudes. Results Children with refractory Mycoplasma pneumoniae pneumonia (RMPP) in the plateau group showed milder clinical manifestations, with shorter duration of fever before admission, lower levels of serum tissue injury markers, and lower incidences of atelectasis. Neutrophils and T cells in the lungs of the plain group were activated, along with the activation of the NOD-like receptor signaling pathway or the inhibition of the PI3K–Akt signaling pathway. The immune cells of children with MPP in the plateau group showed adaptive changes, which manifested as increased M2 polarization of macrophages, CD8+ T cells, and B cells, and decreased neutrophils and CD4+ T cells. Conclusion Excessive activation of the pulmonary immune response in children with MPP of the plain region may be related to the NOD-like receptor signaling pathway and PI3K–Akt signaling pathway. Adaptive changes in immune cells occurred in children with MPP of the plateau region.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/41f9c6a1f207f00de91201f2412fa8ce260fcf9e" target='_blank'>
              High-altitude immune remodeling in children with Mycoplasma pneumoniae pneumonia: a multi-center transcriptome study
              </a>
            </td>
          <td>
            Yingying Luo, Jing Hou, Weifen Lu, Haixia Cao, Erwa Hao, YaoGang Zhang, Feng Liu, Yifan Zhu, Yanyan Ma
          </td>
          <td>2025-12-16</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Since its emergence in 2019, circulating SARS-CoV-2 has been dominated by waves of genetically distinct variants with varying pathogenicity. Understanding the multidimensional responses to SARS-CoV-2 infection and their associations with pathogenesis is critical for developing therapies to prevent severe illness and death. Here, we applied quantitative proteome and phosphoproteome analyses to compare host responses to infections with an ancestral variant (WA-1/2020), a Delta variant (B.1.617.2), and an Omicron variant (BA.1) of SARS-CoV-2 in Syrian golden hamster tissues at 5 days postinfection, when peak inflammatory responses were observed. As has been observed by others, animals infected with the Delta variant lost more weight than those infected with other variants, and this effect was associated with decreased cilia proteins in the trachea tissue and increased signatures of fibrosis in lung tissue. Phosphoproteome analysis revealed a downregulation of Raf-MEK-ERK signaling across all variants, suggesting a suppressed proliferative response in tissues following SARS-CoV-2 infection. These data provide critical in vivo confirmation of observations from in vitro studies and provide a quantitative tissue- and SARS-CoV-2 variant-specific resource of proteome and phosphoproteome responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dd0d313a0a85635cbe7e735c398d3c671308612c" target='_blank'>
              Quantitative Tissue Proteomics Reveals Protein Signatures Associated with SARS-CoV-2 Variant Infection in Hamsters.
              </a>
            </td>
          <td>
            Justin J Frere, Boris Bonaventure, Haylen Rosberger, A. Kurland, David Sachs, Aum R Patel, Amit Garg, Ma Gonzalez, B. tenOever, Jean K Lim, Jeffrey R. Johnson
          </td>
          <td>2026-01-10</td>
          <td>Journal of proteome research</td>
          <td>0</td>
          <td>64</td>
        </tr>

        <tr id="Microglia are the main innate immune cells residing in the brain parenchyma. Their activation and resulting neuroinflammation have emerged as major pathogenic mechanisms in neurodegenerative disorders, particularly in Alzheimer's disease (AD). The accumulation of amyloid‐β oligomers (AβOs) and microglia activation play crucial roles in the pathogenesis of AD. In a second vein, the development of innate immune memory in response to different stimuli is a vital mechanism that enables microglia to adjust their response to subsequent inflammatory challenges. While there is increasing evidence that repeated bouts of peripheral inflammation lead to training or tolerance in microglia, the impact of tolerance on the inflammatory response induced by AβOs remains to be determined. In this study, we investigated whether lipopolysaccharide (LPS)‐induced tolerance affects microglial responses to AβOs. For that, organotypic hippocampal cultures were repeatedly challenged with LPS before being exposed to AβOs. We measured cytokine levels and evaluated changes in microglial activation and morphology following exposure of cultures to AβOs. A significant decrease in cytokine production was observed when hippocampal slice cultures were repeatedly challenged with LPS. Interestingly, microglial activation and the resulting inflammatory response induced by AβOs were prevented when these cultures had been previously challenged with LPS. Moreover, the changes in microglial morphology and cytokine production resulting from repeated LPS stimulation were associated with reduced activation of nuclear factor kappa B (NF‐κB). These results indicate that preconditioning microglia with LPS induces a physiological immune tolerance response rather than pathological inflammation, which may have implications for developing therapeutic strategies for AD aimed at modulating innate immune memory.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f30b28f24e182dd29b261967df3617b845598fe7" target='_blank'>
              Innate Immune Tolerance Regulates Microglia Response to Aβ Oligomers
              </a>
            </td>
          <td>
            Rafaela Rodrigues Valerio, Áquila Rodrigues Costa Santos, Ana Helena Larangeira Nóbrega, Raquel Martins, F. D. De Felice, Sérgio T. Ferreira, Wilson Savino, Adriana Bonomo, Andressa Bernardi, R. Frozza
          </td>
          <td>2026-01-01</td>
          <td>Journal of Neurochemistry</td>
          <td>0</td>
          <td>57</td>
        </tr>

        <tr id="Demyelination is a significant pathological feature of chronic cerebral ischemia. Recent evidence suggested that microglia played a protective role in mitigating brain ischemic injury via phagocytosis of myelin debris resulting from demyelination. Triggering receptor expressed on myeloid cells-like 2 (TREML2) is a newly discovered inflammation-associated transmembrane receptor expressed by microglia. To date, whether microglial TREML2 contributes to the phagocytosis of myelin debris in chronic cerebral ischemia has not been fully clarified. In this study, employing a bilateral carotid artery stenosis animal model and a CoCl2-treated cellular model, we demonstrated for the first time that microglial TREML2 expression was upregulated in response to chronic cerebral ischemia. Utilizing Treml2-knockout mice, we provided the first evidence that Treml2 deficiency alleviated demyelination and cognitive deficits induced by chronic cerebral ischemia. Furthermore, this protective effect might be attributed to the microglial M2-type polarization and enhanced phagocytosis of myelin debris, both of which were induced by the Treml2 deficiency. Additionally, we showed that TREML2 regulated microglial phagocytosis of myelin debris via toll-like receptor 9 under ischemic conditions. These findings elucidated the mechanisms by which microglia modulated the phagocytosis of myelin debris in response to brain ischemic injury and suggested that inhibition of TREML2 might represent a novel therapeutic strategy for treating demyelination and cognitive decline induced by chronic cerebral ischemia.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d8fbc70c6a6973d68d7085a3049c24bff0a8b800" target='_blank'>
              TREML2 Modulates Microglial Phagocytosis of Myelin Debris via TLR9 in Chronic Cerebral Ischemia
              </a>
            </td>
          <td>
            Zhaoui Xu, Jing-Wen Qi, Xin-Yu He, Shi-Yao Wang, Shuai-Yu Chen, Yu-Cheng Gu, Yi Xie, Ying-Dong Zhang, Teng Jiang
          </td>
          <td>2025-12-17</td>
          <td>Inflammation</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="Sepsis-induced immunosuppression is a phenomenon characterized by the development of several changes in immunophenotype which predispose to secondary infections and increased mortality risk. Immunomodulatory therapies have yet to reproducibly demonstrate benefit in large clinical trials. We propose that several changes consistent with an immunosuppressive phenotype in sepsis represent either adaptive changes or epiphenomenon, rather than direct drivers of outcome in infection and sepsis. We therefore conducted a prospective observational study of patients presenting with infections with a spectrum of illness severity, to evaluate canonical features of monocyte and lymphocyte immunosuppression using flow cytometry. Several features consistent with immunosuppression in sepsis are observed in mild infections and non-infectious acute conditions. These features may be better understood as markers along a continuum of illness severity rather than distinct features of critical illness. Monocyte HLA-DR and co-stimulatory molecules (CD80 and CD86), and an increase in soluble PD-L1, discriminate between critically ill patients, patients with mild infection, and patients with non-infectious illness. In contrast, CD4+ and CD8+ lymphocyte phenotype did not discriminate between patient groups. Immunotherapies targeting lymphocyte function may only be effective if simultaneously augmenting monocyte antigen presentation and co-stimulatory pathways. Combination immunotherapy in sepsis requires evaluation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7d340f2e07c32552040a896436c978ad25d0ed8d" target='_blank'>
              Immune signatures of sepsis from mild infection to critical illness - a prospective observational study
              </a>
            </td>
          <td>
            Timothy Arthur Chandos Snow, Francis Ryckaert, I. Hass, Holly Pan, S. Elkhodair, M. Singer, D. Brealey, N. Arulkumaran, , Naveed Saleem, Cesar Antonio, Alessia Waller, Deborah Smyth, G. Bercades, A. Z. Martinez, Laura Gallagher, G. Martir
          </td>
          <td>2026-01-16</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="Epstein-Barr virus (EBV) infection shows the strongest causative association with multiple sclerosis (MS), but its contribution to disease progression and the mechanisms allowing for viral persistence in the MS brain are still elusive. Studies in post-mortem MS brain tissue indicate an ongoing yet ineffective antiviral immune reaction in advanced stages of the disease. EBV has evolved strategies to evade immune recognition and clearance by the host immune system during both the latency and lytic phase of its life cycle. Recent evidence demonstrates that cells expressing EBV latent membrane protein (LMP) 2A exploit the PD-1/PDL1 inhibitory immune checkpoint to escape immune surveillance and maintain a persistent latent infection in the MS brain. This study investigated whether the virus also utilizes this inhibitory mechanism during other phases of the viral life cycle. By using multiple immunostainings on highly inflamed MS brain tissues containing meningeal tertiary lymphoid structures (TLSs), we analyzed PD-L1 expression on EBV-infected cells expressing EBNA2, five EBV lytic gene products, BZLF1, BHRF1, BMRF1, BALF2, and gp350/220, as well as on follicular dendritic cells within the TLSs. This is the first study describing in secondary progressive MS brain tissue the expression and the cellular and tissue distribution of PD-L1 on EBV-infected cells being in different stages of the viral life cycle, and confirms the meningeal TLSs as immune-permissive habitats favoring the maintenance of an intracerebral EBV reservoir.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/870ad961c0e5c100c7165ed6e63b21a8a6ff2f43" target='_blank'>
              EBV Early Lytic Antigens, EBNA2 and PDL-1, in Progressive Multiple Sclerosis Brain: A Coordinated Contribution to Viral Immune Evasion
              </a>
            </td>
          <td>
            Lucia Benincasa, B. Rosicarelli, Chiara Meloni, B. Serafini
          </td>
          <td>2025-12-31</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="This review article attempts to provide a unifying hypothesis to explain the myriad of symptoms and predispositions underlying the development of PASC (Postacute Sequelae of COVID), often referred to as Long COVID. The hypothesis described here proposes that Long COVID is best understood as a disorder of persistent immune dysregulation, with chronic macrophage activation representing the fundamental underlying pathophysiology. Unlike transient post-viral syndromes, Long COVID involves a sustained innate immune response, particularly within monocyte-derived macrophages, driven by persistent spike protein (peripherally in MAIT cells and centrally in Microglial cells), epigenetic imprinting, and gut-related viral reservoirs. These macrophages are not merely activated temporarily but also become epigenetically “trained” into a prolonged inflammatory state, as demonstrated by enduring histone acetylation markers such as H3K27acDNA Reprogramming. It is proposed that recognizing macrophage activation as the central axis of Long COVID pathology offers a framework for personalized risk assessment, targeted intervention, and therapeutic recalibration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5b5f2903ed6d3bcbf8e560a451808bb27c9205bb" target='_blank'>
              The Central Role of Macrophages in Long COVID Pathophysiology
              </a>
            </td>
          <td>
            Philip Mcmillan, Anthony J Turner, B. Uhal
          </td>
          <td>2025-12-27</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="This study investigated how prolonged aggression in male CD1 mice alters responses to chronic LPS (lipopolysaccharide)-induced inflammation. Experience of aggression induced pathological aggression in 36% of mice. Following LPS, aggressors resolved systemic inflammation within five days—evidenced by normalized locomotor activity, WBC (white blood cells), and lymphocyte counts—while controls remained inflamed. LPS did not alter established aggression or anxiety. Furthermore, aggressors demonstrated accelerated inflammation resolution in the brain, showing a higher proportion of resting microglia and a lower percentage of activated microglia following LPS-induced inflammation compared to control animals. Gene expression analysis revealed a more pronounced inflammatory response in the hypothalamus than in the nucleus accumbens. Aggressive mice exhibited a profile associated with inflammation resolution, indicated by increased expression of the Trem2 gene. These differential immune responses may be modulated by the dopaminergic system. Elevated Drd1 gene expression in the hypothalamus could possibly contribute to the anti-inflammatory signaling, while changes in nucleus accumbens dopaminergic activity, involving D2 receptor activation, appear linked to the development of pathological aggression. Thus, this study demonstrates that prolonged aggression induces persistent changes in behavioral, neuroimmune, and neuroendocrine systems in male CD1 mice. Aggressive animals develop a distinct neuroimmune phenotype characterized by accelerated resolution of both systemic and brain inflammation following LPS challenge.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e8af717818ae65429c337dd3a00e34367f6925bd" target='_blank'>
              Prolonged Aggressive Experience Accelerates Resolution of Inflammation in Blood and Microglia After Repeated LPS Treatment
              </a>
            </td>
          <td>
            Anastasia Mutovina, A. Sapronova, Kseniya Ayriyants, Yulia Ryabushkina, Julia Khantakova, Polina Mezhevalova, Polina Ritter, Natalya Bondar
          </td>
          <td>2025-12-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Considerable attention has been recently devoted to the involvement of immune cells in the central nervous system (CNS) during infections with neurotropic viruses, such as SARS-CoV-2, HIV-1, and ZIKV. These viruses are capable of infecting astrocytes and microglia, the main glial cells in the CNS, responsible for regulating neuronal activity. Here, we discuss how viral infections lead to metabolic reprogramming toward aerobic glycolysis in these cells, enhancing pro-inflammatory pathways, such as inflammasome activation, resulting in the secretion of inflammatory cytokines that favor the development of neuroinflammation. In this mini review, we discuss the pivotal interplay between metabolism and immunity towards viral pathogenesis in the CNS, pointing out the relevance of therapeutic strategies targeting both metabolic and immunological pathways to enhance antiviral and neuroprotective responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c603076d92448698be2b3b34d399b974e9d4c131" target='_blank'>
              Viral reprogramming of glial metabolism as a driver of neuroinflammation
              </a>
            </td>
          <td>
            Tamara Rodrigues, Gabriel Salles Beltrão, Heloísa Girardi, Aguinaldo R. Pinto
          </td>
          <td>2025-12-19</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="The SARS-CoV-2 virus has shown incredible finesse in using the cellular machinery of its hosts to replicate itself while in addition escaping the host's immune system. This pivotal review covers the detailed and complex cellular mechanisms that SARS-CoV-2 employs to subvert various cellular processes within the host and focuses on some aspects of the virus cellular entry and replication processes and immune system evasion. After carefully collating the data that has been recently published, we have identified and described the virus mediated cellular subversion of the endoplasmic reticulum stress response, autophagy, innate immune system and its signalling, and cellular metabolism. Our thorough understanding of these processes cellular subverted by SARS-CoV-2 will guide future therapeutic interventions, and will illuminate some of the complex and devious host–pathogen interactions that drive the pathology of COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ac0103346ce84b0faadf6332e3a522b2fc6c2248" target='_blank'>
              Cellular pathways exploited by SARS-CoV-2 for replication and immune evasion: a comprehensive analysis of viral hijacking mechanisms
              </a>
            </td>
          <td>
            Shanmukha Madras
          </td>
          <td>2025-12-30</td>
          <td>International Journal of Therapeutic Innovation</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="HIV-associated neurocognitive disorders (HAND) are exacerbated by comorbid substance abuse, particularly cocaine use. However, the mechanisms by which HIV-1 proteins and cocaine synergize to induce neuronal dysfunction remain poorly understood. Emerging evidence suggests that astrocytes regulate neuronal health through metabolic and mitochondrial communication. Primary rat astrocytes were exposed to HIV-1 Tat protein and cocaine to assess changes in metabolic phenotype and mitochondrial dynamics. Mitochondrial morphology was evaluated via confocal microscopy, while extracellular vesicles (EVs) were isolated and characterized. Cell-type-specific mitochondrial labeling and live-cell imaging were used to track mitochondrial transfer from astrocytes to neurons. Neuronal viability, mitochondrial function, and bioenergetic profiles were assessed following exposure to astrocyte-derived EVs. Astrocytic mitochondrial fragmentation was inhibited using a GTPase-inactive Drp1 mutant or dominant-negative Orai1 to test rescue effects. Tat and cocaine co-exposure induced a hypermetabolic shift and mitochondrial fragmentation in astrocytes. Fragmented mitochondria were incorporated into astrocyte-derived extracellular vesicles (AEVs) and transferred to neurons. Neuronal uptake of these AEVs led to impaired mitochondrial function and reduced viability. Inhibition of astrocytic mitochondrial fission significantly decreased mitochondrial transfer and preserved neuronal bioenergetics and health. These findings identify a novel mechanism of transcellular mitochondrial transfer from astrocytes to neurons under pathological conditions. Mitochondria contained within AEVs act as neurotoxic agents in the context of HIV-1 Tat and cocaine exposure. Targeting astrocytic mitochondrial dynamics may provide a promising therapeutic approach for preventing or mitigating neurodegeneration in HAND and substance use disorders.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b100ef9021ac17db151d35b2fe9c9d969deed2cd" target='_blank'>
              Transcellular mitochondrial transfer from hypermetabolic astrocytes to neurons during cocaine and HIV-1 exposure
              </a>
            </td>
          <td>
            S. Shanmughapriya, T. M. Ahooyi, B. Torkzaban, V. Garikipati, Raj Kishore, Kamel Khallili, Dianne Langford, K. Natarajaseenivasan
          </td>
          <td>2025-12-09</td>
          <td>Cell Communication and Signaling : CCS</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="Introduction Long COVID (LC), a clinical condition marked by persistent and new symptoms after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), affects up to 10-20% of infected individuals. Although autoimmunity has been proposed as a key mechanism, the specific role of circulating autoantibodies in LC remains unclear. We characterized the autoantibody profiles in individuals with LC and assessed their association with persistent post-COVID symptoms, in comparison to recovered patients and pre-pandemic healthy controls (PPHC). Methods We analyzed 17 autoantibodies in a cohort of 220 pre-pandemic controls and 291 COVID-19 patients, targeting self-antigens. Of those, 237 patients presented symptoms for a month or more after the onset of SARS-CoV-2 infection (long COVID patients), and 54 individuals recovered from the initial infection without chronic symptoms. Autoantibody frequencies and associations with clinical variables were assessed using logistic regression and subgroup analyses. Results Autoantibody prevalence was higher in recovered individuals (37%) than in LC patients (24%) or PPHC (19%). While certain autoantibodies such as a-cardiolipin (a-CL) IgM, a-AML IgG, a-SSA IgG and a-SSB IgG were elevated in some COVID-19 patients, they were not significantly different in LC. The most frequently detected autoantibody was a-CL IgM, found across all groups and especially in individuals that fully recovered from COVID-19. However, a-CL did not differentiate individuals with long COVID or correlate with symptom persistence but was associated with the occurrence of dysphagia and anorexia as symptoms. No correlation was observed between autoantibody presence and disease severity. Discussion These findings do not support a primary pathogenic role for the evaluated autoantibodies in LC and emphasize the need for longitudinal studies to explore their temporal dynamics and interaction with other immunological or clinical factors involved in post-COVID-19 conditions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3eda56950809fc6d0fbb43c3e1d9ce4d782eb02d" target='_blank'>
              Autoantibodies in long COVID in a black/mixed population compared with recovered and pre-pandemic controls
              </a>
            </td>
          <td>
            Jéssica de Jesus Silva, Laila Sampaio Horta, Sayonara Melo Viana, A. B. Cazé, I. S. Oliveira, Mariana M. Pereira, Natalie Antas Nascimento, Blenda de Jesus Pereira, Ícaro Bonyek-Silva, Sara Nunes de Oliveira Araújo, Ananda Isis Lima de Marinho, Juqueline Rocha Cristal, Vishal Rao, Camila Coelho, T. Cerqueira-Silva, K. Malmegrim, A. Camelier, C. R. Cardoso, N. Tavares, Manoel Barral-Netto, Aldina Barral, C. Barbosa, V. Boaventura
          </td>
          <td>2025-12-11</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Respiratory infectious pathogens such as influenza, respiratory syncytial virus (RSV), and SARS-CoV-2 persist as significant threats to global health. Most of the pathogens come in through the respiratory mucosa, with the local immune mechanisms as the first line of defense. Here, we explore the role of mucosal immunity, such as secretory immunoglobulin A (sIgA), tissue-resident memory T cells (TRM), and inducible bronchus-associated lymphoid tissue (iBALT), in the management of respiratory infections in this research. The mechanistic part illustrates how mucosal vaccination achieves these reactions by protecting within the zone of pathogen entry. There is now experimental data on live attenuated influenza vaccination (LAIV), studies on preclinical SARS-CoV-2 mucosal vaccine, and early human trials that demonstrate the possible role of mucosal vaccination in limiting viral replication and transmission. But the translational challenge is still with various aspects, such as uniform mucosal immune correlates, heterogeneity in formulation and delivery, and regulatory obstacles. Mucosal vaccines provide a compelling complement to systemic immunization but remain challenging to implement. By acting via both systemic and local immunity, these vaccines are likely to play a role in comprehensive respiratory disease control as well as preparing populations for pandemics. These results highlight the necessity for mucosal immunity to be considered as a pillar of future vaccine development and public health policy framework.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/389cc307d6027991211242f633790eb7033667cb" target='_blank'>
              The Role of Mucosal Immunity in the Control of Respiratory Infectious Diseases
              </a>
            </td>
          <td>
            Yue Zhang
          </td>
          <td>2025-12-19</td>
          <td>MedScien</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Dengue virus (DENV) is the causative agent of dengue, a mosquito-borne disease that represents a significant and growing public health burden around the world. A unique pathophysiological feature of dengue is immune-mediated enhancement, wherein preexisting immunity elicited by a primary infection can enhance the severity of a subsequent infection by a heterologous DENV serotype. A leading mechanistic explanation for this phenomenon is antibody dependent enhancement (ADE), where sub-neutralizing concentrations of DENV-specific IgG antibodies facilitate entry of DENV into FcγR expressing cells. Accordingly, this model posits that phagocytic mononuclear cells are the primary reservoir of DENV. However, multiple independent groups have shown that B cells are the largest reservoir of virally infected cells in circulation during acute dengue, representing a disconnect in our understanding of immune-mediated DENV tropism. In response to this persistent knowledge gap, our team has previously identified a novel mechanism of immune-mediated enhancement we have termed BCR-dependent enhancement (BDE) of DENV infection. In this study, we show that DENV infection of DENV-reactive B cells is highly sensitive to BCR/DENV envelope (E) protein interactions. DENV entry into this subset of B cells is dynamin-mediated and requires proximal BCR signaling. Finally, we show that DENV-reactive B cells are productively infected by live DENV, capable of supporting active viral replication and dissemination. We propose that BDE provides an additional layer of pathogen-specific immune-mediated infection risk that complements existing models of ADE and offers additional insight into potential mechanisms of DENV immunopathogenesis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6e623512c4d44d160e5f7f9707687b24d41d2ed8" target='_blank'>
              Molecular and biophysical requirements for B cell receptor dependent enhancement of dengue virus infection
              </a>
            </td>
          <td>
            Gaby Madrigal, Chad Gebo, Benjamin D McElvany, Sean A. Diehl, A. Waickman
          </td>
          <td>2026-01-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="The effect of human coronaviruses (HCoVs) on airway epithelial cells is known and very well described. However, their influence on the human lung endothelium remains poorly understood. In this study, we assess the effect of low pathogenic HCoV‐229E on the inflammatory and antiviral response of Human Lung Microvascular Endothelial Cells (HMVEC‐L). Human Lung Microvascular Endothelial Cells were infected with HCoV‐229E and then mRNA expression, protein release, cell viability, apoptosis rate, and presence of AP‐N in flow cytometry were assessed. The infection of HMVEC‐L with HCoV‐229E led to the massive replication picked at 96 h post infection (hpi); however, the virus efficiently replicated at 48 hpi. Despite the inflammatory (IL‐8, IL‐6) and antiviral (IFN‐β, OAS‐1, PKR, MX‐1) response, as well as the pattern recognition receptors activation (TLR3, TLR7/8, RIG‐I, MDA5) occurred only at hour 72. Additionally, the cytopathic effect and the increase in apoptosis were observed. AP‐N blockade inhibited inflammatory and antiviral induction, as well as decreased HCoV‐229E genome copy numbers in HMVEC‐L. We proved that the lung microvascular endothelium may be infected by human coronavirus 229E and that this infection may lead to a robust, but delayed inflammatory and antiviral response. Secondly, HMVEC‐L may play an important role during Coronaviridae upper and lower airway infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/60df68fff5ccc846c3dfbe14d1954e07bc5ca731" target='_blank'>
              Human Coronavirus 229E May Infect Human Lung Vascular Endothelium and Induce Delayed Inflammatory and Antiviral Response
              </a>
            </td>
          <td>
            Robert Szewczyk, M. Gawrysiak, Jolanta Kalinowska, A. Gajewski, Sylwia Michlewska, M. Chałubiński
          </td>
          <td>2026-01-01</td>
          <td>APMIS</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/38a0f5816cdbca641c12e802430b062f1ffdb077" target='_blank'>
              Acute IFN-γ elicits long-term proteomic IFN-γ signature in melanoma cells
              </a>
            </td>
          <td>
            Agnete W. P. Jensen, A. Rasmussen, Ilaria Piga, Anne Weiss, Marta Sanchez Sanchez, Marco Donia, G. Franciosa, J. Olsen
          </td>
          <td>2025-12-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Congenital viral infections can have severe consequences for pregnancy and fetal outcomes. Remarkably, the fetal-derived placenta serves as a robust barrier to infection through meticulous regulation by immune effectors and cytokines. Yet, the regulatory roles of many cytokines remain undefined at the maternal-fetal interface, including Interleukin-27 (IL-27). Here, we show that trophoblast organoids derived from human placentas constitutively express both IL-27 and its receptor, and restrict Zika virus infection through IL-27 signaling. Through bulk RNA-sequencing of trophoblast organoids in the absence and presence of IL-27 signaling, we demonstrate IL-27-mediated upregulation of antiviral genes. Finally, we show that IL-27 signaling is critical to restricting placental viral burdens and protecting against pathologic fetal outcomes during murine congenital Zika virus infection. In this work, we demonstrate a novel role for IL-27 in the placenta and establish IL-27 as an innate antiviral defense at the maternal-fetal interface during congenital viral infection. Merlino et al. demonstrate that the cytokine Interleukin-27 contributes to innate antiviral immunity in the placenta and is an important defense against congenital Zika virus infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/af04db4e672049b38d44c3e517de2ea7e8270e8e" target='_blank'>
              Interleukin-27 is antiviral against Zika virus at the maternal-fetal interface
              </a>
            </td>
          <td>
            Madeline S Merlino, Briah Barksdale, S. Negatu, Drake T. Philip, Rebecca L. Clements, Taylor Miller-Ensminger, Alexandra H. Lopez, S. Mani, Monica N. Mainigi, Christopher A. Hunter, K. Jurado
          </td>
          <td>2025-12-19</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="The olfactory epithelium (OE) undergoes life-long renewal and regeneration. This process is supported by the globose basal cells (GBC) during the homeostatic state, as well as horizontal basal cells (HBC) during severe damage. Inflamm-aging refers to the low-grade, chronic and progressive state of heightened pro-inflammation associated with aging. However, the impact of inflamm-aging on OE homeostasis, regeneration, and the inflammatory microenvironment is not fully understood. In this study using mouse models, we elucidate the role of interleukin-17a (IL-17a) in OE regeneration and olfactory function. Our findings implicate that inflamm-aging in aged OE promotes the recruitment and activation of immune cells, accompanied by crosstalk between HBC and T cells. Elevated expression of IL-17a in aged OE triggers inflammatory signals and impairs olfactory function. Administration of IL-17a inhibitor Y-320 or neutralizing antibody promotes sensory neuronal regeneration and reverses age-related respiratory metaplasia in OE. Co-culturing mouse OE organoids with Th17 cells impairs neuronal generation and enhances the transformation towards respiratory cells, while neutralizing antibody against IL-17a alleviates neuronal loss and respiratory transformation. Additionally, conditional knockout of IL-17a in T cells facilitates OE regeneration by promoting HBC recruitment and differentiation into GBC. Collectively, our study identifies a function of IL-17a in OE regeneration and age-related deficits in olfactory function, providing evidence for further investigation of IL-17a as a possible therapeutic target against presbyosmia. The olfactory epithelium (OE) undergoes changes during aging and this may affect inflammatory responses and immune cell infiltration. Here the authors look at the effect of aging on OE and how this involves cross talk between T cells and horizontal basal cells involving Il17a expression in OE which is increased in aging and inhibition of IL-17a function reduces respiratory metaplasia.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9b0cdaaf839c307c7796ab663ac0d7e5e69fc1de" target='_blank'>
              IL-17a induces age-related olfactory dysfunction by impairing regeneration and promoting respiratory metaplasia in mice
              </a>
            </td>
          <td>
            Sheng-Qin Wang, X. Cha, Yingqi Xie, Zengyi Xu, Boyu Cai, Fengzhen Li, Tengfei Li, Zhe Wang, Tianyu Wang, Yiqun Yu, Huanhai Liu, Wenwen Ren
          </td>
          <td>2025-12-29</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Sepsis, a life-threatening condition triggered by a dysregulated immune response to infection, remains one of the leading causes of mortality worldwide. Thrombocytopenia, a common sepsis complication, is linked to poor outcomes and reflects disease severity and specific immunological changes affecting patient outcomes. This study aimed to investigate transcriptomic differences between septic patients with and without thrombocytopenia and to explore immune features related to clinical outcomes using whole-transcriptome RNA sequencing (RNA-Seq). We conducted a prospective study on 52 patients who were admitted to ICU for sepsis, including 22 with thrombocytopenia and 30 without. Blood samples were collected on both day 1 and 8, and RNA-Seq was performed to analyze transcriptomic profiles. Differentially expressed genes (DEGs) were identified, and functional enrichment analyses were conducted to explore biological pathways and processes. T-cell receptor (TCR) diversity was assessed using MiXCR and VDJTools software. Thrombocytopenic critically ill septic patients exhibited significantly higher Sequential Organ Failure Assessment (SOFA) scores and mortality rates compared to non-thrombocytopenic patients. Transcriptomic analysis revealed distinct gene expression profiles between the two groups, with marked upregulation of myeloproliferative and T-cell activation signaling pathways in thrombocytopenic patients on day 1. Additionally, TCR diversity counts showed no statistically significant differences between thrombocytopenic and non-thrombocytopenic patients at day 1 or day 8. Thrombocytopenia in septic ICU patients is associated with altered heme/porphyrin metabolism, erythrocyte development, and immune activation. Lower TCR diversity on day 1 in thrombocytopenic patients suggests early immune repertoire perturbations; however, these findings should be interpreted cautiously and validated with targeted immune repertoire sequencing.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8fe7b0e0807bf970cf37def1ec815b50292dd4fc" target='_blank'>
              Whole transcriptome analysis reveals T cell signaling activation in septic patients with thrombocytopenia
              </a>
            </td>
          <td>
            I-Chieh Chen, Yu-han Jiang, Tzu-Hung Hsiao, Wen-Cheng Chao
          </td>
          <td>2025-12-24</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Alzheimer’s disease (AD) is a progressive neurodegenerative disorder defined by amyloid-β (Aβ) plaques, tau hyperphosphorylation, and neuroinflammation. Although earlier work emphasized brain-resident glia (microglia and astrocytes), recent studies highlight adaptive immune cells, particularly T and B lymphocytes, as modulators of AD pathology. This review synthesizes animal and human findings from 2022–2025 to provide updated insights into the multifaceted roles and therapeutic potential of adaptive immunity in AD. Infiltration of peripheral T and B cells into the brain parenchyma links peripheral immunity to central nervous system (CNS) pathology. Both infiltrating lymphocytes and resident glia show context-dependent dual effects, either exacerbating neurodegeneration or promoting neuroprotection. Therapeutic strategies under active investigation include modulation of CD4+ T cell differentiation, adoptive transfer of regulatory T cells, and next-generation active vaccines for AD. Overall, selective modulation of discrete immune subsets may enable adaptive-immunity-based treatments, a complex yet promising avenue for AD therapy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3b57de078f4e9067551a7f587763ddb6ea70cdf6" target='_blank'>
              Adaptive Immunity and Alzheimer’s Disease: Dual Roles in Neurodegeneration and Neuroprotection with Therapeutic Implications
              </a>
            </td>
          <td>
            You Min Ahn, Min-Kyoo Shin
          </td>
          <td>2025-12-31</td>
          <td>Biomolecules & Therapeutics</td>
          <td>1</td>
          <td>1</td>
        </tr>

        <tr id="General Background Parasitic infections remain a major challenge in human and veterinary health due to their systemic physiological and immunological consequences. Specific Background Beyond tissue damage, parasites induce metabolic disturbances and immune modulation that influence disease progression. Knowledge Gap Integrated experimental evidence linking physiological alterations with immune cell activation and cytokine regulation remains limited. Aims This study aimed to investigate host physiological responses and immune dynamics during experimental Toxoplasma gondii and Plasmodium berghei infections. Results Infected hosts exhibited significant weight loss, fever, hypoglycemia, elevated CD4+ and CD8+ T cell activation, increased pro-inflammatory cytokines IL-6, TNF-α, IFN-γ, and concurrent upregulation of IL-10. Gene expression analysis confirmed significant modulation of IL-6 and IL-10. Novelty The study provides an integrated assessment of physiological parameters, immune activation, cytokine production, and gene expression within a single experimental framework. Implications These findings highlight the complex balance between immune activation and regulation during parasitic infections and support the need for therapeutic strategies targeting immune modulation to improve parasite control while limiting immunopathology. 
Keywords: Parasitic Infection, Host Physiology, Immune Response, Cytokine Regulation, Experimental Model 
Key Findings Highlights: 


Experimental infection induced marked metabolic and thermoregulatory alterations in hosts. 


Adaptive immune activation involved significant CD4+ and CD8+ T cell responses. 


Concurrent pro- and anti-inflammatory signaling reflected immune regulation during infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d13266d3422b83b381056bacac987b552d895ee5" target='_blank'>
              Physiological and Parasitological Interactions: Investigating Host Responses to Parasitic Infections through Experimental Analysis
              </a>
            </td>
          <td>
            Aliaa Kadhem Mohsin
          </td>
          <td>2026-01-05</td>
          <td>Academia Open</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Five years after the onset of the SARS-CoV-2 pandemic, post-COVID-19 condition continues to affect millions of subjects with persistent symptoms that significantly impair quality of life. Post-COVID-19 pain, particularly in women, has emerged as a frequent yet underestimated symptom. The validation and identification of animal models that reproduce persistent symptoms after an acute SARS-CoV-2 infection is crucial for a better understanding of the underlying mechanisms. The aim of the current study was to evaluate thermal nociception, biomarkers of inflammation, and nerve tissue damage in a female animal model of post-COVID-19 condition. A SARS-CoV-2 infection model was established by intranasal administration of the Omicron variant (BA.1.17 lineage) in transgenic female C57BL/6 mice expressing the human ACE2 receptor (hACE2). Nociception was assessed using the hot-plate test for 28 days post-infection. Afterwards, animals were sacrificed to analyze plasma inflammatory biomarkers by multiplex analysis. In addition, IL-6, IL-18, and IL-1β expression were evaluated by immunohistochemistry to analyze neural inflammation in the saphenous nerve. The results revealed that heat nociceptive thresholds in infected mice did not significantly differ from those of non-infected, but a trend toward lower thresholds was observed in the infected group (days 14 and 28 post-infection). In addition, a slight modification in pro- and anti-inflammatory cytokines/chemokines in plasma was detected, but no changes in the expression of IL-6, IL-1β, or IL-18 were observed in the saphenous nerve. Based on all the analyses conducted, infection with the Omicron variant of SARS-CoV-2 did not induce thermal sensitization in animals nor alterations in the expression of inflammatory biomarkers in the saphenous nerve. Finally, a slight state of systemic inflammation was present in the infected animals. The absence of detectable changes in this animal model underscores the need for further research to clarify the discrepancies observed in human patients and to explore alternative pathways potentially involved in post-COVID-19 pain syndromes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c5891963e60492cf50fdb97401736f4c20927eb7" target='_blank'>
              Assessment of Nociception and Inflammatory/Tissue Damage Biomarkers in a Post-COVID-19 Animal Model
              </a>
            </td>
          <td>
            Eva M. Sánchez-Robles, C. Rodríguez-Rivera, Nancy Paniagua Lora, Esperanza Herradón Pliego, Carlos Goicoechea Garcia, L. Arendt-Nielsen, C. Fernández‐de‐las‐Peñas, Visitación López-Miranda
          </td>
          <td>2025-12-29</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>87</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3fc8ff2573897e0ada53acc75e2ba0024f6203b5" target='_blank'>
              Natural killer cells mediated antibody dependent cellular cytotoxicity response in acute and recovery phases of chikungunya
              </a>
            </td>
          <td>
            Diptee Trimbake, M. Ganu, A. Ganu, Anuradha S. Tripathy
          </td>
          <td>2026-01-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Introduction Venezuelan Equine Encephalitis virus (VEEV) is a mosquito-borne alphavirus that causes neurotropic disease with significant morbidity and mortality, especially in children. While interferon-stimulated genes (ISGs) are central to host defense, therapeutic modulation of host responses remains underexplored. Omaveloxolone (OMA), an FDA-approved NRF2 activator, has been proposed as a candidate for host-directed antiviral therapy. Methods We investigated transcriptomic responses of human umbilical vein endothelial cells (HUVECs) infected with VEEV TC-83 in the presence or absence of OMA at 24 hours post-infection using RNA-Seq. Differential expression analysis was performed with Generalized Linear Model with Quasi-Likelihood and Magnitude-Altitude Scoring (GLMQL-MAS), followed by Cross-MAS to distinguish shared and condition-specific programs. Results Untreated VEEV infection induced a canonical ISG signature including IFIT1-3, OASL, RSAD2, and MX1, together with cytokine and chemokine signaling (IL6, CXCL10, CXCL11), consistent with a strong proinflammatory and antiviral state. In contrast, OMA treatment elicited a broader shift, with 729 upregulated and 1,264 downregulated genes. Key OMA-induced genes (HMOX1, NQO1, GCLM, TXNRD1, SLC7A11) mapped to NRF2-dependent antioxidant, ferroptosis resistance, and detoxification pathways, accompanied by widespread repression of histone cluster genes. Cross-MAS revealed 695 OMA-unique upregulated genes, 86 untreated-unique genes, and 34 shared genes forming a compact interferon-centered antiviral backbone. Network analyses highlighted NRF2-driven antioxidant modules under OMA and cytokine-chemokine modules under untreated infection. Discussion These findings demonstrate that OMA redirects host transcription from an interferon-centric, inflammatory response toward an NRF2-driven cytoprotective program while preserving core antiviral mechanisms, which supports NRF2 activation as a therapeutic strategy against VEEV.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0567f940ccb9d13c80a3a8155b26b41193308467" target='_blank'>
              Transcriptomic profiling of human endothelial cells infected with venezuelan equine encephalitis virus reveals NRF2 driven host reprogramming mediated by omaveloxolone treatment
              </a>
            </td>
          <td>
            Mostafa Rezapour, L. Opoku, Stephanie V. Trefry, Abbas Alili, Maame Konadu, Maria Galarza Dionisio, M. N. Gurcan, Aarthi Narayanan
          </td>
          <td>2025-12-18</td>
          <td>Frontiers in Genetics</td>
          <td>1</td>
          <td>7</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e1448848f5a7ad4b9088567f390be0424cf144a8" target='_blank'>
              Identification of Lupus Immune Complex-Driven Pathogenic Pro-inflammatory Monocytes and Macrophages in Systemic Lupus Erythematosus
              </a>
            </td>
          <td>
            Lais Osmani, Min Shin, S. J. Lee, Helen Cai, Won Jae Seong, Hyoungsu Kim, Jongjin Yoo, Minhyung Kim, William Bracamonte, Mario Felix, Jong Gyun Ahn, Hong-Jai Park, Junghee J. Shin, Serhan Unlu, J. Par-Young, Edward Doherty, Jiaye Chen, Mei X Dong, F. Koumpouras, Jose L. Gomez, Naftali Kaminski, R. Bucala, Sungyong You, Insoo Kang
          </td>
          <td>2026-01-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2c1f647c519c30083006af87ea81f8e90bf0e920" target='_blank'>
              The altered T cell landscape in Systemic Sclerosis patients is characterized by dysfunctional type 1 immunity
              </a>
            </td>
          <td>
            Victoria Volfson-Sedletsky, Hannah A. DeBerg, Mitchell L. Fahning, Ian R. Rifkin, A. Bujor, Daniel J. Campbell, P. Morawski, Anna C. Belkina, H. Dooms
          </td>
          <td>2025-12-13</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="A comprehensive understanding of human systemic immune responses to mosquito-borne dengue virus (DENV) infection is vital for addressing challenges posed by viral heterologous serotypes and potential adverse memory immune responses. Asymptomatic DENV infection offers an opportunity to explore protective immunity because infected individuals effectively clear the virus without symptomatic manifestations. However, data on asymptomatic dengue are scarce because of limited sample availability during silent viremia. Here, we conducted single-cell RNA and immune receptor sequencing of peripheral blood mononuclear cells (PBMCs) from donors with varying disease severities including asymptomatic dengue and performed longitudinal analysis in a symptomatic dengue cohort, enabling identification of distinct immune responses. In asymptomatic dengue, we observed potential indications of enhanced viral antigen processing via MHC-I, correlating with increased CD8 effector T cell activities, distinct NK cell profiles, and enriched IGHA1+ plasmablasts. In contrast, symptomatic dengue cases exhibited indications toward antibody-mediated viral entry, elevated type I interferon responses, and IL-10-associated expansion of IGHG1+ plasmablasts with biased V(D)J gene usage and a shared B cell receptor clonotype network. Our study reports a gene expression and immune receptor repertoire resource for systemic immune responses to DENV infection and suggests distinct mechanisms for potential protection and pathogenicity in individuals with asymptomatic compared with symptomatic dengue.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c7bb9f910edf96aa4b48875f672155a01dcef22c" target='_blank'>
              Distinct systemic immune responses in asymptomatic and symptomatic dengue virus infection.
              </a>
            </td>
          <td>
            W. Sungnak, Natnicha Jiravejchakul, Tiraput Poonpanichakul, Chawinya Trakoolsoontorn, Sirawit Srikor, A. Opasawatchai, J. Arora, Damita Jevapatarakul, Narita Thungsatianpun, Sarintip Nguantad, Juthamard Chantaraamporn, Pattarakul Pakchotanon, Nuntaya Punyadee, Thaneeya Duangchinda, Panisadee Avirutnan, J. Mongkolsapaya, Kerstin B. Meyer, O. Matangkasombut, Varodom Charoensawan, Sarah A. Teichmann, P. Matangkasombut
          </td>
          <td>2025-12-17</td>
          <td>Science translational medicine</td>
          <td>0</td>
          <td>68</td>
        </tr>

        <tr id="In nature, animals encounter diverse pathogens that trigger specific peripheral defense programs and elicit sickness behavior, a set of stereotyped physiological and behavioral changes thought to promote host fitness. Most studies to date have relied on one or a few mouse models of infection, limiting insights into pathogen-specific neuroimmune interactions that generate sickness. We hypothesized that different pathogens might elicit distinct sickness states by engaging different cell types and brain circuits. Using inflammatory models representing bacterial, viral, allergic, parasitic or colitis conditions, we assessed sickness across scales: organismal – behavior and physiology; cellular – brain-wide neural activity; and molecular – single-cell in situ transcriptomics in hypothalamus areas associated with social and homeostatic functions affected during sickness. Remarkably, immune challenges elicited unique repertoires of changes across all scales. Our findings reveal pathogen-specific sickness states encoded by the brain across scales, thereby broadening our understanding of how infections make us sick.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a973ce07eaa0ba52a5d26dc1ae4c7f5dadb199db" target='_blank'>
              Brain-immune interactions generate pathogen-specific sickness states
              </a>
            </td>
          <td>
            Zuri A. Sullivan, Bertrand J. Wong, Vikrant Kapoor, Paula Kathleen Vincze, Harris S. Kaplan, Pia Giraudet, Brianna R. Watson, Adel Misherghi, Sebastian Lourido, Jeffrey R. Moffitt, Catherine Dulac
          </td>
          <td>2025-12-08</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="ABSTRACT Toxoplasma gondii exploits host phagocytes to disseminate systemically and establish infection in the central nervous system (CNS). Yet, the mechanisms governing the interaction between parasitized phagocytes and the brain endothelium remain elusive. Here, we show that T. gondii infection, but not parasite lysates, robustly induces transcriptional and secretory upregulation of the chemokine C–C motif ligand 5 (CCL5/RANTES) in primary brain endothelial cells and dendritic cells (DCs). This response was triggered by the parasite effector GRA15 through NF-κB signaling, while the effector TEEGR counteracted CCL5 induction in an MYR-translocon-dependent manner. In response to recombinant CCL5, infected DCs displayed increased hypermotility, chemotaxis toward CCL5 gradients, and enhanced transmigration across polarized endothelial monolayers. Intraperitoneally infected mice rapidly upregulated CCL5 in the blood and Ccl5 expression in the cerebral microvasculature, thereby increasing the adhesion of parasitized DCs and cerebral parasite loads. Pretreatment of mice with recombinant CCL5 dramatically elevated the sequestration of infected DCs, while treatment with the selective chemokine receptor 5 (CCR5) antagonist Maraviroc reverted sequestration. Together, these findings reveal that T. gondii co-opts the host CCL5/CCR5 axis via GRA15-mediated signaling to promote leukocyte-dependent dissemination and early colonization of the CNS. IMPORTANCE The intracellular parasite Toxoplasma gondii invades immune cells to spread through the circulatory system, eventually reaching the brains of humans and animals. It is not well understood how parasitized immune cells interact with blood vessel walls, a process that ultimately helps Toxoplasma colonize the brain tissue. We found that when Toxoplasma infects the cells lining the blood vessels (endothelium), these produce C-C motif chemokine ligand 5 (CCL5), a potent signaling and attractant molecule. CCL5 production was triggered by a parasite-derived secreted protein, GRA15. CCL5 activated and attracted infected immune cells. In mice, the levels of CCL5 increased quickly in the brain microvasculature after infection, helping the infected immune cells adhere to brain vessels. When the effect of CCL5 was pharmacologically blocked, fewer infected cells sequestered in the brain vessels, lowering the parasite loads. These findings reveal a mechanism through which Toxoplasma manipulates host cells to produce factors that facilitate its colonization of the brain. The intracellular parasite Toxoplasma gondii invades immune cells to spread through the circulatory system, eventually reaching the brains of humans and animals. It is not well understood how parasitized immune cells interact with blood vessel walls, a process that ultimately helps Toxoplasma colonize the brain tissue. We found that when Toxoplasma infects the cells lining the blood vessels (endothelium), these produce C-C motif chemokine ligand 5 (CCL5), a potent signaling and attractant molecule. CCL5 production was triggered by a parasite-derived secreted protein, GRA15. CCL5 activated and attracted infected immune cells. In mice, the levels of CCL5 increased quickly in the brain microvasculature after infection, helping the infected immune cells adhere to brain vessels. When the effect of CCL5 was pharmacologically blocked, fewer infected cells sequestered in the brain vessels, lowering the parasite loads. These findings reveal a mechanism through which Toxoplasma manipulates host cells to produce factors that facilitate its colonization of the brain.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7249fd28c72bc9c23c81136fe3a5d93ec2f4e52f" target='_blank'>
              Toxoplasma effector GRA15-driven CCL5 secretion enhances brain parasite load through microvascular sequestration of phagocytes
              </a>
            </td>
          <td>
            Elena Afanaseva, Matias E. Rodriguez, A. Barragan
          </td>
          <td>2026-01-13</td>
          <td>mBio</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="Porcine epidemic diarrhea virus (PEDV) causes acute, highly contagious enteric disease in pigs, leading to severe economic losses, particularly due to high mortality in suckling piglets. Currently, no specific antiviral drugs are available. In this study, we evaluated the anti‐PEDV potential of celastrol, a natural triterpenoid derived from Tripterygium wilfordii, in Vero E6 cells. We found that celastrol significantly inhibited PEDV replication in a dose‐dependent manner, primarily targeting the postentry stage of the viral life cycle. Network pharmacology analysis highlighted apoptosis as a key signaling pathway, and mechanistic studies revealed that celastrol enhanced PEDV‐induced reactive oxygen species (ROS) accumulation, which triggered apoptosis and suppressed viral RNA synthesis, protein expression, and progeny production. Importantly, inhibition of ROS abolished celastrol’s antiviral activity, confirming a ROS‐dependent mechanism. Furthermore, celastrol demonstrated inhibitory effects against porcine deltacoronavirus (PDCoV) and porcine reproductive and respiratory syndrome virus (PRRSV) in vitro. These findings suggest celastrol as a promising candidate for the prevention and control of PED and other swine viral infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dd4c50c9f633a2ee786803822cbffccb161cf70f" target='_blank'>
              Celastrol Inhibits Porcine Epidemic Diarrhea Virus Replication by Promoting ROS‐Mediated Apoptosis
              </a>
            </td>
          <td>
            Junhai Zhu, Kaifang Yang, Pengfei Zhang, Hao Yuan, Nan Yan, Longxiang Zhang, Meiyu Jia, Yue Wang, Bin Li
          </td>
          <td>2025-01-01</td>
          <td>Transboundary and Emerging Diseases</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Taking COVID-19 as an illustrative example, this review systematically elucidates the central pathological mechanism of viral sepsis, termed the endothelial-immunothrombotic storm. This mechanism is initiated by the direct viral infection of endothelial cells, which provokes excessive immune activation and disrupts coagulation through immunothrombosis, including cytokine storms, NETosis, and complement activation. Meanwhile, these processes establish a vicious cycle leading to multiple organ failure. Compared with classical bacterial sepsis, viral sepsis exhibits distinctive features such as interferon dysregulation, direct endothelial damage, a hypercoagulable state, and T-cell exhaustion. This review integrates the latest research findings, contrasts the pathophysiological differences between viral and bacterial sepsis, and proposes precision strategies focused on endothelial protection, immune modulation, and anticoagulation. Finally, we discuss the clinical translational prospects of these approaches and suggests directions for future research.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/90d991dae38228c25a5a0a1a6a1e4b25d0b7a3e8" target='_blank'>
              The endothelial-immunothrombotic storm in viral sepsis: lessons from COVID-19
              </a>
            </td>
          <td>
            Kaihuan Zhou, Yin Chen, Jielong Pang, Jianfeng Zhang, Junyu Lu
          </td>
          <td>2026-01-06</td>
          <td>Frontiers in Immunology</td>
          <td>1</td>
          <td>11</td>
        </tr>

        <tr id="Virus-induced inflammation and programmed cell death (PCD) are critical antiviral defenses, prompting viruses like respiratory syncytial virus (RSV) to develop PCD regulation mechanisms. Here, we demonstrate that RSV orchestrates the temporal and sequential regulation of distinct PCD pathways in human macrophages to optimize replication and dissemination. During early stages of infection, RSV activates the PI3K-Akt pathway to induce cFLIP expression, effectively suppressing TNF-driven extrinsic apoptosis. Simultaneously, viral degradation of ZDHHC9 prevents GSDMD-mediated pyroptosis downstream of NLRP3 activation, thereby sustaining an intracellular environment permissive to viral propagation. In contrast, following the completion of replication, RSV subverts caspase-1 signaling to trigger the intrinsic apoptotic cascade via the Casp-1–BID–APAF1–Casp-9 axis, and subsequently promotes GSDME-mediated secondary pyroptosis. This late-stage PCD reprogramming enables synchronized release of virions and pro-inflammatory cytokines, exacerbating pulmonary pathology. These findings delineate a temporally resolved strategy by which RSV balances early immune evasion with subsequent viral dissemination and immunopathology, and identify discrete stage-specific molecular targets for therapeutic intervention in RSV-induced lung disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/af3368e98c5fbb5b8cac01fc524596520637b71e" target='_blank'>
              RSV temporally reprograms apoptosis and pyroptosis to balance immune evasion and replication
              </a>
            </td>
          <td>
            Cong Liu, Haiwu Zhou, Jian Li, Yang Meng, Jingyu Wang, Mingbin He, Weiwei Wang, Zhifei Li, Yali Qin, Mingzhou Chen
          </td>
          <td>2026-01-23</td>
          <td>Science Advances</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Immunocompromised patients, including those with advanced HIV infection, hematologic malignancies treated with anti-CD20 monoclonal antibodies, or combined immunodeficiencies, are at increased risk of persistent SARS-CoV-2 infection. While long-term viral shedding has been described in these patients, the extent and nature of intra-host viral evolution during long-term infection remain insufficiently documented. In this study, we report longitudinal genomic analyses of SARS-CoV-2 from three immunocompromised individuals with persistent COVID-19: (i) a female patient with follicular lymphoma receiving bendamustine-rituximab therapy with 9 months of persistence, (ii) a male patient with advanced HIV infection following prolonged antiretroviral therapy interruption with 10 months of persistence, and (iii) a female patient with Good’s Syndrome characterized by combined humoral and cellular immune deficiency with apparently four years of persistence. Replication-competent virus was detected over extended periods. Sequential whole-genome sequencing revealed the gradual accumulation of non-synonymous mutations across multiple viral genes, consistent with ongoing viral replication and intra-host diversification in the absence of effective immune control. Although based on a limited number of cases, these findings provide descriptive evidence that persistent SARS-CoV-2 infection in immunocompromised hosts can be associated with sustained viral evolution. This work highlights the importance of continued virological monitoring in selected patients with prolonged infection and contributes to the understanding of SARS-CoV-2 dynamics in settings of impaired immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/14b459ba90f72fa7655a6a71dd3e8977fa73524e" target='_blank'>
              Molecular Characterization of Persistent SARS-CoV-2 Infections in Immunocompromised Patients
              </a>
            </td>
          <td>
            P. Volkow-Fernández, M. Villanueva-Reza, Santiago Ávila-Ríos, Enrique Mendoza-Ramírez, A. Vera-Jiménez, Alexandra Martin-Onraet, B. Islas-Muñoz, Pamela Alatorre-Fernández, Rogelio Pérez-Padilla, Daniel Carpio-Guadarrama, Andrea Cárdenas-Ortega, V. Ahumada-Topete, Clara Espitia, K. L. Reyes-Barrera, Edgar Sevilla-Reyes, J. Vázquez-Pérez
          </td>
          <td>2026-01-30</td>
          <td>Viruses</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="Long COVID affects a substantial proportion of survivors of acute infection with severe acute respiratory syndrome-associated coronavirus-2 (SARS-CoV-2), who suffer a variety of symptoms that limit their quality of life and economic activity. Although the aetiology of long COVID is obscure, it appears to be a chronic inflammatory condition. Complement dysregulation is a prevalent feature of long COVID. Specifically, markers of classical, alternative, and terminal pathway activation are often elevated in patients with this condition. Here, we used a sensitive assay for mannan-binding lectin-associated serine protease-2 (MASP-2)/C1Inh complexes to analyse lectin pathway activation in a previously characterised cohort of patients with long COVID (n = 159) and healthy convalescent individuals with no persistent symptoms after infection with SARS-CoV-2 (n = 76). The data were combined with those from the most predictive complement analytes identified previously to delineate potential biomarkers of long COVID. MASP-2/C1Inh complexes were significantly elevated in patients with long COVID (p = 0.0003). Generalised linear modelling further identified an optimal set of four markers, namely iC3b (alternative pathway), TCC (terminal pathway), MASP-2/C1Inh (lectin pathway), and the complement regulator properdin, which had a receiver operating characteristic predictive power of 0.796 (95% confidence interval = 0.664-0.905). Combinations of the classical pathway markers C4, C1q, and C1s/C1Inh were poorly predictive of long COVID. These findings demonstrate that activation of the lectin complement pathway, which occurs upstream of the alternative and terminal pathways and can be inhibited therapeutically, is a salient feature of long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b12563fc298f770e8384104e312bcdfe7c924010" target='_blank'>
              Activation of the Lectin Pathway Drives Persistent Complement Dysregulation in Long COVID.
              </a>
            </td>
          <td>
            Sam Keat, Priyanka Khatri, Youssif M. Ali, Chanuka H Arachchilage, G. Demopulos, Kirsten Baillie, K. Miners, K. Ladell, Samantha A. Jones, Helen E. Davies, David A. Price, W. Zelek, B. P. Morgan, Wilhelm Schwaeble, Nicholas J Lynch
          </td>
          <td>2026-01-25</td>
          <td>Immunology</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4437ab41c95bdd52966491c32a1d506d63726938" target='_blank'>
              A distinct monocyte transcriptional state links systemic immune dysregulation to pulmonary impairment in long COVID.
              </a>
            </td>
          <td>
            Saumya Kumar, Chaofan Li, Liang Zhou, Qiuyao Zhan, Ahmed Alaswad, Sonja Volland, Bibiana Costa, S. Krooss, Isabel Klefenz, Hagen Schmaus, Antonia Zeuzem, Dorothee von Witzendorff, Helena Lickei, L. Pueschel, Anke R. M. Kraft, Markus Cornberg, A. R. Koczulla, I. Pink, Marius M. Hoeper, Chengbin Xu, Susanne Häussler, M. Wiestler, M. Netea, Thomas Illig, Jie Sun, Yang Li
          </td>
          <td>2026-01-14</td>
          <td>Nature immunology</td>
          <td>1</td>
          <td>16</td>
        </tr>

        <tr id="Introduction The role of Regulatory T cells (Tregs) in severe COVID-19 remains unclear. Some authors reported that Tregs increased in peripheral circulation, while other investigators reported that these cells decreased in severe COVID-19 patients. The expression of FoxP3 in Tregs remains inconsistent and controversial. These observations have been made using immune phenotyping via flow cytometry and T-cell sequencing; however, none of these data provide a clear indication of what Tregs are doing in this chaotic hyperactivated immune response. Methods We conducted a comprehensive characterization of the Treg compartment in a longitudinal cohort of patients with acute COVID-19, including individuals with mild or severe disease. Using RNA-seq, we analyzed gene expression across the cohort, while flow cytometry enabled us to determine Treg phenotype and observe changes during disease progression. Furthermore, we assessed Treg activity through a suppression assay. Results Gene expression analysis revealed significant downregulation of genes involved in regulatory pathways supporting T regs' functional activities, consistent across the severe patients analyzed. In contrast, we found increased expression of these genes in patients with mild disease. This finding was further confirmed by phenotyping analysis, which showed significant differences in CD25+CD127- Treg cells between mild and severe patients, positively associated with CTLA-4 and PD-1 inhibitory markers. Surprisingly, these results did not correlate with FoxP3 expression. Furthermore, a high frequency of CD25+CD127- Treg cells was associated with young, mild patients. In contrast, a lower frequency of CD25+CD127- cells and a higher frequency of FoxP3+ cells were associated with elderly patients. Finally, a Treg functional assay showed a lower capacity for suppression in Tregs obtained from severe patients compared to those from mild patients in the acute phase of the disease. Discussion Our findings offer critical insights into the role of Tregs in SARS-CoV-2, with implications that extend beyond this viral infection. Understanding how Tregs contribute to immune responses in COVID-19 could inform therapeutic strategies to modulate immune regulation in infectious diseases more broadly.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/375e622ef27c7342cf0c8ff5baa1cafe0077df24" target='_blank'>
              Longitudinal immune profiling uncovers regulatory T cell signatures associated with the progression of COVID-19
              </a>
            </td>
          <td>
            Camila Kossack, Felipe Bravo, Francisco Fuentes-Villalobos, Claudio Quevedo, Matias A. Medina, Raúl Riquelme, M. Rioseco, Mario Calvo, Karina Pino-Lagos, Felipe Aguilera, M. I. Barria, J. Garrido
          </td>
          <td>2025-12-19</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Neuroimmune interactions have arisen as central contributors to the pathogenesis and progression of Alzheimer’s disease. The exacerbation of neuronal dysfunction in Alzheimer’s disease is collectively contributed by dysregulation of astrocytic and microglial responses, invasion of peripheral immune cells, and chronic inflammation. A mechanistic understanding of molecular, cellular, and systems-level neuroimmune interactions in Alzheimer’s disease is enabling rational, testable therapeutic strategies. We have tried to extensively address the molecular regulation of glial activation, inflammasome signaling, and immune cell invasion in Alzheimer’s disease. This review highlights microglial metabolic reprogramming and lipid-metabolism dysregulation as major drivers of neuroinflammation. Existing and future therapeutic approaches to glial activation, immunometabolism, and inflammasome signaling are thoroughly reviewed, together with novel strategies involving stem cell-derived exosomes and peripheral immunity modulation. Artificial intelligence and machine learning technologies are the latest game-changing technologies in unraveling neuroimmune complexity, discovering biomarkers, simulating disease courses, and speeding up drug discovery. Integration of multi-omics information and AI-based predictive models is suggested as a critical strategy for the development of precision medicine strategies in neuroimmune therapeutics. Advancements in neuroimmune research, coupled with computational biology technological advancements, hold the promise to transform the therapeutic environment for Alzheimer’s disease. Multitargeted, integrated interventions and data-driven strategies are set to overcome current limitations and advance closer to effective, personalized therapies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7ca23136c415c3e8dfb40c59de3b6cb279f9f504" target='_blank'>
              Neuroimmune Dysregulation and AI-Driven Therapeutic Strategies in Alzheimer’s Disease
              </a>
            </td>
          <td>
            Shampa Ghosh, Rakesh Bhaskar, Krishna Kumar Singh, Samarth Sharma, Bhuvaneshwar Yarlagadda, J. K. Sinha, S. Han
          </td>
          <td>2025-12-26</td>
          <td>Cellular and Molecular Neurobiology</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Background: The SARS-CoV-2 spike protein, a key component in viral entry, has been implicated in modulating inflammatory responses even in the absence of complete viral infection. Spike protein exposure can alter signaling pathways in colon epithelial cells, leading to increased expression of proinflammatory cytokines and disruption of epithelial barrier integrity. Objectives: This study evaluates the time-dependent effects of recombinant spike protein on proinflammatory gene expression and cytokine release in lung (BEAS-2B) and colon (CRL-1831) epithelial cells. Methods: BEAS-2B and CRL-1831 cells were treated with varying doses of spike protein, and samples were collected at 12, 24, 48, and 72 hours. Cell viability was assessed via XTT assay. Quantitative PCR (qPCR) was used to measure IFN-γ, TNF-α, IL-6, and IL-1β mRNA levels. Cytokine secretion was analyzed via ELISA. Results: In BEAS-2B cells, spike protein induced a transient increase in IFN-γ at early time points, followed by a reduction in IFN-γ and IL-6 at later times. Conversely, CRL-1831 cells demonstrated sustained or delayed increases in TNF-α and IFN-γ expression, with notable IL-6 fluctuation. ELISA data confirmed these trends in cytokine secretion profiles. No significant cytotoxicity was observed across the tested conditions. Conclusions: The spike protein elicits distinct temporal inflammatory responses in lung and colon epithelial cells, underscoring tissue-specific susceptibility and regulatory mechanisms in SARS-CoV-2 pathogenesis. While some previous studies have examined individual components of SARS-CoV-2, the present study's specific focus on the time-dependent, differential effects of the spike protein on two distinct epithelial cell types (lung and colon) appears to be a unique contribution to the field. These findings may contribute to understanding gastrointestinal and respiratory complications observed in COVID-19 patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/086ae9b91adf96682acd853601717da84d62a49d" target='_blank'>
              Time-Dependent Differential Effects of SARS CoV 2 Spike Protein in Lung and Colon Epithelial Cell Lines
              </a>
            </td>
          <td>
            A. Yilmaz, Utku Yaka, S. Turk, U. Malkan, S. Gocer, I. Haznedaroglu, Sukru Volkan Ozguven, C. Turk
          </td>
          <td>2025-12-23</td>
          <td>Jundishapur Journal of Microbiology</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="Long COVID (LC) is a multisystem, post-infectious conditions diagnosed ≥3 months after acute SARS-CoV-2 infection and marked by relapsing, persistent, or progressive symptoms, especially fatigue, post-exertional symptom exacerbation and neuropsychiatric syndromes. We synthesized evidence suggesting that LC arises from intersecting pathways including viral persistence, intestinal dysbiosis and barrier compromise with microbial translocation, innate immune activation with neutrophil extracellular traps (NET) and thromboinflammation, and immune dysregulation with features of exhaustion and autoimmunity. These processes adversely impact blood-brain barrier (BBB) function and lead to neuroinflammation. We propose a mechanistic model in which viral antigens and translocated microbial products amplify pro-inflammatory networks promoting immunothrombosis and tissue hypoperfusion. Hematogenous and gut-brain pathways may then deliver inflammatory mediators to the central nervous system (CNS), resulting in BBB disruption and glial activation that underpin nervous system disorders in LC. Treatment regimens aimed at lowering antigen load, restoring mucosal barrier integrity and modulating myeloid/coagulation pathways may warrant investigation as novel therapeutic strategies to treat LC.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ceb2aaf0ce2883d4089bc9aa0d5a8d1565fe9dfa" target='_blank'>
              Intestinal barrier compromise, viral persistence, and immune dysregulation converge on neurological sequelae in Long COVID
              </a>
            </td>
          <td>
            Laurence Leclerc, Johanne Poudrier, Christopher Power, Grace Y. Lam, E. L. Falcone
          </td>
          <td>2026-01-20</td>
          <td>Frontiers in Aging Neuroscience</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/97aa2343cc3f40eb7c452dc50f451e6fac835427" target='_blank'>
              The role of pyroptosis during HIV infection
              </a>
            </td>
          <td>
            M. Yaseen, Nizar M. Abuharfeil, H. Darmani, Mohammed N. Shatnawi
          </td>
          <td>2026-01-08</td>
          <td>Inflammation Research</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="Plasmacytoid dendritic cells (pDCs) are best known for their outstanding ability to rapidly produce large amounts of type I interferons (IFN‐I), which are key antiviral mediators. However, after their initial IFN‐I burst, the pDC lineage undergoes a number of adaptations that converge on the attenuation of pDC‐derived interferons, ensuring their production remains short‐lived regardless of whether the pathogen is cleared or persists. The convergence of multiple host adaptations that result in reduced pDC numbers and/or function after infection highlights the double‐edged sword nature of pDCs: while they can be beneficial for antiviral defense, they can also drive tissue pathology. In this review, we summarize selected pDC‐lineage adaptations that arise after their initial IFN‐I peak following a viral infection, including compromised pDC development from bone marrow progenitors, fate plasticity that enables pDC conversion into conventional dendritic cells type 2 (cDC2)–like cells, and loss of the pDCs' hallmark capacity to produce IFN‐I. We also provide an overview of the underlying molecular mechanisms contributing to the aforementioned adaptations, discuss potential evolutionary advantages, and highlight future avenues to dissect the fundamental biology of pDC reprogramming with the ultimate goal of leveraging these insights to therapeutically target pDCs in infections and beyond.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cb1bc29ce0ad99c199dec49375e6c4567352274b" target='_blank'>
              Plasmacytoid Dendritic Cell Lineage Adaptations During a Viral Infection
              </a>
            </td>
          <td>
            Carolina Chiale, S. Dallari, Elina I. Zúñiga
          </td>
          <td>2025-12-12</td>
          <td>Immunological Reviews</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="The COVID-19 pandemic has demonstrated that its effects go far beyond the initial respiratory illness, with many survivors experiencing lasting neurological problems. Some patients develop a condition known as Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), which includes current issues such as reduced cognitive function, chronic headaches, depression, neuropathic pain, and sensory disturbances. These symptoms can severely disrupt daily life and overall well-being. In this narrative review, we provide an overview of current understanding regarding the neurological effects of COVID-19, with a focus on Long COVID. We discuss possible underlying mechanisms, including direct viral invasion of the nervous system, immune-related damage, and vascular complications. We also summarize findings from cohort studies and meta-analyses that explore the causes, symptom patterns, and frequency of these neurological issues. Approximately one-third of people who have had COVID-19 report neurological symptoms, especially those who experienced severe illness or were infected with pre-Omicron variants. Emerging research has identified potential biomarkers such as neurofilament light chain (NFL) and glial fibrillary acidic protein (GFAP) that may help in diagnosis. Treatment approaches under investigation include antiviral medications, nutraceuticals, and comprehensive rehabilitation programs. Factors like older age, existing health conditions, and genetic differences in ACE2 and TMPRSS2 genes may affect an individual’s risk. To effectively address these challenges, current research is essential to improve diagnostic methods, develop targeted treatments, and enhance rehabilitation strategies. Ultimately, a coordinated, multidisciplinary effort is crucial to reduce the neurological impact of Long COVID and support better recovery for patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ffce28a9cb072c289f8e3889294366d640062728" target='_blank'>
              Neurological Sequelae of Long COVID: Mechanisms, Clinical Impact and Emerging Therapeutic Insights
              </a>
            </td>
          <td>
            Muhammad Danial Bin Che Ramli, Beevenna Kaur Darmindar Singh, Zakirah Zainal Abidin, Athirah Azlan, Amanina Nurjannah, Zaw Myo Hein, Che Mohd Nasril Che Mohd Nassir, Rajesh Thangarajan, Noor Aishah Bt. Mohammed Izham, Suresh Kumar
          </td>
          <td>2025-12-16</td>
          <td>COVID</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Introduction Aging increases vulnerability of the elderly to influenza, but the mechanisms have not been fully understood. Although lethally infected aged mice are frequently used as models of influenza infection in the elderly, they are more suitable for studying mortality rather than the increased disease severity frequently observed in non-lethal infections. Therefore, understanding age-related differences under sublethal infection conditions is crucial. Methods Adult (8–12 months) and aged (22–24 months) mice were infected with a sublethal dose of H1N1 (PR8). Body weight loss, lung viral titers, pulmonary innate immune cell composition, and transcriptional levels of key inflammatory cytokines were assessed. Results Despite similar body weight loss, the aged mice showed significantly higher lung viral titers at day 8. Notably, key innate immune populations, including alveolar macrophages, neutrophils, and eosinophils, showed distinct age-related patterns. In the adult mice, alveolar macrophages negatively correlated with weight loss, whereas no protective immune factor was identified in the aged mice. Moreover, our data showed that persistent viral replication led to distinct innate immune cell composition in the adult and aged mice despite comparable transcription levels of inflammatory cytokines. The numbers and frequencies of both the neutrophils and eosinophils were significantly higher in the virus-persistent adult mice than those in the virus-persistent aged mice. Discussion Our findings reveal skewed acute immune responses to influenza in aged mice, which may partially account for their mild weight loss despite delayed viral clearance and highlight age-related impairments in early antiviral immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5c351ed0e5d3df4fe77cb078ab0d2b65afface5c" target='_blank'>
              Skewed pulmonary innate immune cell composition underlies the delayed influenza clearance in aged mice
              </a>
            </td>
          <td>
            Xiaoyang Cheng, Fang Zhao, Jing Wu, Yanmin Wan, Zhaoqin Zhu, Jialin Jin
          </td>
          <td>2025-12-10</td>
          <td>Frontiers in Microbiology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated not only with respiratory illness but also with profound vascular and coagulation disturbances. Long COVID (LC) is characterized by persistent symptoms such as fatigue, dyspnea, cognitive impairment, and palpitations. Mechanistically, SARS-CoV-2 induces direct endothelial injury, promotes a pro-inflammatory cytokine milieu, and activates platelets, leading to immunothrombosis and impaired fibrinolysis. Consequently, patients exhibit microthrombosis, elevated plasma D-dimer, fibrinogen dysregulation, and persistent hypercoagulability. Clinically, this translates into an increased risk of venous thromboembolism, including deep vein thrombosis and pulmonary embolism, as well as arterial thrombotic events such as myocardial infarction and stroke, which may persist months after acute infection. Understanding the interplay between endothelial injury, inflammation, and coagulation is crucial for risk stratification and the development of preventive and therapeutic strategies. We conducted a systematic narrative review of the literature, including human clinical and mechanistic studies identified through PubMed, Scopus and Web of Science up to 30 September 2025. This review synthesizes current evidence on vascular complications in LC, highlighting endothelial dysfunction as a central pathophysiological nexus linking the acute phase of SARS-CoV-2 infection with chronic LC manifestations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f14dffbb63f077cbdc46f26a8295d84afd04c13d" target='_blank'>
              Vascular Complications of Long COVID—From Endothelial Dysfunction to Systemic Thrombosis: A Systematic Review
              </a>
            </td>
          <td>
            Maja Stojanović, Marko D Djuric, Irina B Nenadic, Suzana C. Bojic, Ana Andrijevic, Aleksa Popovic, Slobodan Pešić
          </td>
          <td>2025-12-31</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Human cytomegalovirus (CMV), a member of the Herpesviridae family, is a ubiquitous pathogen that causes mild or asymptomatic infection in healthy individuals but leads to severe complications in immunocompromised patients and congenitally infected newborns. CMV exhibits marked neurotropism, and infection of the central nervous system (CNS) can result in a broad spectrum of neurological manifestations, including encephalitis, cognitive impairment, and developmental anomalies such as microcephaly, cerebral palsy, and sensorineural hearing loss. Though the clinical importance of CMV on the nervous system is well known and studied, the molecular mechanisms underlying CMV neuropathogenesis remain incompletely understood. In this review we present current knowledge on CMV infection of the CNS, highlighting the viral and host determinants that influence neurotropism, latency, immune evasion, and neural injury. We discuss important molecular pathways involved in viral entry, replication, and host immune modulation that contribute to CNS pathology. The article summarises recent insights from in vitro and in vivo models elucidating how CMV interacts with cells of CNS to disrupt neurodevelopment and brain homoeostasis. Furthermore, we review the neurological manifestations of CMV with emphasis on long term neurological sequelae of congenital and acquired CMV infection, as well as characteristic radiological findings associated with CMV neuroinfection. Understanding the complex interplay between CMV and the host nervous system is essential for identifying therapeutic targets and developing effective preventive strategies. This review aims to provide a comprehensive overview of CMV neuropathogenesis and to identify critical knowledge gaps that can guide future research on CMV‐associated neurological disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/23ebcfc05abf795314ae418f12610fb2a47a0d98" target='_blank'>
              Neurological Consequences of CMV Infection: Overview of Pathogenesis and Host Responses
              </a>
            </td>
          <td>
            Vijaylakshmi Reddy, Lonika Lodha, Shipra Gupta, Reeta S. Mani, M. Ashwini
          </td>
          <td>2025-12-30</td>
          <td>Reviews in Medical Virology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="HIV-1-associated neurocognitive disorders (HAND) are highly prevalent in the era of combination of antiretroviral therapies. Recent studies suggest that damage of blood–brain barrier (BBB) may serve as an early biomarker of cognitive dysfunction in people living with HIV. This is due to the ability of HIV-1, along with infected monocytes and macrophages, to traverse the BBB via either paracellular or transcellular way. HIV-1 viral proteins have been shown to disrupt tight junctions within the BBB, thereby directly compromising its structural and functional integrity. This study determined the effects of the HIV-1 transactivator of transcription (Tat) protein on the morphological profiles and gene expression of mouse prefrontal cortex endothelial cells (ECs) and human brain microvascular endothelial cells (HBMVEC). Both mouse ECs and HBMVEC were exposed in vitro to 12.5 nM recombinant Tat1-86 for 48 h. After treatment, cells were immunostained with CD31, DAPI or phalloidin, and harvested for RNA sequencing to access changes in gene expression. Staining results showed a reduction in CD31 expression accompanied by an increase in phalloidin staining intensity in both mouse ECs and HBMVECs after Tat exposure. Moreover, the phalloidin staining revealed disruption of actin cytoskeleton structure in both mouse ECs and HBMVECs after Tat exposure. RNA sequencing analysis of mouse ECs and HBMVECs exposed to Tat displayed strikingly comparable transcriptomic signatures, as confirmed by gene set enrichment analysis (GSEA). In particular, both mouse ECs and HBMVECs showed significant upregulation of hallmark inflammatory response pathways following Tat exposure. These findings provide mechanistic insight into HIV-1 Tat drives endothelial injury, leading to both morphological and transcriptional alterations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/655a47e4407da6f7843fa80d27e1cede82554a3e" target='_blank'>
              HIV-1 Tat Protein Exposure Alters the Morphological Characteristics and Gene Expression in the Primary Mouse Cortex Endothelial Cells and Human Brain Microvascular Endothelial Cells
              </a>
            </td>
          <td>
            Lili Quan, I. Manabe, Rieko Muramatsu, Jun Zhu
          </td>
          <td>2025-12-06</td>
          <td>Cellular and Molecular Neurobiology</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1908b3b3226f8c7878c6e6b6c337b73f90a53429" target='_blank'>
              Dual-function cytokines as modulators of autophagy: reprogramming inflammatory resolution in severe COVID-19
              </a>
            </td>
          <td>
            Sohrab Khan, Ping Tang, Pingchang Yang, Jing Li, Haiqiang Wu
          </td>
          <td>2026-01-08</td>
          <td>Inflammation Research</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="ABSTRACT Astrocytes are central to lipid metabolism in the central nervous system. Due to their morphological and functional characteristics, astrocytes can uptake fatty acids (FAs) from the bloodstream and extracellular space and store them in lipid droplets (LD). LD are dynamic organelles, whose accumulation in astrocytes has been shown to occur upon exposure to various stress stimuli. Different hypotheses proposed to explain motor neuron degeneration in amyotrophic lateral sclerosis (ALS) implicate mitochondrial dysfunction and oxidative stress. Mitochondrial dysfunction in astrocytes is associated with elevation of cytoplasmic lipids and lipid‐binding proteins. We observed increased LD in the spinal cord of symptomatic ALS mice, as well as in human transdifferentiated astrocytes obtained from ALS patients. Using a co‐culture model, we examined the effect of FA overload and its impact on astrocyte–motor neuron interaction. LD accumulation was tightly coupled with an NF‐κB‐driven proinflammatory response in nontransgenic astrocytes, correlating with motor neuron toxicity. These results provide additional evidence to the notion that altered energy balance may contribute to neuronal death in ALS. Furthermore, pharmacological inhibition of lactate dehydrogenase (LDH) reversed LD accumulation in mouse and human astrocytes expressing ALS‐linked mutations. Genetic ablation of LDHA similarly reduced LD accumulation in response to FA treatment. Collectively, our data underscore the role of lipid metabolism in astrocyte–neuron interactions in ALS models and suggest that LD accumulation, rather than serving solely as a protective mechanism, reflects a metabolic stress state linked to a detrimental phenotypic transformation in astrocytes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5605fe78a98aec0380a589f4afae28a324a82f4d" target='_blank'>
              Lactate Dehydrogenase Inhibition Reverts the Fatty Acid‐Induced Neurotoxic Phenotype of Astrocytes
              </a>
            </td>
          <td>
            Daniel Esteve, Mariana Bresque, Daniel Okhuevbie, Sandhya Ramachandran, Mariana Pehar, Marcelo R. Vargas
          </td>
          <td>2026-01-06</td>
          <td>Glia</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="
 Microglia, the resident immune cells of the central nervous system (CNS), play a pivotal role in health and disease maintaining homeostasis and mediating neuroinflammatory responses. Their activation is a dynamic and context-dependent process characterized by diverse phenotypic states defined by transcriptomic, proteomic, and morphological characteristics. While lipopolysaccharide (LPS) is widely used as an inflammatory stimulus in microglial research, its physiological relevance remains debated. Interferon gamma (IFNγ), a key pro-inflammatory cytokine involved in immune priming, more closely mimics CNS inflammatory conditions. In this study, we systematically investigated the temporal activation profiles of human iPSC-derived microglia (hiMG) in response to LPS, IFNγ, and their combination. Transcriptomic analysis at 24 h revealed robust differential gene expression, with over 7,000 genes altered by LPS and more than 8,500 by LPS/IFNγ co-stimulation. These profiles partially overlapped with disease-associated microglia (DAM) signatures, including upregulation of
 S100A9
 ,
 CD44
 ,
 ACSL1
 , and
 HIF1A
 , and downregulation of
 TREM2
 ,
 GPNMB
 ,
 FABP3
 ,
 LGMN
 , and
 LPL
 . Cytokine expression changes were detectable as early as 1 h post-treatment, predominantly following LPS exposure, and displayed distinct early (≤2 h), mid (4–12 h), and late (24–96 h) temporal patterns. IFNγ alone induced modest transcriptomic and cytokine responses but contributed to sustained inflammatory signatures when combined with LPS. Morphological analysis showed marked LPS- and LPS/IFNγ-induced structural remodeling of hiMG consistent with activation. To assess protein-level dynamics, targeted mass spectrometry quantified secreted ApoE, CD44, FUCA1, Galectin-3, and Osteopontin, all relevant to microglial activation, which were compared to cellular protein expression measured by western blot. Time-dependent increases were most prominent following LPS and LPS/IFNγ treatment, although secreted Osteopontin levels were highest with IFNγ alone, highlighting stimulus-specific effects. Collectively, these data demonstrate that microglial activation is highly time- and stimulus-dependent, with LPS eliciting the strongest responses, and IFNγ modulating these effects. Our findings underscore the importance of temporal resolution in modeling microglial activation and provide insight into the mechanistic underpinnings of microglial activation relevant to neurodegeneration and therapeutic targeting.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ecfc039046b3ca19a9e392eb4db5e460c2d2f4eb" target='_blank'>
              The temporal and stimuli-specific effects of LPS and IFNγ on microglial activation
              </a>
            </td>
          <td>
            Christina N. Heiss, Andrew S. Naylor, Ida Pesämaa, Arketa Meshi, Benjamin Céspedes-Cortés, Chiméne Lounès, Ayat Taki, Katarina Türner Stenström, D. Vizlin-Hodzic, Henrik Zetterberg, Verónica Palma, G. Brinkmalm, A. Brinkmalm, Stefanie Fruhwürth
          </td>
          <td>2026-01-29</td>
          <td>Frontiers in Aging Neuroscience</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="Dengue virus (DENV) is an important human pathogen that infects millions of people each year and can cause diseases such as dengue haemorrhagic fever and dengue shock syndrome. Despite the efforts of the immune system to control the innate and adaptive immune responses to the virus, DENV escapes from immune responses using complex and multiple mechanisms. In certain cases, these immune evasion strategies may also contribute to the neurotropic potential of DENV, facilitating its ability to invade or affect CNS. This narrative review summarises the current knowledge by focusing on major immune evasion pathways of dengue virus at three levels of innate, adaptive and effector mechanisms, including inhibition of interferon production, disruption of immunological signalling pathways, regulation of proliferation proteins and inhibition of effector cells. The aim of this review is to collect, compare and describe all the ways in which this virus evades immunity, which will help identify knowledge gaps for future research and subsequently guide the development of effective vaccines and therapeutics.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3a3900b5a7b973b8eb4ad3a6e518ae430ffa1de9" target='_blank'>
              Immune Evasion Mechanisms of Neurotropic Dengue Virus
              </a>
            </td>
          <td>
            Ahmed M. Basri, Mona M Almramhi, Wajnat A. Tounsi, Ammar A Basabrain, Amany I. Almars
          </td>
          <td>2025-12-13</td>
          <td>Reviews in Medical Virology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Background The host response to SARS-CoV-2 depends on multiple factors including age, gender, underlying diseases and genetic background. Viral sensing and activation of the interferon signaling pathway in the early antiviral response could affect disease outcome. This study evaluated gene expression of Toll-like receptor 7 (TLR7), tyrosine kinase 2 (TYK2) and 2’-5’ oligoadenylate synthetase 1 (OAS1) in two early longitudinal samples from mild, moderate and severe cases. Methods Demographic and clinical variables were obtained from 157 COVID-19 patients. Peripheral blood mononuclear cells were used for genotyping and gene expression determination, and plasma for viremia detection, by qPCR and digital PCR, respectively. Gene expression was analyzed using Generalized Linear Mixed Models nested by patient. First, univariate analyses determined which variables were significantly associated with gene expression. Next, multivariate models were built with these variables, following the backward method. Results TLR7 levels were higher in patients with mild disease compared to those with moderate disease and decreased over time. In contrast, patients with severe disease had lower TLR7 expression, which remained stable. OAS1 behavior was similar, whereas TYK2 remained unchanged. Multivariate analysis confirmed the relation of low TLR7 expression with severity and viremia. OAS1 levels directly correlated with higher viremia. TYK2 was associated with OAS1 expression, and OAS1 with both TLR7 and TYK2 levels. Conclusions Low TLR7 levels were associated with severe COVID-19, and together with OAS1 expression were modulated over time according to severity. While TLR7 expression decreased across all severity groups as the disease resolved, OAS1 expression persisted in severe cases with higher viremia.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fa069123cd3aa2607cda4c137a1e8f7972b1b186" target='_blank'>
              Modulation of TLR7, TYK2 and OAS1 expression during SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Estíbaliz Alegría-Carrasco, Marta Jaén-Castaño, Pablo Delgado-Wicke, Nelly D. Zurita-Cruz, Nuria Montes, Emilia Roy-Vallejo, Sara Fernández de Córdoba-Oñate, Ana Nicolao-Gómez, Rosa Carracedo-Rodríguez, A. Marcos-Jiménez, Laura Cardeñoso-Domingo, Isidoro González-Álvaro, Elena Fernández-Ruiz
          </td>
          <td>2025-12-09</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d7e50479312e2bd855533d1f22c1060db4197b2e" target='_blank'>
              Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression
              </a>
            </td>
          <td>
            P. Hoover, T. Eisenhaure, J. Hodgin, W. Apruzzese, Joseph R. Mears, Michael Peters, Tony Jones, Sujal I. Shah, Haniya Kamal, Rollin Leavitt, Shaun W. Jackson, Patrick Danaher, Deepak A. Rao, Qian Xiao, Siddarth Gurajala, Andrea Fava, C. Berthier, Alice Horisberger, P. Izmirly, H. Michael Belmont, R. Clancy, R. Furie, Joel Guthridge, M. Dall'Era, D. Wofsy, D. Kamen, Kenneth C. Kalunian, Maureen A. McMahon, Jennifer Grossman, F. Payan-Schober, Dave Hildeman, E. Steve Woodle, Chaim Putterman, M. Kretzler, Soumya Raychaudhuri, Judith A. James, J. Anolik, Michelle A. Petri, Jill P Buyon, Betty Diamond, A. Davidson, N. Hacohen, A. Arazi
          </td>
          <td>2025-12-19</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>118</td>
        </tr>

        <tr id="Alcohol misuse is twice as prevalent among people living with HIV (PWH), and this increases the risk of pulmonary complications even in those receiving antiretroviral therapy. Our prior work showed that the alcohol metabolite, acetaldehyde, activates nuclear factor kappa B p65 (p65), leading to HIV replication and interleukin (IL)-1β activation in alveolar macrophages (AMs). Since the aforementioned processes are energy-demanding, which conversely impair mitochondrial functions, we hypothesized that acetaldehyde-induced p65 drives AMs to a mitochondrial hyperactive state to promote HIV replication and IL-1β release and induces oxidative stress and mitochondrial dysfunction. Since we found pioglitazone (PIO) to be a negative regulator of p65, we postulate that PIO suppresses HIV replication and IL-1β activation in AMs by restricting p65-induced mitochondrial hyperactivation. Murine AMs were exposed to acetaldehyde via the acetaldehyde generating system (AGS) and infected in vitro with EcoHIV, a chimeric ecotropic HIV construct. AGS + EcoHIV activated p65, resulting in enhanced ATP-linked mitochondrial respiration, proton leak, non-mitochondrial respiration and the generation of reactive oxygen species (ROS) in AMs. Inhibition of mitochondrial ATP synthesis with low-dose oligomycin attenuated AGS-induced HIV replication and AGS + EcoHIV-induced IL-1β release from AMs. PIO treatment, which attenuated AGS-induced p65 activation, suppressed proton leak, non-mitochondrial oxygen consumption, ROS, and IL-1β and p24 release. While p65-induced mitochondrial hyperactivation represents AMs’ adaptive response to the energy demands imposed by HIV replication and proinflammatory activation when exposed to acetaldehyde, PIO treatment may offer a novel therapeutic strategy to restore adequate mitochondrial bioenergetics in the AMs of PWH who misuse alcohol.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e248e5ba7602c18ae3fff3dd9aeb0e4be9937680" target='_blank'>
              Pioglitazone Modulates p65-Mediated Mitochondrial Bioenergetics: Implications for Acetaldehyde-Induced HIV Replication in Alveolar Macrophages
              </a>
            </td>
          <td>
            M. New-Aaron, Sarah S Chang, Xian Fan, Ashish Mehta, Sara C. Auld, B. Staitieh, Michael Koval, Samantha M. Yeligar
          </td>
          <td>2025-12-01</td>
          <td>Biomolecules</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/62a04a0381701a296bb8ca11863bbc1a7909a057" target='_blank'>
              IFITM3 deficiency drives SARS-CoV-2 adaptation while preserving variant-specific traits.
              </a>
            </td>
          <td>
            Parker J. Denz, Samuel Speaks, Matthew I McFadden, Jana M. Cable, Ahmed K Aladhami, Jonathan L. Papa, R. Rayner, Prerana R Rao, Steve Leumi, Jack E Roettger, M. Dhariwala, E. Cormet-Boyaka, Adriana Forero, Jacob S. Yount
          </td>
          <td>2026-01-29</td>
          <td>Nature communications</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="The Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is characterized by profound immune dysregulation where interleukins play a central role in determining disease severity and response to interventions. This review summarizes the role of interleukins in the immunopathogenesis of COVID-19, with particular emphasis on differences observed across major SARS-CoV-2 variants. Pro-inflammatory interleukins like IL-1β, IL-6, IL-2, IL-17 and IL-18 are critically involved in cytokine storm, hyperinflammation, and acute respiratory distress syndrome, whereas anti-inflammatory cytokines like IL-10 contribute to immune regulation and resolution of inflammation. Elevated levels of IL-1α, IL-1β, IL-4, IL-8, IL-9, IL-16, IL-18 have been documented in the Delta variant as compared with the Omicron variant, with IL-6 being the most frequent interleukin reported to be increased across all SARS-CoV-2 variants relative to the ancestral Wuhan strain. Elevated IL-2, IL-4, IL-6, and IL-10 levels have been associated with Omicron sub-variants. The review encompasses interleukin-based therapeutic strategies, where several IL-1 and IL-6 inhibitors were studied across clinical trials, but only tocilizumab has shown some promise against severe COVID-19. IL-2, IL-6, IL-15 and IL-21 levels were positively correlated with IgG and neutralizing antibody activity after vaccination with longevity of post-vaccination immunity being determined by IL-2 and IL-7.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2c954fc0069a67c9a88349d51dbdf125e173004d" target='_blank'>
              Interleukins in COVID-19 and SARS-CoV-2 Variants: Immunopathogenesis, Therapeutic Perspectives and Vaccine-Induced Immune Responses
              </a>
            </td>
          <td>
            Supriya Mahajan, Saurabh Mahajan, Akanksha Gusain
          </td>
          <td>2026-01-30</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/31b66cdc5218c0816b0bd18cc296ad74d29aceff" target='_blank'>
              Immune dysregulation triggered by inflammatory cytokines in patients with severe respiratory infections.
              </a>
            </td>
          <td>
            Jingwei Li, Shufan Liang, Yalun Li, Jiayang Wu, Changshu Li, Jiadi Gan, Weimin Li, Chengdi Wang
          </td>
          <td>2026-01-15</td>
          <td>Respiratory research</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="ABSTRACT Rett syndrome (RTT) is a rare neurodevelopmental disorder of genetic origin characterized by chronic low-grade inflammation, immune imbalance, and frequently associated with compromised respiratory function. During the COVID-19 pandemic, individuals with RTT were classified as high-risk and invited to follow stringent vaccination protocols that included multiple booster doses. However, the immune response elicited by vaccination in this population has never been systematically investigated. Here, we provide the first characterization of spike-specific antibody and memory B cell responses in 23 RTT patients following two or three doses of SARS-CoV-2 mRNA vaccines. RTT patients developed spike-specific IgG levels comparable to those observed in healthy female controls (GMT 8476 [range 5120–20480] and 9213 [640–81920] after the first two vaccine doses, respectively). The frequencies and phenotype of spike-specific memory B cells were also similar between RTT and controls (mean frequency of 1.3 ± 0.6 and 1.6 ± 1.1, respectively) and these cells displayed functional reactivity upon antigenic stimulation in vitro. The assessment of vaccine-induced immunity in RTT addresses a critical knowledge gap by demonstrating the ability of these patients to develop an immune response to mRNA vaccination, thereby providing insights that may inform tailored vaccination strategies and improve understanding of immune competence in this rare disorder.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2eba99d0500e7de7504115b97b3dd188eac68c92" target='_blank'>
              Unexpectedly competent immune response to SARS-CoV-2 vaccination in Rett syndrome
              </a>
            </td>
          <td>
            Ludovica Soldateschi, S. Leoncini, F. Fiorino, S. Lucchesi, Jacopo Polvere, Lidia Boasiako, Gabiria Pastore, Caterina Fazzi, Marilyn T. Altamura, Valeria Scandurra, Salvatore Grosso, F. Montagnani, Claudio De Felice, Annalisa Ciabattini, D. Medaglini
          </td>
          <td>2026-01-28</td>
          <td>Human Vaccines & Immunotherapeutics</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="Chronic HIV infection drives B cell dysfunction associated with the accumulation of tissue-like memory (TLMs) and activated memory B cells (MBCs) but decline in resting memory B cells. TLMs express multiple inhibitory receptors and lack response to soluble antigens. However, their origin and the mechanisms driving their expansion in HIV infection remain unclear. From bulk heavy chain BCR sequencing of MBC subsets from 5 PLWH with no detectable viremia, we hypothesized that TLMs (CD21- CD27- B cells) were significantly less mutated but also less diverse than other MBCs, suggesting an enrichment for innate-like B cells or that they belong to a less mature subset. Subsequent detailed multi-omics study of an immune response to a transient HIV viremia in an elite controller demonstrated a functional increase in Env-reactive IgG and MBCs with non-TLM phenotype. Single-cell RNA/BCR sequencing of PBMCs enriched for B cells revealed an orchestrated TNF-α response followed by interferon-α and -γresponses across all B cell subsets. This study provides new insights into multifaceted functional B cell response to transient HIV viremia and highlights TLM heterogeneity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/46013734e573b53cbb67c0c4d1938bb50c8f4ad7" target='_blank'>
              Multifaceted B cell response to transient HIV viremia in elite controllers.
              </a>
            </td>
          <td>
            L. Muir, Ondrej Suchanek, Peter Thomas, Sarah A. Griffith, E. Touizer, C. Rees-Spear, Robert Krause, M. Yoshida, C. Pinder, Rutuja Patil, Marko Z. Nikolić, K. Doores, M. V. van Gils, A. Leslie, A. Sigal, Ravindra K. Gupta, M. Clatworthy, Laura E McCoy
          </td>
          <td>2026-01-16</td>
          <td>PLoS pathogens</td>
          <td>0</td>
          <td>59</td>
        </tr>

        <tr id="Dendritic cells (DCs) play a central role in both the development and maintenance of adaptive immunity by their ability to prime and regulate T cell function. These interactions between DCs and T cells are crucial to the pathogenesis of multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). Myeloid differentiation primary response protein 88 (MyD88) signalling is pivotal in the pathogenesis of MS and EAE; however, its specific contributions across various cell types in the context of these conditions remain inadequately understood. In this study, we reanalysed single-cell RNA sequencing data from MS patients and revealed significant upregulation of MYD88 in DCs and CD4+ T cells isolated from PBMCs of MS patients. Single-cell RNA sequencing analysis revealed that during the peak phase of EAE, Myd88 is highly expressed in moDCs and pDCs compared to cDCs. Notably, the absence of Myd88 in DCs resulted in significantly reduced interactions with T cell clusters. Our in vivo and in vitro results showed that while MyD88 deficiency did not affect lymphocyte production in the thymus, it resulted in impaired Th1 and Th17 cell differentiation and diminished T cell activation. Mechanistically, MyD88-/- DCs exhibited impaired maturation and a reduced production of pro-inflammatory cytokines, such as IL-6, TNF-α, and IL-12, which may be linked to their role in directing Th1 and Th17 cell differentiation. Our findings suggest that MyD88 is essential for the priming of inflammatory T cells and the activation of DCs, and their interactions with T cells, underscoring its role in neuroinflammation. This study highlights the potential therapeutic implications of targeting MyD88 pathways in MS and related disorders.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/07143d3aea4af59d5ef86ee7d3bbbaf941891061" target='_blank'>
              MyD88 Deficiency Protects Mice From Experimental Autoimmune Encephalomyelitis by Influencing Both Dendritic Cells and T Cells.
              </a>
            </td>
          <td>
            Wen Si, Gaochen Zhu, Qianling Jiang, Xin Ma, Guan Yang
          </td>
          <td>2025-12-09</td>
          <td>Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/29fe25ea72e27bc7febd50ceacab0f0b8d2a1098" target='_blank'>
              SARS-CoV-2 infection and gut-lung axis: the potential role of rifaximin
              </a>
            </td>
          <td>
            T. N. Almanaa, H. Al-kuraishy, A. Al-Gareeb, Maii A. Abdelnaby, A. Alexiou, M. Papadakis, Islam E Abo-ElFetoh, G. Batiha
          </td>
          <td>2025-12-18</td>
          <td>Inflammopharmacology</td>
          <td>0</td>
          <td>53</td>
        </tr>

        <tr id="BACKGROUND: Severe COVID-19 is characterized by profound immune system disturbances, a key component of which is lymphopenia. A detailed comparative characterization of changes in the T-lymphocyte subpopulations in patients with different disease severities remains an important task for identifying prognostic markers and understanding the pathogenesis. 
AIM: To perform a comparative analysis of the absolute counts of the main T-lymphocyte subpopulations (CD3⁺, CD4⁺, CD8⁺) and their ratio in patients with moderate and severe COVID-19, in order to identify immunological markers associated with disease progression. 
METHODS: A single-center, prospective, comparative, observational study was conducted on a cohort of 89 hospitalized patients with confirmed SARS-CoV-2 infection who provided informed consent. Patients were divided into two groups: 66 patients with moderate disease and 23 patients with severe disease requiring invasive mechanical ventilation (IMV). The absolute counts of CD4+ and CD8+ lymphocytes were determined in whole blood using flow cytometry. Statistical analysis was performed using the Mann-Whitney U test. 
RESULTS: Patients with the severe form of COVID-19 showed a significant (p 0.001) decrease in the absolute counts of both CD4+ and CD8+ lymphocytes compared to the moderate group. The median value of CD4+ cells in the severe group was 222 [135; 446] cells/μl, which was more than 3 times lower than in the comparison group (750 [470; 1061] cells/μl). The CD8+ lymphocyte count was also significantly lower (98 [72; 275] cells/μl vs. 337 [238; 444] cells/μl). However, no statistically significant differences in the CD4+/CD8+ ratio were found between the groups (p = 0.073). 
CONCLUSION: Severe COVID-19 is associated with profound combined suppression of both helper and cytotoxic arms of cellular immunity, without a significant change in the immunoregulatory index. The absolute counts of CD4+ and CD8+ lymphocytes can serve as objective laboratory markers for risk stratification and assessment of disease severity in patients with COVID-19, which is important for timely clinical management.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e5843169aaf70a97c18dc7ea65409d921ec052e0" target='_blank'>
              Comparative Characteristics of the T-Lymphocyte Subpopulation Composition in Patients with Moderate and Severe Forms of COVID-19
              </a>
            </td>
          <td>
            L. Anisko, Igor Karpov
          </td>
          <td>2025-12-31</td>
          <td>Epidemiology and Infectious Diseases</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Significance Persistent neurological disease after COVID-19 is a major problem, yet the underlying mechanism is unclear. Using mouse-adapted SARS-CoV-2, we show that infection confined to the respiratory tract triggers long-lasting loss of dopaminergic neurons in the olfactory bulb and substantia nigra, mirroring pathology in COVID-19 decedents. These deficits arise without viral persistence but with sustained microglial activation and inflammatory gene expression resembling human neurodegenerative disease. Behavioral analyses reveal corresponding neurobehavioral impairments. Antiviral therapy alone fails to prevent most of these effects, whereas combining antivirals with corticosteroids, even when initiated three days after infection, restores behavioral function. These findings identify inflammation as the major driver of post-COVID neurological sequelae and suggest early immunomodulation as an effective intervention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b584d18974b0aa971de59c6e27544a571d208d19" target='_blank'>
              Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection
              </a>
            </td>
          <td>
            A. Verma, Lu Tan, Noah Schuster, Skyler L Moye, Li-Chun Lin, Shearon A. Lowery, Eazhisaivallabi Duraisami, Juan E Abrahante Lloréns, Qiang Qiu, Marco Hefti, D. K. Meyerholz, Mitchell C Coleman, C. R. Yu, Mark W Albers, Stanley Perlman
          </td>
          <td>2026-01-07</td>
          <td>Proceedings of the National Academy of Sciences of the United States of America</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Abstract Objectives Human immunodeficiency virus 1 (HIV-1)-associated neurocognitive disorders (HAND) persist despite antiretroviral therapy (ART), driven by ongoing neuroinflammation and metabolic dysfunction. This study assesses whether chemical exchange saturation transfer (CEST) MRI can detect HIV-1–induced neurometabolic impairments and ART-mediated improvements in a humanized mouse model. Methods HIV-1–infected CD34-NSG mice underwent CEST MRI at baseline (Week 0), 6 weeks post-infection (6 WPI), and after 6 weeks of ART or vehicle treatment (12 WPI). CEST contrast was quantified at 2 ppm (creatine-related), 3 ppm (glutamate-related), and −3.5 ppm (nuclear Overhauser effect, NOE). Neuroinflammation and infection were evaluated using immunohistochemistry and qPCR. Results At 6 WPI, HIV-1 infection reduced 2-ppm CEST contrast in the cortex and hippocampus and increased NOE in the cortex. By 12 WPI, vehicle-treated mice showed decreased 3-ppm contrast in the cortex, hippocampus, and piriform cortex, whereas ART restored contrast in the cortex and hippocampus. Vehicle-treated mice also showed reduced 2-ppm contrast in the cortex, hippocampus, piriform cortex, and thalamus; ART restored this in the hippocampus, piriform cortex, and thalamus. Increased NOE at −3.5 ppm was observed but did not show measurable improvement following ART. CEST alterations corresponded with decreased HIV-1 p24+ cells and reduced neuroinflammatory markers in ART-treated brains. Conclusions CEST MRI detects region-specific metabolic abnormalities during HIV-1 infection and region-specific metabolic recovery with ART, consistent with reduced viral burden and neuroinflammation. These findings support CEST MRI as a promising non-invasive biomarker for monitoring treatment response and disease progression in neuroHIV.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/909a9f04153639bfbf05bd9eecf72b47e25676dc" target='_blank'>
              CEST MRI assessment of HIV-1-associated neurometabolic impairments in a humanized mouse model
              </a>
            </td>
          <td>
            Gabriel C. Gauthier, Micah Summerlin, B. Sajja, Mariano Uberti, Emma G Foster, Manjeet Kumar, Matthew Thiele, S. Gorantla, Aditya N. Bade, Yutong Liu
          </td>
          <td>2025-12-29</td>
          <td>NeuroImmune Pharmacology and Therapeutics</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="BACKGROUND
Sepsis is a global health challenge associated with high morbidity and mortality rates. Early diagnosis and treatment are challenging because of the limited understanding of its underlying mechanisms. This study aimed to identify effective biomarkers for diagnosing and treating sepsis through an integrated multi-method approach.


METHODS
Publicly available single-cell RNA sequencing (scRNA-seq) and bulk RNA-seq datasets were analyzed for naive CD4+ T cell-specific genes. Based on these hub genes, Mendelian randomization (MR) analysis, followed by the MR-Bayesian model averaging (MR-BMA) algorithm, was implemented to explore the causality between these genes and sepsis. In addition, single-cell-type expression analysis, cell-cell communication detection, metabonomic evaluation, clinical samples, and both in vivo and in vitro studies were conducted to unveil the underlying mechanisms of potential therapeutic targets.


RESULTS
scRNA-seq revealed significant depletion of naive CD4+ T cells in sepsis, identifying 33 key genes. Both MR and MR-BMA analyses confirmed that elevated proportion of naive CD4+ T cell in total CD4+ T cells (naive CD4+ T cell % CD4+ T cell) were related to sepsis occurrence (odds ratio [OR] = 0.90, 95% confidence interval [CI], 0.83-0.97, P = 0.007) and 28-day mortality associated with sepsis (OR = 0.75, 95% CI, 0.64-0.88, P <0.001). Notably, among the 33 hub genes, PC-esterase domain containing 1B (PCED1B) exhibited a strong causal association with 28-day mortality in patients with sepsis (OR = 0.64, 95% CI, 0.51-0.81, P <0.001), which was further validated by bulk RNA-seq analysis. PCED1B mediated the impact of proportion of naive CD4+ T cell in CD4+ T cell on sepsis-related mortality. In addition, clinical samples and both in vivo and in vitro experiments validated the elevated expression of PCED1B in naive CD4+ T cells derived from sepsis patients and mice. Mechanistic investigations revealed PCED1B+ CD4+ T cells may interact with monocytes/dendritic cells through the MIF-(CD74+CD44) axis, concurrently engaging with B cells/plasmablasts through the MIF-(CD74+CXCR4) axis, thereby regulating multiple metabolic alterations in sepsis.


CONCLUSION
The interplay between PCED1B and naive CD4+ T cells, as revealed by this study, is instrumental in developing immunotherapeutic strategies for sepsis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c186c074def1f10bd7da9400d2880c5fca5e3b66" target='_blank'>
              Protective role of PCED1B-expressing naive CD4+ T cells in sepsis.
              </a>
            </td>
          <td>
            Weifeng Shang, Hang Qian, Dongjie Chen, Sheng Zhang, Xiaojun Pan, Sisi Huang, Zhenliang Wen, Jiao Liu, Dechang Chen
          </td>
          <td>2026-01-06</td>
          <td>Chinese medical journal</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="Background: Dendritic cell (DC) maturation is traditionally triggered by pathogen-associated molecular patterns (PAMPs) through Toll-like receptors. However, emerging evidence suggests that the cytokine interleukin-1β (IL-1β) can act independently of PAMPs to drive DC activation and T cell priming. Objectives: This study aimed to perform a comparative transcriptomic analysis of IL-1β- and R848-induced maturation in human DCs to uncover shared and distinct molecular signatures underlying these activation pathways. Materials and Methods: RNA-seq data from dataset GSE108526 were analyzed following normalization and quality control. Differential gene expression was assessed using a linear model incorporating both treatment type and timepoint as factors. Functional enrichment analyses were conducted to identify pathways and biological processes enriched under each condition. Results: Both IL-1β and R848 activated core immune response programs, yet exhibited distinct transcriptional emphases. IL-1β preferentially upregulated genes associated with cytokine regulation, surface receptor signaling, and cell communication, whereas R848 induced stronger interferon-stimulated gene networks and antiviral defense pathways. Comparative visualization of key maturation, cytokine, and IL-2 receptor genes revealed overlapping but stimulus-specific expression profiles. Conclusions: The findings highlight that IL-1β can substitute for PAMPs in inducing DC activation, yet orchestrates a unique immune transcriptional landscape. This suggests a specialized immunomodulatory potential for IL-1β distinct from classical TLR-mediated pathways.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/93cd6452eeed9ea5e0ff91ba455fa6a8675fb0ce" target='_blank'>
              Comparative Transcriptomic Profiling Identifies IL-1β as a Non-Canonical Driver of Human Dendritic Cell Maturation
              </a>
            </td>
          <td>
            Vural Yilmaz
          </td>
          <td>2026-01-01</td>
          <td>Iranian Journal of Biotechnology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Intracellular pathogens must evade cytotoxic immunity to establish persistent infection. Although immune escape is typically viewed through a biochemical lens, the ability of certain pathogens to alter the mechanical properties of infected cells suggests that biophysical mechanisms may also contribute to the process. Here, we show that a subset of CD4+ T cells infected with the human immunodeficiency virus (HIV) resist elimination through a soft phenotype that inhibits killing by mechanosensitive cytotoxic T lymphocytes (CTLs). This phenotype arises from the combined effects of the HIV virulence factor Nef, which remodels the actin cytoskeleton, and intrinsic heterogeneity in the basal cytoskeletal properties of infected T cells. Pharmacological or genetic perturbations that reverse Nef signaling to the cytoskeleton or that stiffen the filamentous-actin cortex sensitize infected cells to CTL-mediated lysis. Taken together, these findings define a novel, biophysical paradigm of immune evasion with implications for HIV cure strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1a4f51743a919ef271e4cd1d83a51db2f6165482" target='_blank'>
              HIV Nef amplifies mechanical heterogeneity to promote immune evasion
              </a>
            </td>
          <td>
            Louise Leyre, Farah Mustapha, Alberto Herrera, Esther Lee, Emily Huntsman, P. Zumbo, J. Weiler, Parul Sinha, Ethan Naing, Connor Smith, Colin C. Kovacs, Micheal Galiano, Nada Wahman, D. Betel, Kiera L. Clayton, Morgan Huse, R. B. Jones
          </td>
          <td>2025-12-26</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>41</td>
        </tr>

        <tr id="Cytoplasmic RNA serves as a typical damage-associated molecular pattern (DAMP) signal; yet the mechanisms governing its release and role in inflammatory tissue damage remain poorly understood. In our study, we demonstrated that mimicking bacterial infection by lipopolysaccharide (LPS) combined with Nigericin (Ng) effectively activates Gasdermin D (GSDMD). Conversely, Vesicular Stomatitis Virus (VSV) selectively activates Gasdermin E (GSDME). Both GSDMD and GSDME form pores in the mitochondrial membrane, facilitating the release of mitochondrial RNA (mtRNA) into the cytosol. This released mtRNA is recognized by the RNA sensor Viral Interferon Stimulated Gene Activator (VISA), which subsequently induces a robust secondary inflammatory response. Importantly, the inhibition of GSDMD and GSDME prevents mitochondrial dysfunction and mtRNA release, thereby attenuating secondary inflammatory response mediated by the VISA pathway. Utilizing an experimental mice model, we found that LPS-induced lung tissue inflammation was restored by VISA knockout (VISA-/-) mice. Our findings highlight the potential targeting of GSDMD, GSDME, or VISA pathway signaling as a therapeutic strategy to modulate mtRNA-mediated inflammatory responses in microbial infectious diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/06ac5f5838f73012bb382ecd48202f655725c473" target='_blank'>
              The role of gasdermin-mediated mitochondrial RNA release in amplifying secondary immune response during microbial infection
              </a>
            </td>
          <td>
            Uzair Afaq, Muhammad Suhaib Qudus, Siyu Liu, Kailang Wu, Yu Chen, Mingfu Tian, Jianguo Wu
          </td>
          <td>2026-01-02</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>38</td>
        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

</body>

<script>

  function create_author_list(author_list) {
    let td_author_element = document.getElementById();
    for (let i = 0; i < author_list.length; i++) {
          // tdElements[i].innerHTML = greet(tdElements[i].innerHTML);
          alert (author_list[i]);
      }
  }

  var trace1 = {
    x: ['2025', '2026'],
    y: [4, 3],
    name: 'Num of citations',
    yaxis: 'y1',
    type: 'scatter'
  };

  var data = [trace1];

  var layout = {
    yaxis: {
      title: 'Num of citations',
      }
  };
  Plotly.newPlot('myDiv1', data, layout);
</script>
<script>
var dataTableOptions = {
        initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;

                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);

                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';

                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    scrollX: true,
    scrollCollapse: true,
    paging: true,
    fixedColumns: true,
    columnDefs: [
        {"className": "dt-center", "targets": "_all"},
        // set width for both columns 0 and 1 as 25%
        { width: '7%', targets: 0 },
        { width: '30%', targets: 1 },
        { width: '25%', targets: 2 },
        { width: '15%', targets: 4 }

      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  }
  new DataTable('#table1', dataTableOptions);
  new DataTable('#table2', dataTableOptions);

  var table1 = $('#table1').DataTable();
  $('#table1 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table1.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
    }
  });
  var table2 = $('#table2').DataTable();
  $('#table2 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table2.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
    }
  });
</script>
<style>
  .child-row-content {
    text-align: justify;
    text-justify: inter-word;
    word-wrap: break-word; /* Ensure long words are broken */
    white-space: normal; /* Ensure text wraps to the next line */
    max-width: 100%; /* Ensure content does not exceed the table width */
    padding: 10px; /* Optional: add some padding for better readability */
    /* font size */
    font-size: small;
  }
</style>
</html>







  
  




  



                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8v12Z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    <script id="__config" type="application/json">{"base": "..", "features": ["navigation.top", "navigation.tabs"], "search": "../assets/javascripts/workers/search.b8dbb3d2.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script>
    
    

      <script src="../assets/javascripts/bundle.c8d2eff1.min.js"></script>
      
    
<script>
  // Execute intro.js when a button with id 'intro' is clicked
  function startIntro(){
      introJs().setOptions({
          tooltipClass: 'customTooltip'
      }).start();
  }
</script>
<script>
  

  // new DataTable('#table1', {
  //   order: [[5, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });

  // new DataTable('#table2', {
  //   order: [[3, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });
  new DataTable('#table3', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
  new DataTable('#table4', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
</script>


  </body>
</html>